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Proteinaceous infectious particles, termed “prions” are self-perpetuating protein 
isoforms that transmit neurodegenerative diseases in mammals and phenotypic traits in 
yeast. Each conformational variant of a prion protein is faithfully propagated to a 
homologous protein in the same cell environment. However, a reduction in the efficiency 
of prion transmission between different species is often observed and is termed “species 
barrier.” Prion transmission to a heterologous protein may, in some cases, permanently 
change the structure of the prion variant, and divergent proteins may interfere with prion 
propagation in a species-specific manner. To identify the importance of both protein 
sequence and the cell environment on prion interference and cross-species transmission, 
we employed heterologous Sup35 proteins from three Saccharomyces sensu stricto 
species: Saccharomyces cerevisiae (Sc), Saccharomyces paradoxus (Sp), and 
Saccharomyces bayanus (Sb). We performed our experiments in two different cell 
environments (Sc and Sp). Our data show that Sup35 from one species can form a prion 
in another, and we employed a transfection procedure to perform cross-species transfer of 
the prion. Using a shuffle procedure, we demonstrate that the specificity of prion 
transmission is determined by the protein itself rather than by the cell environment. 
Interestingly, we noted that variant-specific prion patterns can be altered irreversibly 
during cross-species transmission through S. bayanus module II. We further show that 
prion interference does not always correlate with cross-species prion transmission, and 
the identity of particular regions or even a specific amino acid, rather than the overall 
level of PrD homology is crucial for determining cross-species transmission and 
xvii 
 
interference. Lastly we provide evidence to suggest that prion interference is specific to 






















CHAPTER 1 INTRODUCTION: BACKGROUND AND 
SIGNIFICANCE 
 
This chapter includes data published in Seminars in Cell and Developmental Biology. 
[Bruce KL, Chernoff YO. (2011) Sequence specificity and fidelity of prion transmission 
in yeast. Semin Cell Dev Biol 22(5): 444-451] 
 
1.1 AN INTRODUCTION TO AMYLOIDS AND PRIONS 
 Amyloid is a fibrous highly ordered cross-β protein aggregate that is highly 
resistant to degradation [1]. Many proteins form amyloids in vitro. Amyloid disorders 
include more than 30 diseases, among them such widespread conditions as Alzheimer’s 
and Parkinson’s diseases and type-II diabetes [1]. Amyloid may also play a variety of 
positive biological roles [2, 3]. In addition, many proteins have been found to form 
amyloids in vitro [4]. 
Amyloid-based prions (proteinaceous infectious particles) can be transmitted to 
other cells or organisms [3]. Once induced, the prion state propagates through 
immobilization of endogenous monomeric protein to the ends of existing prion “seeds” 
(Fig. 1).  Fragmentation of polymers initiates new rounds of prion propagation. 
Mammalian and human prion diseases or spongiform encephalopathies, including “mad 
cow” disease and scrapie, are fatal and incurable. Recent studies show that other amyloid 
disorders may also be transmissible, at least in experimental conditions or at a cellular 
level [5-7]. This hastens the need for novel therapies aimed at slowing or preventing 






Figure 1: Model for prion propagation: The prion model proposes that a 
prion aggregate or “seed” comes in contact with a monomeric protein 
having the exact or similar sequence. The monomer then joins onto the 
ends of the aggregate, using the aggregate as a structural template for its 
own incorporation as part of the aggregate. 
 
 Remarkably, prions exist as distinct “strains” that have the same primary 
sequence but differ in the structural organization of their amyloid core [8,9]. Particular 
strains of mammalian prion protein PrP correspond to distinct disease phenotypes and can 
be distinguished by characteristics such as differences in disease incubation periods, 
overall disease severity, proteinase K restriction patterns, and amyloid core length [10-
12]. 
 Prion transmission between heterologous proteins, originated from different 
organisms, is typically less efficient or not observed and is strongly influenced by the 
degree of sequence divergence [13]. This phenomenon is known as a “species” or 
“transmission” barrier (Fig 2). Uncovering the mechanisms underlying the sequence-
dependence of prion transmission will ultimately allow predictions of interspecies prion 







Figure 2: Example of a species barrier for cross-species transmission: 
PrP is known to adopt a prion fold and can propagate as a prion in 
different mammalian species. PrP homologues are found in sheep, cows, 
and humans, and the % given indicates the PrP sequence similarity 
between them. Despite the high level of sequence similarity, species-
specific differences in protein sequence or cell environment may prevent 
cross-species prion transmission, thus generating a “species barrier” 
(Arrows indicate successful prion transmission; “X” represents a species 
barrier) 
 
 A variety of amyloid-based prions have been identified in fungi, especially in 
yeast.  Yeast prions serve as a convenient model for investigations of amyloid and prion 
formation in general, and for elucidation of the sequence determinants of the species 
barrier. To date, at least eight different proteins have been proven to form a prion in S. 
cerevisiae yeast [14-22], and 18 others showed the ability to promote prion 
characteristics in Saccharomyces cerevisiae when fused to a reporter protein [23]. These 
proteins possess prion domains (PrDs) that convey prion-forming ability and are located 
at the terminal ends of proteins. Yeast PrDs are generally unrelated to the major cellular 
function of a protein and typically contain a QN-rich sequence (Fig. 3). Some PrDs also 
contain a region of oligopeptide repeats. Some well-characterized yeast prion-forming 
proteins (for review, see [3, 24]) include: 1) the translational termination factor Sup35 
(eRF3) whose prion form is termed [PSI
+
], 2) a protein of unknown function, Rnq1 
whose prion form is termed [PIN
+






Arrows indicate prion transmission.




metabolism pathway, Ure2, whose prion form is termed [URE3]. Sup35 and other yeast 
proteins can form prions de novo, albeit the presence of [PIN
+
] greatly speeds up prion 





then thought to cross-seed aggregation of other proteins, such as Sup35, by serving as a 
structural template for their assembly and nucleation into a prion form [81, 31, 15, 87].  
It is debated whether yeast prions play biologically positive regulatory roles [3, 
23, 25, 26] or whether they are detrimental to their host, Regardless, prion formation can 
be classified as an epigenetic change analogous to a gene mutation but occurring at the 
protein level [30]. 
 
Figure 3: Structural and functional organization of yeast prion 
proteins Sup35, Ure2, and Rnq1. PrD refers to the prion domain. “QN” 
denotes the glutamine/asparagine-rich regions (shaded in figure). “Ors” 
refers to the region of oligopeptide repeats. “N,” “M,” and “C” mark the 
Sup35N-terminal (prion) domain, middle domain, and C-proximal 
domain, respectively. “Functional domain” refers to the region essential 
for cellular function of the protein. Numbers correspond to amino acid 
positions. 
 
1.2. PRION VARIANTS IN YEAST 
 As in the case of mammalian prions, yeast prions with the same primary 




characteristics are controlled by the prion protein itself. Note that the term variant is used 
to avoid confusion with yeast strains that differ genotypically. Prion variants have been 
well documented to occur in well studied yeast prions including [PSI
+
], [URE3] and 
[PIN
+
] [31-33]. Not only are distinct phenotypes observed for their corresponding prion 
strains, but these differences are faithfully perpetuated as the prion is propagated both in 
vitro and in vivo. Prion variants were further shown to be maintained by a purified prion 
protein as they are reproduced through various cycles of propagation in vitro [8,9]. 
Impairment of Sup35 function in translation (Fig 4) is more severe in the strong 
variants when compared to the weak variants [31]. At a phenotypic level, “strong” [PSI
+
] 
variants were shown to exhibit close to 100% mitotic stability (that is homologous 
transmission in cell divisions) while weak variants can lose the prion state in mitotic 
division with a detectable frequency (Fig 5). Prion variants also differ in sensitivity to 
molecular chaperones that control prion fragmentation in yeast [31, 34]. 
 
Figure 4: ade1-14 supression assay for [PSI
+
] detection. Detection of 
the Sup35 prion ([PSI
+
]) by nonsense suppression. (Left of figure) The 
ade1-14 allele contains a premature UGA stop codon, allowing Sup35 to 
help termination before the complete Ade1 protein is made, so cells cannot 
live on media lacking adenine. When Sup35 is misfolded to form [PSI
+
], 
translation termination is less efficient, allowing readthrough of the stop 
codon to produce the complete Ade1 protein, so cells can live on media 
lacking adenine. [psi
-
] cells are red in color due to the accumulation of an 
intermediate in the adenine pathway.   
 
[psi-] cells [PSI+] cells















inversely correlates with prion core length  A—Strong variant having less 
of the PrD composing the prion core as compared to  B—having a larger 
core but a weak phenotype. (boxes - β-strands, dashes - H-bonds). C—
Prion variant strength can be measured by color on YPD or by suppression 
on media lacking adenine. D—Strong [PSI
+
] variants exhibit stable 
propagation after many mitotic divisions, but weak variants lose the prion 
with higher frequencies. E—after ultracentrifugation, strong [PSI
+
] 
variants exhibit most of the Sup35 in the pellet fraction; weaker variants 
contain a significant fraction in both the supernatant and pellet.  
 
Various biochemical and biophysical methods can be employed to distinguish 
between different [PSI
+
] strains. Zhou et al. [35] showed that “weak” prion variants 
contain more protein remaining in the soluble fraction after centrifugation while “strong” 
prions showed almost all Sup35 protein in the pellet. This explains more severe 
impairment of translation termination in strong prion variants. Strong prions are more 
readily fragmented, and this facilitates more efficient propagation of a prion [36]. A 
smaller average size of SDS-insoluble prion polymers, uncovered by agarose 




polymer size possibly results from more efficient fragmentation by the Hsp104 chaperone 
in vivo, and this explains a greater efficiency of prion propagation. Protection from H-D 
exchange revealed a shorter amyloid core in a strong variant of Sup35 prion as compared 
to a weak variant [38]. Derdowski et al. [39] observed that smaller prion polymers are 
more readily transmitted to daughter cells. That may explain higher transmissibility of 
strong prion variants.  
While phenotypic manifestation of the variant-specific patterns is achieved via 
interactions between the prion protein and cellular machinery, the molecular differences 
underlying these patterns are controlled by the prion protein itself. It was demonstrated 
that propagation of a purified S. cerevisiae Sup35NM amyloid was able to maintain a 
particular prion pattern in vitro and was then able to transfer the prion state to yeast cells 
upon transfection, providing strong support for a mechanism of protein-only templating 
[8,9]. 
1.3. PRION SPECIES BARRIER IN YEAST 
1.3.1. “Long distance” transmission barriers 
 Prion species barriers between heterologous proteins are well documented in 
yeast. Examples of “long-distance” species barriers include those between 
Saccharomyces cerevisiae and highly divergent yeast species Pichia methanolica and 
Candida albicans (Fig. 6). The PrD of Sup35 evolves much faster than the C-proximal 
release factor domain [3], so that only 30-40% amino acid similarity is retained between 
PrDs of S. cerevisiae, on one side, and Pichia or Candida, on the other side [40]. It 
appears that such a low level of sequence similarity is insufficient to promote co-




result, a strong species barrier that is controlled by the QN-rich stretch is detected. A 
chimeric Sup35 PrD with fused portions of the S. cerevisiae and C. albicans QN-rich 
stretch exhibited a “promiscuous” prion behavior allowing transmission of prion 
conformation from both S. cerevisiae and C. albicans PrDs [42]. 
  Heterologous coaggregation with the S. cerevisiae Sup35 protein was observed 
for its orthologs from less divergent species, Kluyveromyces lactis and Yarrowia 
lipolytica [28]. Although these proteins aggregate, it is unclear whether or not stable 
transmission of a prion state occurs between proteins from these species.  
Despite a profound barrier normally observed between S. cerevisiae and Pichia or 
Candida, rare instances of cross-species transmission were detected. In such cases, 
generation of multiple prion variants, rather than faithful reproduction of the initial prion 
variant, was observed [43]. Thus, cross-species prion transmission between highly 
divergent PrDs is reminiscent of promotion of prion nucleation by a non-homologous 
aggregated protein [16, 44].  Heterologous nucleation is covered in more detail by Nelson 
and Ross [45].   
 
Figure 6: Yeast species used in the prion species barrier studies. The 
phylogenetic tree is not drawn to scale. The percentage of amino acid 
sequence identity between the Sup35N domain of each species and the 





1.3.2. “Short distance” transmission barriers 
 The level of sequence divergence between PrDs of proteins from the different 
yeast genera is much higher that the level of divergence between the mammalian PrP 
proteins, for which the species barrier was initially described. Protein of closely related 
yeast species of the Saccharomyces genera, therefore, represent a more appropriate model 
for studying the general mechanisms of the species barrier that are applicable to 
mammalian systems [46]. Our lab has obtained detailed information about transmission 
of the prion state between the Sup35 protein originated from the species of the 
Saccharomyces sensu stricto group, namely S. cerevisiae, S. paradoxus, and S. bayanus 
(Fig 7). The level of identity between the PrDs of these proteins varies from 94% (S. 
cerevisiae to S. paradoxus) to 77% (S. cerevisiae to S. bayanus) [46]; that is similar to the 




Figure 7: Saccharomyces Sup35 proteins. Sup35 proteins are shown 
from three closely related Saccharomyces species. Sup35 has 3 domains: 
Sup35N or the “prion domain” (PrD), Sup35M which is highly charged 
and influences the solubility of the protein, and Sup35C which is essential 




and “OR” refer to a region of QN-rich residues in the Sup35N sequence, 
and oligopeptide repeats, respectively. Numbers correspond to amino acid 
positions. Percentages indicate the sequence similarity between the 
domain of a particular species and that of Saccharomyces cerevisiae.  
 
Our lab has previously shown that Sup35 proteins of S. paradoxus and S. bayanus 
are found to co-aggregate with endogenous Sup35 prion in S. cerevisiae cells [46]. 
However, a prion transmission barrier was detected in at least some combinations, despite 
coaggregation [46]. Our latest results show that cross-species transmission depends on 
both sequence divergence and the prion variant. We also show that the short distance 
barrier is not necessarily controlled by differences in the QN-rich stretch and is not 
directly proportional to the overall percentage of sequence divergence. These results will 
be discussed in Chapter 3. Interestingly, our data resemble results obtained for 
mammalian PrP [13] and support the hypothesis that the identity of relatively short key 
stretches, rather than overall sequence identity of PrDs controls is crucial for cross-
species prion transmission. 
 “Short distance” transmission barriers were also observed for Ure2 proteins 
originated from different Saccharomyces species [49-52]. The strength of the barriers 
varied widely for different species combinations and did not directly correlate with the 
overall percentage of sequence divergence. Ure2 from S. paradoxus and S. castellii were 
unable to adopt a prion form despite conservation of the PrD sequence [50]. Like in case 
of Sup35, particular prion variant was shown to determine the extent to which the species 
barrier can be crossed.  For one specific [URE3] variant produced in a S. bayanus protein, 
the prion could be readily transmitted to other Ure2 proteins from different species.  
However, for different [URE3] variants produced in a S. bayanus protein, a strong 




Transmission barriers were also recorded for artificially prepared Rnq1 constructs 
that contained no aa mismatches but did contain various deletions in one or more of the 
protein’s four QN-rich regions [53]. Data were consistent with the model suggesting that 
multiple prion determinants work in tandem to produce a particular conformation. For all 
three proteins, Sup35 ([46, 48]; see Fig. 3B), Ure2 [50] and Rnq1 [53], transmission 
barriers in some combinations were asymmetric, resembling the observations made in 
mammalian systems [54].   
 
1.4. AMYLOID INTERFERENCE 
 Another possible consequence of interactions between non-identical 
amyloidogenic proteins is amyloid interference, sometimes called “poisoning.” It occurs 
when a heterologous protein, its fragment (or altered derivative) of the homologous 
protein is co-expressed in the presence of a pre-existing amyloid. For the [URE3] prion, 
amyloid interference was detected as prion curing by truncated versions of Ure2 or by 
GFP-tagged Ure2 [49, 55]. In a perhaps related process, [PSI
+
] propagation from wild-
type Sup35 to Sup35 having a single amino acid mutation was diminished, and was 
further inhibited by higher Hsp104 dosage. [102]. An interference component may also 




], and [URE3] that can, 





], such incompatibility was shown to be variant-specific [57]. 
Furthermore, our lab previously found that overexpression of Sup35 or its PrD caused 
loss of [PSI
+
] in vivo [58], although it was not clear in that study if such curing occurred 




amyloids in vitro: in some combinations, introduction of the previously polymerized 
protein delayed rather than “seeded” polymerization of a heterologous soluble substrate 
[46].  In this work we provide evidence that heterologous interference also occurs in vivo 
and is attributed to heterologous interaction rather than sequestration of cofactors 
mechanisms or was due to sequestration of cofactors. Previously, our lab also observed 
that (K. Bruce, A. Romanyuk, and Y. Chernoff, unpublished). We show these results in 
chapter 6. 
 
1.5 FIDELITY AND AMBIGUITY OF CROSS-SPECIES 
 PRION TRANSMISSION 
Amyloid transmission is characterized by a high level of conformational fidelity. 
Prion propagation faithfully reproduces patterns of the original variant or “strain.” 
However, fidelity of prion transmission is not absolute. Phenotypic changes to the prion 
state were observed after a prion crosses a transmission barrier [12, 60, 61]. It is worth 
noting note that Sup35N regions of different lengths were found to be necessary for 
faithful maintenance of particular strong and weak [PSI
+
] prion variants in yeast [62, 63]. 
In this work, we show that for the yeast “short-distance” cross-species transmission, two 
types of variant changes were detected. The first type is a transient change in the 
phenotypic manifestation of prion variant patterns. The second type is an irreversible 
variant switch. Our results are presented in chapters 3 and 5 of this work. Kadnar et al. 
[53] also observed variant alterations occurring during transmission of the [PIN
+
] prion 




prion, variant type originating from S. cerevisiae also exhibited a high degree of fidelity 
as it was passaged across other Saccharomyces species [50]. 
 
1.6. STRUCTURAL BASIS OF AMYLOID SPECIFICITY AND FIDELITY 
1.6.1. Structural models for yeast prions 
 Unfortunately, the inability to crystallize prion material has prevented researchers 
from solving the prion structure to the level of atomic resolution, although [Het-s] 
provides an exception. Regions of prion-forming proteins (called the “prion domain” or 
“PrD”) are thought to aggregate in a cross β-sheet rich amyloid fold, making up the 
fiber’s axis (or “core” region), and portions of the protein may remain soluble (Fig 8). 
This explains how prions or amyloids may retain cellular function, even while a portion 
of the protein is aggregated. However, there is debate about the mechanisms of amyloid 
formation by yeast prion proteins, and in vitro evidence is interpreted in support of two 
distinct models. A parallel in-register β-sheet fold is suggested by NMR analysis of 
Sup35NM, Rnq1, and Ure2 amyloids formed in vitro [64, 1]. This model proposes that 
cross-β stretches are separated by regions of unpaired loops, facilitating a superpleated 
arrangement of β-sheets, although the precise boundaries of the β-strands are not known. 
This is referred to as a “β-archade” structure and may be a feature common to stable 
pathogenic amyloids produced in vivo. [100, 101]. An alternative β-helix model was 
proposed based on cross-linking studies performed on Sup35NM amyloids generated in 
vitro and suggests “head-to-head” and “tail-to-tail” cross-β intermolecular interactions 
between short stretches (Figure 8). Unfortunately, the β-helix model cannot currently 






Figure 8 .Structural model of Sup35 amyloids.  Only a portion of the 
protein (the prion domain, or “PrD,” shown as boxes) may adopt the 
compact β-rich conformation, leaving the rest of the protein without an 
amyloid fold. A – parallel in-register β-sheet. Boxes indicate β-strands. B 
– β-helix. Colored boxes indicate sites of intermolecular contact (H – 
head, T – tail). Dashes indicate hydrogen bonds. The core and the rest of 
the protein are not drawn in scale. 
 
1.6.2. The role of short sequences 
 
 Overall, the identity of specific short sequence regions or even individual residues 
was found to be crucial for faithfully maintaining propagation of specific prion variants. 
The roles these sequences or residues play is still under investigation, but direct 
correlation between the overall PrD sequence divergence and the success of cross-species 
prion transmission was not observed. Interestingly, experiments with small sequence 
changes such as single substitutions in mammalian PrP [69] or to the interspecies Sup35 
chimera [42] produced transmission barriers  
Accumulated evidence also indicates that regions which are significantly shorter 
than the whole PrD are required for the maintenance of variant-specific prion patterns. 
Moreover, strong variants of [PSI
+
] require shorter regions of PrD for their faithful 
reproduction, compared to weak variants [63, 70, 71]. The 40-50 amino acid fragment 
was sufficient to faithfully propagate strong prion through in vitro stage [70]. 
Mutagenesis studies of Sup35 PrD were used to define specific regions that control a 




identity of only a 15 amino acid stretch was required for susceptibility to the strong prion 
[70]. 
 Peptide arrays that were composed of overlapping 20-mer peptides, together 
covering the whole Sup35 PrD sequence were employed to identify the primary sites of 
interaction between Sup35 molecules potentially involved in amyloidogenesis. For 
proteins derived from either S. cerevisiae or C. albicans, interacting peptides were 
located at species-specific positions. Chimeric protein, capable of acquiring a prion state 
from both parental proteins, also interacted with both sets of peptides. Changes in 
temperature, altering the species specificity of a chimeric protein, also altered the 
efficiency of interaction with the respective peptide set, suggesting a role for the short 
amino acid stretches in determining the host-specific and variant-specific properties of a 
prion [72, 73].  
Remarkably, the interacting region defined by peptide arrays is also included in 
the above mentioned stretch required for the faithful reproduction of a strong prion, and 
overlaps the so-called “amyloid stretch” consensus located at positions 9-14 (Fig. 22, Fig. 
23). Hexapeptides conforming to this vague consensus are found in essentially all 
proteins capable of efficient amyloid formation and propagation in vitro [74]. The S. 
cerevisiae Sup35 PrD contains two more hexapeptides conforming to an amyloid stretch 
consensus, at positions 45-50 and 102-107 (Fig. 22, Fig. 23). Amino acid substitutions 
breaking the amyloid stretch consensus were found in S. paradoxus at position 12, and in 
S. bayanus at position 49 (here and further, S. cerevisiae numbering is used for 
simplicity). In this work, we present results obtained by using mutagenesis to restore the 




single substitutions to generate respective changes in the S. cerevisiae sequence. These 
results are shown in chapter 3 and 5. Overall, our data implicate the amyloid stretch 
consensus in the control of transmission specificity and fidelity, but also indicate that 
other sequence elements influence these processes as well. An additional indication in the 
same direction is that while a majority of yeast PrDs (see ref. [3]), including the 
artificially made “scrambled” versions of Sup35 PrD [1], contain the amyloid stretch 




The overall objectives of this work were to document the effects of both 1) 
protein sequence and 2) the cell environment on cross-species [PSI
+
] transmission and 
interference. Before this work was begun, the Saccharomyces model for species barrier 
was in use by our lab, but much was unknown about the role of protein sequence on these 
processes. Our objective was to determine conclusively whether overall sequence 
divergence or divergence in key sequence regions of the protein is most important for 
these processes, and we sought to map the sequence elements responsible for 
transmission barriers. Our hypothesis now states that such sequence elements may be 
crucial for initial interactions between aggregates and soluble protein and may determine 
the type of variants formed. Another objective was to determine variant-specific 
differences in cross-species infectivity. Such knowledge is useful for dissecting the 
mechanisms governing prion propagation, and for providing insight into predicting cross-
species prion transmission and control of amyloid aggregation kinetics. We further 
sought to compare aspects of [PSI
+




introducing the same [PSI
+
] state used for previous S. cerevisiae experiments into the S. 
paradoxus species and then performing the same experiments in the new cell 
environment. A related goal was to document the effect of heterologous Sup35 co-
expression on [PSI
+
] propagation and to pinpoint key sequence elements responsible for 
interference with [PSI
+
] propagation. Furthermore, we wanted to determine whether 
[PSI
+
] propagation is possible in S. bayanus. Finally, we removed our studies of prion 
species barriers and [PSI
+
] interference from the dependence of cellular influences in vivo 
to ascertain the roles attributed by the sequence alone. Overall, accomplishing these goals 
has provided new information about how prions propagate, and uncovered factors and 
processes that can inhibit their propagation. Ultimately, our continuing goal is to 
contribute to a thorough understanding of protein misfolding, allowing the process to be 
thoroughly controlled for applications in amyloid disease treatments and for advances in 
biotechnology  
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 MATERIALS 
2.1.1 Yeast strains 
The genotypes for all yeast and bacterial strains used for this work are provided on Table 
1 (Appendix). 
S. cerevisiae strains 
The GT81 strain [27], served as the parent strain for all S. cerevisiae strains used 
in this work, with the exception of cytoduction strains. GT81 has the following genotype: 
MATa (or MATα) ade1-14SC his3 leu2 lys2 trp1 ura3. Some specified strains contained 
the sup35∆::HIS3 chromosomal replacement and were maintained by different SUP35 
versions expressed from plasmids (for plasmid descriptions, see [27, 77]). A plasmid 
shuffle procedure (Described in Figure 11 [77]) was used to exchange different Sup35 
versions. S. cerevisiae strains GT256-23C (strong [PSI
+
]) and GT988-1A (weak [PSI
+
]), 
as well as the control [psi
-
] strain GT255-2A, were haploid derivatives of GT81 with the 
following genotype: MATα ade1-14 (UGA) his3 leu2 lys2 trp1 ura3 (see [46] and 
references therein). They contained the sup35Δ::HIS3 transplacement on the 
chromosome (constructed as described previously, see [27], and were maintained alive by 
the S. cerevisiae – E. coli shuttle plasmids bearing the SUP35 gene. S. cerevisiae stains 
having strong [PSI
+
] (GT256-23C) and weak [PSI
+
] (GT988-1A) were used as the source 
of donor [PSI
+
] for transfection into S. paradoxus and S. bayanus. 
The 1B-D910 strain (a gift from Dr. A. Galkin; St. Petersburg University, Russia) 
served as the parent for all S. cerevisiae cytoduction recipient strains used in this work. 












] and had the sup35∆::HIS3 chromosomal replacement. The strains were 
maintained by different SUP35 versions expressed from plasmids (for plasmid 
descriptions, see [27, 77]) A plasmid shuffle procedure (Described in Figure 11 [77]) was 
used to exchange different Sup35 versions. 
 
S. paradoxus strains 
The diploid GT749-1B strain (engineered by Mr. G. Newnam in the Chernoff lab) 
served as the parent strain for all S. paradoxus strains used in this work. GT749-1B has 
the following genotype: MATα/MATa lys2/lys2 ura3-P2/ura3-P2. 
The S. paradoxus strain GT1320-5B was a haploid derivative of SP7-1D (kindly 
provided by Dr. G. Naumov, State Institute for Genetics and Selection of Industrial 
Microorganisms, Moscow, Russia) with the following genotype: S. paradoxus MATα 
ura3-P2 lys2 Δho::KanMX6 ade1SP::ade1-14Sc [LYS2 SUP35SX]. This strain contained 
the sup35Δ::natNT2 transplacement on the chromosome (constructed as described in 
Chapter 4), and was maintained alive by S. cerevisiae – E. coli shuttle plasmids bearing 
the SUP35 gene originating from either S. cerevisiae, S. paradoxus, or S. bayanus. Strong 
or weak [PSI
+
] was induced in Sup35Sc by transfection from S. cerevisiae strains 
GT256-23C (strong variant) or GT988-1A (weak variant). 
 
S. bayanus strains 
The haploid Su1A and Su1B strains (kindly provided by Dr. N. Talarkek) [78] 
served as the parent strains for all S. bayanus strains used in this work. Sul1A and Sul1B 





Table 2 (Appendix) provides a list of all plasmids constructed or used for this work 
together with their descriptions. Plasmids used for a particular chapter are listed in that 
chapter’s material and methods. 
The SUP35Sp gene used for this work was obtained from the SP7-1D S. 
paradoxus strain (a gift from Dr. G. Naumov; State Institute for Genetics and Selection of 
Industrial Microorganisms, Moscow, Russia.) The SUP35Sb gene used for this work was 
obtained from the FM361 S. bayanus strain (a gift from Dr. M. Johnston; Washington 
University, St. Louis, MO). Descriptions of these strains are listed with their descriptions 
on Table 1 (Appendix). 
 
2.1.3 Primers 




The Sup35C antibody was kindly provided by Dr. D. Bedwell (University of 
Alabama; Birmingham, AL). The Sup35M antibody was a gift from Dr. I. Vorberg 
(German Center for Neurodegenerative Diseases; Bonn, Germany). Ssb antibody was 
provided by E. Craig (University of Wisconsin; Madison, WI). Hsp104 antibody was a 
gift from Dr. Susan Lindquist (Massachusetts Institute of Technology, MA). The Ade2 




Russia). The Sup35NM antibody was produced and purchased from Cocalico 
Biologicals, Inc. (Reamstown, PA).  
2.1.5 Gammabodies 
Three different gammabodies, each having different Sup35 residues (either 
residues 7-17, 7-26, or 12-21) grafted into a variable domain were provide by Dr. Pete 
Tessier (Rensselaer Polytechnnic Institute)  
 
2.2 GENETIC AND MICROBIOLOGICAL TECHNIQUES 
2.2.1 Standard yeast media and growth conditions 
S. cerevisiae yeast cultures were grown at 30°C, and S. paradoxus and S. bayanus 
were grown at 25°C, unless otherwise indicated. Liquid yeast cultures were grown with at 
least a 1:5 culture: flask volume ratio in a shaking incubator (New Brunswick Scientific 
series 25D incubator/shaker (30°C), New Brunswick Scientific G24 incubator/shaker 
(37°C) or New Brunswick Scientific Innova 4080 (25°C) for 200-250 rpm. Standard 
procedures for yeast cultivation, phenotypic and genetic analysis, sporulation and 
dissection were used [79]. Synthetic media lacking an amino acid such as uracil, 
trypophan, leucine, lysine, adenine, or histidine were labeled as “–Ura”, “-Trp”, “-Leu”, 
“-Lys”, “-Ade”, or “–His,” respectively. Synthetic media lacking a combination of amino 
acids such as uracil and leucine was labeled as “–Ura-Leu”. Unless otherwise specified, 
2% glucose was used as a carbon source for all yeast media. To induce expression of the 
GAL promoter (PGAL), 2% galactose was used as a carbon source rather than 2% glucose. 
To induce expression from the PCUP promoter, copper sulfate (CuSO4) was added at the 




resistant colonies, hygromycin B was added to YPD at a concentration of 0.3 mg/ml. To 
select for nourseothricin resistant colonies, nourseothricin was added to YPD at a 
concentration of 0.1 mg/ml. A Singer MSM System 300 micromanipulator was used for 
tetrad dissection of sporulating cultures.  
 
2.2.2 Bacterial transformation procedure 
Chemicals competent DH5α E. coli were transformed using standard laboratory protocols 
[80].  
2.2.3 Yeast transformation procedure 
A single yeast colony was inoculated into 5mls YPD and cultured at 30°C with 
shaking to OD600 = 1.0-5.0. The culture was diluted with 5 ml of YPD and allowed to 
grow for 2-4 hours as described. Cells were collected using centrifugation at 4000 x g for 
5 minute and were resuspended in 10 mls of Lithium Acetate-TE solution (LiAc-TE) 
(100 mM lithium acetate, 10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and were grown for 1 
hour at 30° C with shaking. Cells were collected and resuspended in 0.5-1 ml LiAc-TE. 
100 μl of cells was added to a microcentrifuge tube together with 20 μg carrier DNA and 
1-10 μg of plasmid DNA. Tubes were placed on a rotator at room temperature for 30 
minutes. 700 μl PEG-LiAc-TE (40% PEG 4000, 100 mM lithium acetate, 10 mM Tris-
HCl, pH 7.5, 1 mM EDTA) was added, and cells were rotated at room temperature for 1 
hour. The sample was heat-shocked for 5 minutes in a 42° C waterbath and was 
centrifuged at 3000 x g for 5 minutes to pellet the cells. Cells were resuspended in 150 μl 
water and plated on media selective for the plasmid. This transformation procedure was 




2.2.4 Yeast transfection procedure 
Sonicated in vitro-generated amyloids or prion-containing yeast cellular extracts 
was transfected into yeast using our modified version of a protocol described by [16] (Fig 
9). Our modifications differed from the published protocol as follows; 1) 
1 M dithiothreitol was added separately to the SCE buffer (1 M sorbitol, 100 mM sodium 
citrate, 10 mM EDTA, pH 5.8) to a final concentration of 10 mM; 2) PEG buffer was 
prepared with 44% (w/v) PEG 3350; and 3) the top agar concentration was 0.8%, and it 
was incubated at 42°C to prevent solidification. An empty plasmid containing a URA3 
marker was transformed together with the transfected protein as a marker for protein 
uptake, and cells were plated on media lacking uracil to identify transformants (having 
plasmid uptake and therefore, potential protein uptake as well). Colonies that grew on 
media lacking uracil were replica plated onto YPD and –Ade for phenotypical 
characterization of the strains.  
 
 
Figure 9: Transfection scheme. The cell wall of a [psi
-
] recipient cell is 
fragmented with zymolase, generating a spheroplast with an intact cell 
membrane. A—Cell extract (including prion material) is isolated from a 
[PSI
+
] strain and is chemically transfected across the recipient cell 




recipient as an indicator that material has passed across the cell membrane. 
The cells are plated on –Ura-Trp to select for recipient colonies (donor 
strain is trp
-
) successfully transformed with the URA3 plasmid. Both small 
and large colonies are observed on –Ura-Trp. Only large colonies contain 
the –URA3 plasmid, smaller colonies (without the plasmid) are present 
due to a low concentration of YPD in the transfectant selection medium. 
The large Ura
+
 colonies are tested on –Ade medium to check for [PSI
+
]. 
B—protein aggregated in vitro is sonicated (optional) and chemically 
transfected across the cell membrane. Transfection medium contains Trp 
because no selection against a donor strain is needed. Other steps are the 
same as described in panel A. 
 
 
The effect of sonication on transfection efficiency of in vitro generated amyloid 
Sup35NM(His)6 was purified from E. coli and aggregated in vitro. Because the in 
vitro aggregation mix lacks disaggregation factors such as Hsp104, aggregates may grow 
too large to be efficiently transfected across the cell membrane. Thus, sonication at low 
setting for 20 seconds, was used prior to transfection to break up the aggregates. The 
influence of sonication on transfection efficiency was tested for two different yeast 
strains.  
 Here, Sup35NM(His)6 aggregates generated in vitro at either 4° or 37°C were 
transfected with or without sonication for comparison. It was observed that aggregates 
produced at 4° were more efficiently transfected without sonication. However, aggregates 
produced at 37°C were more efficiently transfected with sonication. See Figure 10 and 
Table 4. 
 This may be explained by findings that aggregates prepared at 4° tend to have a 
stronger [PSI
+
] phenotype than those generated at 37°C [9]. It has been shown that a 
stronger [PSI
+
] phenotype is correlated with a shorter prion core [38]. Therefore, 




whereas, sonication would be beneficial to break down larger aggregates (produced at 
37°C) for more efficient transfection. 
 
Figure 10 The effects of sonication on transfection efficiency of in vitro 
generated aggregates. Sup35NM(His)6 protein originated from S. 
cerevisiae was purified from E. coli and aggregated at either 4° or 37° C. 
The protein was transfected into two yeast strains, either with prior 
sonication (S) or without (NS) sonication. The numbers of transfectants 
obtained were recorded with percentages of [PSI
+
] shown. Yeast having 
no protein transfected was also included as a negative control. The yeast 
strain GT17 carried a chromosomal copy of SUP35, while GT671 was 
chromosomally deleted for SUP35 but carried a copy on a plasmid. Data 




2.2.5 E. coli HMS174 [pLysS] expression system 
 Sup35NM(His)6 was isolated from the E. coli strain HMS174 [pLysS] (Novagen) 
by binding of the protein’s (His)6 tag to nickel resin. This strain is a lysogen of 
bacteriophage λDE3. HMS174 [pLysS] was transformed with a pET20b expression 
plasmid having the desired Sup35NM version. IPTG (isopropyl-ß-thiogalactopyranoside) 
was used to turn on expression of a target gene by inducing expression of a T7 RNA 
polymerase gene that is under control of a lacUV5 promoter. The strain also contains a 
plysS plasmid (to prohibit basal expression from the pET20b vector before IPTG is 


































chloramphenicol (Cm) with bacteria and was cultured overnight with shaking at 37°C. 
100 μL of the culture was added to 5 ml of fresh LB + 75 μg/ml chloramphenicol and 
was grown for three hours under the same conditions. Cells were obtained by 
centrifugation at 3000 x g for 5 minutes and were resuspended in 2.5 ml cold (4°C) 50 
mM CaCl2 and placed on ice for 40 minutes. The sample was centrifuged again, and cells 
were resuspended in 0.5 ml of cold (4°C) 50 mM CaCl2. 100 μl of cells was added to 1-
10 μg of plasmid DNA in a microcentrifuge tube and was mixed well and placed on ice 
for 30 minutes. The sample was heat shocked at 42°C for 2 minutes and immediately 
placed on ice for 2 minutes. 0.5 mL SOC media (0.5% yeast extract, 2% tryptone, 10 mM 
NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose) was added, and the 
culture was incubated for 1.5 hours at 37°C with shaking.  Cells were pelleted using 
centrifugation at 3000 x g for 5 minutes and were resuspended in 150 μl water and plated 
on LB + 50 μg/ml ampicillin (Amp) to select for the plasmid. 
 
2.2.6 Plasmid shuffle 
 To perform the plasmid shuffle (Fig. 11) [77, 46, 48], a S. cerevisiae [PSI
+
] 
sup35Δ strain with the S. cerevisiae SUP35 gene on a LEU2 (or LYS2) plasmid was 
transformed by a URA3 plasmid bearing a homologous, heterologous, chimeric or 
mutated SUP35 construct. Transformants were obtained on medium lacking uracil and 
leucine (−Ura, Leu) that is selective for both plasmids, and checked for suppression of 
the ade1-14 reporter on both medium lacking only adenine (−Ade) and medium lacking 
uracil, leucine and adenine (−Ura, Leu, Ade). The former medium enabled us to identify 
and exclude from further analysis colonies that have lost [PSI
+




of transformation, while the latter medium was used to determine whether newly 
introduced Sup35 protein is converted into a non-functional form or remains functional. 
Transformation-associated [PSI
+
] loss was almost negligible for strong [PSI
+
] but 
significant for weak [PSI
+
]. In parallel, transformants were streaked out on −Ura medium 




 colonies that have 




 colony was analysed from each 
individual [PSI
+
] transformant, to ensure independence of all colonies from each other. 
Reverse shuffle was performed in a similar way, except that medium with 5-fluoroorotic 
acid (5-FOA) was used to cure transformants of the URA3 plasmid. 
 
Figure 11: Plasmid shuffle scheme: Scheme of direct and reverse 
plasmid shuffle. “Sc” refers to SUP35 from S. cerevisiae. “PrDX” refers to 
SUP35 genes of various origins, or chimeric constructs.  
 
 
2.2.7 Prion interference assay 
Prion interference is phenotypically detected in a procedure similar to plasmid 
shuffle. The difference in these procedures is that for interference, the newly transformed 
URA3 plasmid (rather than the original plasmid) is lost after a period of co-existence. 
Following loss of the newly added plasmid, the original [PSI
+
] phenotype is analyzed to 
look for changes caused by co-existence of the interfering protein. A modification to this 
































Figure 12: Interference scheme: Scheme of prion interference using a 
plasmid shuffle technique. “Sc” refers to SUP35 from S. 




Cytoduction experiments (Fig. 13) were performed as described previously [46]. 
Donor strains were mated to the respective derivatives of the strain 1B-D910 by mixing 
them on YPD medium. After overnight incubation, mixtures were streaked onto selective 
synthetic medium with 5 µg ml
−1
 cycloheximide, containing 2% ethanol and 2% glycerol 
instead of glucose. This medium is selective for cytoductants getting the cytoplasm with 
mitochondrial DNA from the donor. Selected colonies were tested on the medium lacking 
adenine, and for the transfer of the donor plasmid on −Ura medium. Rare colonies 
getting URA3 plasmid from the donor were excluded. 
 
Figure 13: Cytoduction scheme: Donor strains were mated to the 
respective derivatives of the S. cerevisiae strain 1B-D910 by mixing them 
on YPD medium. After overnight incubation, the mixtures were streaked 
onto selective medium having 5 µg ml
−1
 cycloheximide and containing 
2% ethanol and 2% glycerol instead of glucose. This medium is selective 


































2.3 DNA ANALYSIS AND CONSTRUCTIONS 
2.3.1 E. coli small-scale DNA isolation protocols 
Two methods were used for quick isolation of small amounts of plasmid DNA from E. 
coli. 
Boiling-prep method 
 E. coli was patched onto LB plates containing antibiotics selective for the target 
plasmid. Wooden toothpicks were used to collect cells that were resuspended in 180 μl 
STET buffer (5% Triton X-100, 8% sucrose, 20 mM ethylenediaminetetraacetic acid 
(EDTA), 50 mM Tris-HCl, pH 8.0) with lysozyme added to a final concentration of 1 
mg/ml. Samples were boiled for 3 minutes and were centrifuged at 16000 x g for 15 
minutes. The pellet was removed using a sterile toothpick and discarded. One volume of 
isopropanol was used to precipitate the DNA at -20 for 30 minutes. DNA was 
precipitated by centrifugation at 16000 x g for 10 minutes, was washed once with 70% 
ethanol, dried, and resuspended in TE + RNase (10mM Tris-HCl, 1 mM EDTA, 0.1 
mg/ml RNase, pH 7.4.) The sample was incubated at 37° for 30 minutes for RNA 
removal [80]. 
Alkaline lysis method 
The alkaline lysis method yielded cleaner DNA than that obtained from the 
boiling prep method.  E. coli was patched onto LB plates containing antibiotics selective 
for a target plasmid. Wooden toothpicks were used to collect cells that were then 
resuspended in 100 μl of Solution I (25 mM Tris-HCl, 10 mM EDTA, 50 mM glucose, 
pH 8.0). 200 ul of Solution II (0.2 M NaOH, 1% sodium dodecyl sulfate (SDS)) was 




Lysis Solution III (5 M potassium acetate, pH 5.0) was added and mixed by inversion. 
The sample was then incubated on ice for 3-5 minutes and centrifuged at 16,000 x g for 5 
minutes at 4°C to pellet the cell debris. The supernatant was collected in a new tube, and 
2 volumes of 95% ethanol was added, followed by vortexing to mix, and incubated at 
room temperature for 5 minutes. The sample was centrifuged at 16000 x g (4°C) for 5 
minutes, and the supernatant was discarded. The pellet was washed with 70% ethanol and 
vortexed briefly. The sample was centrifuged again at 16000 x g (4°C) for 5 minutes, and 
the supernatant was discarded. The DNA pellet was dried thoroughly and resuspended in 
50ul of TE (or water) containing 10ug/ml RNase A. The sample was incubated at 37° for 30 
minutes for RNA removal. 
 
2.3.2 E. coli large-scale DNA isolation protocol 
For large-scale preparation of plasmid DNA from E. coli DH5α, 250 mLs of 
Luria-Bertani broth (LB)  + antibiotic selective for the plasmid was inoculated with 
bacteria and was incubated to OD550=0.8 (New Brunswick Series G24 Environmental 
Incubator/Shaker). Cells were collected by centrifugation at 7000 rpm for 5 minutes and 
were washed with 10 mLs of Solution I (50 mM glucose, 10 mM EDTA, 25 mM Tris-
HCl pH 8.0) and were collected again using centrifugation. The cell pellet was 
resuspended in 4.5 mLs of Solution I, and 0.5 mLs of 20 mg/mL lysozyme was added. 
The sample was incubated at room temperature first for 10 minutes and then 20 minutes 
on ice. 10 mLs of freshly prepared Solution II (0.2 N NaOH, 1% SDS) was added, and 
the sample was placed on ice for 15 minutes. 7.5 mLs of 3 M sodium acetate pH 5.0 was 




4°C for 20 minutes. The supernatant was collected, and DNA was precipitated by 
addition of 20 mLs isopropanol (20 minute at room temperature). The DNA was 
collected by centrifugation at 12,000 rpm for 15 minutes and was washed once with 70% 
ethanol and dried. The pellet was resuspended in 4 mLs of Tris-EDTA buffer, pH 8.0 
(TE) and was combined with 4 mLs of 9M Lithium Chloride and placed at -20°C for 20 
minutes. The sample was centrifuged at 12,000 rpm for 20 minutes. DNA was 
precipitated by the addition of 16 mLs ethanol (1 hour incubation on ice) and was 
collected by centrifugation at 12,000 for 15 minutes. The pellet was washed with 70% 
ethanol, dried thoroughly, and resuspended in TE buffer to the desired concentration.  
 
2.3.3 Yeast DNA isolation 
Modifications to a standard protocol [79] were used to isolate genomic DNA from 
yeast. 10 mLs of YPD was inoculated with one yeast colony and was cultured overnight 
at 30° C with shaking. Cells were collected by centrifugation at 2000 rpm for 5 minutes 
and were resuspended in 0.5mL of 1 M sorbitol, 0.1 M Na EDTA (pH7.5). 20 μL of 4 
mg/mL lyticase (or zymolase 100,000) was added, and the sample was incubated at 37° C 
for 60-90 minutes and then centrifuged at high speed for 1 minute. The cell pellet was 
resuspended in 0.5 mL of 50 mM Tris-Cl (pH7.4), 20 mM Na EDTA on a rotator or by 
pipetting. 55 μL of 10% SDS was added; the sample was mixed well; and was incubated 
at 65° C for 30 minutes. 0.2 mL of 5 M potassium acetate was added, and the sample was 
mixed and incubated on ice for 1 hour followed by centrifugation at high speed for 5 
minutes. DNA was precipitated by combining the supernatant with 0.75 mL of 




12,000 x g. The DNA pellet was washed with 70% ethanol, dried briefly, and 
resuspended in 0.4 mL of TE buffer (pH 7.4) on a rotator. 22 μL of a 1 mg/mL solution 
of RNase A was added and followed by incubation at 37° C for 30 minutes. If desired, 
plasmid DNA was ethanol precipitated to yield cleaner DNA. 
 
2.3.4 IsoPure gel extraction protocol 
DNA fragments generated from restriction digestion were run on a 1% TBE 
agarose gel stained with ethidium bromide (100V). Bands were visualized using a UV 
transilluminator (UVP Gel Doc-it 300 Imaging system.) Target fragments were excised 
with a scalpel and were purified using an IsoPure DNA Purification Prep Kit (Denville). 
 
2.3.5 DNA sequencing 
DNA was purified for sequencing using an IsoPure DNA Purification Prep Kit 
(Denville) and was eluted in water. DNA sequencing was performed by Eurofins MWG 
Operon Sequencing (Huntsville, AL). 
 
2.4 PROTEIN ANALYSIS 
2.4.1 Yeast protein isolation 
Previously described methods [81] were used to isolate protein from yeast. Yeast 
cultures were grown to the desired OD600. Samples were centrifuged at 5000 x g (4°C) 
for 5 minutes to collect a cell pellet. The cells were washed with water, collected again, 
and resuspended in 300 μl of chilled lysis buffer (25 mM Tris HCl pH7.5, 100 mM NaCl, 




cocktail). Next, the samples were combined with an equal volume of acid-washed glass 
beads (Sigma) and were lysed at 4°C using a Vortex Genie 2 (USA Scientific) at 4°C for 
6 minutes. To remove cell debris, the samples were centrifuged at 3000 x g (4°C) for 2 
minutes. Protein was analyzed immediately or stored at -80°C.  
2.4.2 Protein ultracentrifugation 
Ultracentrifugation is used to separate polymerized vs. monomeric Sup35 from 
crude cell extracts. Polymerized Sup35 is precipitated in the pellet, while the soluble 
Sup35 remained in the supernatant [81]. The strength of a [PSI
+
] variant is positively 
correlated with the amount of Sup35 precipitated in the pellet, whereas [psi
-
] yeast 
contains most Sup35 in the supernatant. Yeast strains were grown to an OD600 of 2.0 and 
lysed to obtain total protein (as described above). Cell lysate was centrifuged at 39 000 x 
g at 4° in an Optima TXL tabletop ultracentrifuge (Beckman Coulter) for 30 minutes. The 
pellet was dissolved in the original volume of protein lysis buffer, and equal amounts of 
dissolved pellet and supernatant were run side by side on a polyacrylamide gel for either 
gel entry assay or boiled gel analysis. 
 
2.4.3 SDS-PAGE/ western blot 
Proteins were isolated from yeast as described and were centrifuged at 3000 x g 
for 2 minutes to precipitate cell debris. Protein samples were combined in a 1:3 ratio with 
4X Loading Buffer (240 mM Tris-Cl, pH 6.8, 8% SDS,40% glycerol, 12% 2-
mercaptoethanol, and 0.002% bromophenol blue), were boiled for 15 minutes (if soluble 
protein was desired) and were loaded on a 10% SDS-polyacrylamide gel having a 4% 




running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3). Protein was 
transferred to Hybond-ECL nitrocellulose membrane (Amersham) using a Trans-Blot® 
SD Semi-Dry Electrophoretic Transfer Cell (BIO-RAD), and the membrane was blocked 
in 5% milk. The membrane was then incubated with the desired antibodies. 
 
2.4.4 Boiled-gel procedure 
The ‘Boiled gel’ procedure was performed as described [76] (see Fig. 14). In 
brief, protein samples containing 2% SDS were loaded onto a SDS-PAGE gel and run 
halfway. Electrophoresis was interrupted, and the wells were sealed with the addition of 
acrylamide. Once the newly added polyacrylamide was solidified, the gel was placed in a 
water-tight bag, and the entire gel was boiled for 15 min and cooled. Electrophoresis was 
resumed. SDS-resistant polymers initially trapped in the wells became solubilized by 
boiling and could enter the gel when electrophoresis was resumed. 
 
 
Figure 14 The boiled gel assay. A — Amyloid aggregates are too large 
and cumbersome to enter polyacrylamide gel. Boiling for 15 minutes in 
Sample buffer (see methods) containing 2% SDS sufficiently solubilizes 
the protein into monomers that can enter the gel. B—A boiling gel 
procedure [76] is used to measure the percentage of protein in the soluble 
(monomeric) vs. polymerized (amyloid) form. Protein samples are 
combined in a 1:3 ratio with Sample Buffer and are loaded onto a standard 
10% polyacrylamide gel. The gel is run halfway at 100V, allowing the 
soluble protein to enter the gel, but polymerized protein is trapped in the 
2% SDS

















wells. Electrophoresis is stopped, and the wells are sealed with 
polyacrylamide to prevent escape of aggregates while boiling. The entire 
gel is then sealed in a bag and boiled for 15 minutes to solubilize the 
trapped aggregates. Electrophoresis is resumed, and the newly solubilized 
protein in the wells can now also enter polyacrylamide.  
 
 
2.4.5 Gel-entry procedure 
To perform the gel-entry procedure, the protein sample to be tested is mixed with 
4X loading buffer containing 2% SDS and then divided into two aliquots. One aliquot is 
boiled for 15 minutes to solubilize any aggregates. Both samples are then run side-by-
side on a standard 10% polyacrylamide gel. Aggregated protein (present in the sample 
that is not boiled) cannot enter the gel, allowing only the soluble protein to enter. The 
amount present on the gel can then be compared to the boiled control in the neighboring 
lane to determine the percentage of aggregated protein. The protein is then transferred to 
a nitrocellulose membrane, blocked, and incubated with the appropriate antibodies as 
previously described. 
2.4.6 SDD-AGE 
Aggregates were separated according to size using the semi-denaturing detergent 
agarose gel electrophoresis procedure (SDD-AGE) [37]. Protein isolated from yeast 
(previously described) was combined in a 1:3 ratio with 4X loading buffer (240 mM Tris-
Cl, pH 6.8, 8% SDS, 40% glycerol, 12% 2-mercaptoethanol, and 0.002% bromophenol 
blue). This was run loaded on a 1.8% Tris-acetate-EDTA (TAE)-based agarose gel and 
was run in 1X TAE buffer containing 0.1% SDS was used. The proteins were transferred 
to a nitrocellulose Protran membrane (Whatman) using a capillary blotting procedure. 5% 






2.4.7 Sup35NM(His)6 purification from E. coli using Ni-NTA His-bind® resin 
Several fresh bacterial colonies were inoculated into 100 mL of LB media 
containing 75 μg/ml Cm and 50 μg/ml Amp and were grown overnight at 37° C with 
shaking. An aliquot was added to flasks containing a combined total of 1.7L of LB+75 
μg/ml Cm and 50 μg/ml Amp and was grown at 37° C with shaking for several hours to 
an OD550 of 0.5. 1M IPTG was added to a final concentration of 1 mM, and cultures were 
incubated for 4 hours at 37° C with shaking to induce the expression of Sup35NM. 
Samples were centrifuged at 2000 x g for 10 minutes at 4° C to collect the cells for either 
immediate protein purification or short-term storage at -80° C. 
Either a guanidine hydrochloride or a urea-based method was used to purify 
Sup35NM(His)6. The guanidine-based method allowed for all purification steps to be 
performed at 4°C (the urea-based method required room temperature purification due to 
urea precipitation from the buffer) but was not ideal for electrophoresis. The urea-based 
method worked well for electrophoresis but was hypothesized to yield modified protein 
that was not preferred for hydrogen/deuterium exchange. 
To purify Sup35NM using the guanidine hydrochloride-based method, cells were 
mechanically disrupted in the presence of 16g of guanidine hydrochloride and 16 ml of 
guanidine buffer (6 M guanidine hydrochloride, 40 mM Tris-HCl, 300 mM NaCl, 3 mM 
imidazole). The slurry was centrifuged at 18,000 rpm at 4° C for 25 minutes. The 
supernatant was combined with Ni-NTA His-Bind® resin (Novagen) prewashed with 
guanidine buffer and incubated for several hours on a rotator at 4° C to allow protein 




The beads were added to the column and washed with guanidine buffer to an OD 280 
<0.02. The column was clamped to prevent flow-through, and 10 ml of elution buffer (6 
M guanidine hydrochloride, 40 mM Tris-HCl, 300 mM NaCl, 200 mM imidazole) was 
added. After 30 minutes, the protein was collected and combined with methanol and 
placed at -20 overnight (ratio of 1:5 protein to methanol.) Protein was either stored at -
80° C in methanol or used immediately for experiments. To collect the protein, samples 
were centrifuged at 4000 rpm for 10 minutes and dried to remove methanol. Protein was 
resuspended in a small volume of either 6M guanidine hydrochloride or 8M urea. 
To purify Sup35NM using the urea-based method, cells were mechanically disrupted in 
the presence of 16g of urea and 16 ml of urea buffer (8 M urea, 40 mM Tris-HCl, 300 
mM NaCl, and 3mM imidazole). The slurry was centrifuged at 18,000 rpm at 25° C for 
25 minutes. The supernatant was combined with Ni-NTA His-Bind® resin (Novagen) 
prewashed with urea buffer and incubated for several hours on a rotator at 25° C to allow 
protein binding to the resin. The beads were collected and washed once with urea buffer. 
The beads were added to the column and washed with urea buffer to an OD 280 <0.02. 
The column was clamped to prevent flow-through, and 10 ml of elution buffer (8 M urea, 
40 mM Tris-HCl, 300 mM NaCl, 200 mM imidazole) was added. After 30 minutes, the 
protein was collected and combined with methanol and placed at -20 overnight (ratio of 
1:5 protein to methanol.) Protein was either stored at -80° C in methanol or used 
immediately for experiments. To collect the protein, samples were centrifuged at 4000 
rpm for 10 minutes and dried to remove methanol. Protein was resuspended in a small 





2.4.8 Preparation of in vitro aggregated Sup35NM(His)6 seed 
Sup35NM(His)6 seed was prepared using protein purified from E. coli (sections 
2.2.5, 2.4.7). Sup35NM(His)6
 
was first boiled for 15 minutes to solubilize potential 
aggregates and was then added with aggregation buffer (5 mM KPO4, 150 mM NaCl, pH 
7.4) to an eppendorf tube at the 150μg/ml concentration and was placed on a rotator at 
either 4°C, room temperature (approximately 25°C) or 37°C until the sample was 
aggregated (confirmed by gel entry assay (section 2.4.5)). 
 
2.4.9 In vitro protein polymerization and cross-seeding 
 
Aggregation with rotation 
Sup35NM(His)
6 
was boiled for 15 minutes as a precaution to solubilize potential 
aggregates and was added with aggregation buffer (see 2.4.8). Pre-formed seed was 
added if desired using a 1:20 seed to protein ratio. The sample was placed on a rotator at 
either 4°C, room temperature (approximately 25°C) or 37°C, and aliquots were removed 
at time=0 and at subsequent timepoints. Each aliquots was combined with 4X loading 




was boiled for 15 minutes as a precaution to solubilize potential 
aggregates and was added with aggregation buffer (see 2.4.8). Pre-formed seed was 
added if desired using a 1:20 seed to protein ratio. The sample was mixed by pipetting 
20X and placed without rotation at either 4°C, room temperature (approximately 25°C) or 
37°C, and aliquots were removed at time=0 and at subsequent timepoints. Samples were 




protein concentrations (It was assumed that large aggregates might precipitate). Each 
aliquots was combined with 4X loading buffer and was frozen at -80°C for boiling gel 
analysis followed by coomassie staining. 
2.4.10 Gammabody isolation and use 
Gammabodies (see Chapter 8) were prepared by transforming bacterial strain 
BL21(DE3)pLysS (Stratagene) with the desired gammabody plasmids. The strain was 
inoculated into 150 ml of autoinduction media [98] with 75 μg/ml chloramphenicol and 
50 μg/ml ampicillin to select for both the gammabody plasmid and the LysS plasmid. The 
cells were grown at 30° for 2 days with shaking. Supernatant was collected by 
centrifugation at 3500 x g for 10 minutes at 4°C and was incubated overnight on a rotator 
with Ni-NTA His-bind® resin. The resin was collected and washed with PBS buffer, pH 
7.0 and packed into a column and washed again with the same buffer. Gammabody was 
eluted using PBS, pH 3.0 and then neutralized to a pH of 7.0.  
 Aggregates were detected using the following protocol: Approximately 10 μl 
aliquots of in vitro aggregated protein or total cell lysate was spotted onto a dry Hybond-
ECL nitrocellulose membrane (Amersham) and was allowed to dry for approximately 10 
minutes. The membrane was blocked 3X for a combined time of about 12 hours in a 10% 
powdered milk solution at 4°C without shaking. (Milk was changed to dilute excess 
protein that did not bind to the membrane). The membrane was then incubated in a PBS 
(pH 7.0) solution containing gammabody and 1% powdered milk. After 3, 10 minute 
washes, anti-FLAG antibody was used with 1% milk and was followed by anti-mouse-





CHAPTER 3: CROSS-SPECIES TRANSMISSION AND VARIANT 
SWITCH IN S. CEREVISIAE 
This chapter includes data published in Mol Microbiol. [Chen B, Bruce KB, Newnam 
GP, Gyoneva S, Romanyuk AV , and Chernoff YO. (2010) Genetic and Epigenetic 
Control of the Efficiency and Fidelity of Cross-species Prion Transmission. Mol 
Microbiol 76(6): 1483-1499. 
 
3.1 CHAPTER SUMMARY 
 Our lab previously confirmed the existence of a species barrier for [PSI
+
] 
transmission from the S. cerevisiae Sup35 to Sup35 from S. paradoxus or S. bayanus, and 
implicated the PrD as the major determinant of the barrier [46]. Here, we employ the 
same experimental strategy to further decipher the role of various PrD modules and prion 
variants in cross-species prion transmission. The studies we present in this chapter 
demonstrate that differences between yeast prion variants influence 1) the efficiency of 
cross-species transmission, and 2) the ability to faithfully reproduce variant-specific 
patterns via a heterologous protein in the S. cerevisiae cell environment. Our data also 
identify potential amino acid stretches and single residues within the Sup35 PrD that are 




All plasmids used in this chapter were centromeric (low-copy) vectors with either 




(SUP35Sc), S. paradoxus (SUP35Sp) or S. bayanus (SUP35Sb) under control of the 
endogenous S. cerevisiae SUP35 (PSUP35) promoter were described previously (see [46] 
and references therein). Major plasmids constructed in this work and primers used for 
plasmid construction and mutagenesis are listed in the Appendix in Table 2 and  Table 3, 
respectively).  
For construction of SUP35 genes with chimeric SUP35N domains, we employed 
recognition sites for restriction endonucleases HindIII (located between modules I and II) 
and PflMI (located between modules II and III) that are conserved among the three 
Saccharomyces species in this work. The PflMI site is unique while another HindIII site 
is present in SUP35M, close to the N/M boundary. The construction strategy is explained 
in detail in Figure 35 (Appendix). Due to the construction procedure, all chimeric 
proteins contained the insertion of two additional aa residues at Sup35N/M boundary. To 
make sure that this insertion does not influence prion transmission, the S. cerevisiae 
SUP35 gene with the same insertion was constructed and used as a control in all 
experiments; no differences from intact SUP35 were observed. The mutagenesis strategy 
for constructs with alterations within amyloid stretches is described in Mutagenesis 
strategy in Figure 36 (Appendix) and  Figure 37 (Appendix). All chimeric SUP35N 
domains constructed as described here and further were verified with sequencing by 
Nevada Genomics Center and Eurofins MWG Operon. The various SUP35 constructs 








S. cerevisiae strains used for cross-species transmission studies, cytoduction studies and 
biochemical analysis are described in Chapter 2.  
 
3.3 RESULTS AND DISCUSSION 
3.3.1 The effect of prion variants on cross-species conversion 
 To see whether differences in prion variants affected the efficiency of cross-
species transmission, we compared transmission of the strong and weak S. cerevisiae 
prion variants from the S. cerevisiae Sup35 protein to chimeric proteins, bearing the PrDs 
of S. paradoxus, S. bayanus, or S. cerevisiae at the phenotypic level by using plasmid 
shuffle, (Fig. 11) and cytoduction (Fig. 13). The strong S. cerevisiae [PSI
+
] variant 
showed only a slight decrease in transmission to the S. paradoxus PrD but exhibited a 
clear transmission barrier with the S. bayanus PrD (Fig. 15 and Table 5 (Appendix) and 
Table 6 (Appendix)).  
 
 
Figure 15: Transmission of a strong S. cerevisiae [PSI
+
] variant to 




cerevisiae, S. paradoxus, and S. bayanus, respectively. “PrD” refers to the 
Sup35 prion domain. A—Growth of transformants containing both the 
original and the newly introduced plasmid on –Ade medium selective for 
both plasmids. B—The results of direct plasmid shuffle performed in a 
strong [PSI
+
] variant as shown on Plasmid shuffle scheme Fig. 11. Here, 
standardized errors are indicated. For exact numbers, see Table 5 C 
(Appendix)— Results of cytoduction experiments performed in a strong 
[PSI
+
] variant as shown on Cytoduction scheme Fig. 13.  For exact 
numbers, see Table 6 (Appendix). Errors were not calculated for 
cytoduction experiments, as our procedure does not guarantee that all 




 In contrast, the weak S. cerevisiae [PSI
+
] variant exhibited a transmission barrier 
with the S. paradoxus PrD in both versions of the experiment, but showed a clear barrier 
with the S. bayanus PrD only in plasmid shuffle (Fig. 16 and Tables 7 (Appendix) and 
Table 8 (Appendix)). Even in this case, the barrier was not as severe as for strong [PSI
+
]. 
Relatively efficient transmission of the strong [PSI
+
] variant to the chimeric construct 
having the S. paradoxus PrD contrasted with the previously detected barrier in the 
transmission of this prion variant to intact S. paradoxus Sup35 [46]. This agrees with our 
lab’s observation that the strong S. cerevisiae [PSI
+
] variant efficiently converts all of the 
chimeric construct but not all of the intact S. paradoxus protein into the SDS-insoluble 







Figure 16 Transmission of a weak S. cerevisiae [PSI
+
] variant to Sup35 
proteins with different PrDs. Designations are as on Fig. 15. A—Growth 
of transformants containing both the original and newly introduced 
plasmids on –Ade medium selective for both plasmids. B—Results of 
direct plasmid shuffle performed in a weak [PSI
+
] variant as shown on 
Plasmid shuffle scheme (Fig. 11). Here, standardized errors are indicated. 
For exact numbers, see Table 7 (Appendix). C—Results of cytoduction 
experiments performed in a weak [PSI
+
] variant as shown on Cytoduction 
scheme (Fig. 13). For exact numbers, see Table 8 (Appendix). Errors were 
not calculated for cytoduction experiments, as our procedure does not 
guarantee that all cytoductants, obtained for a given construct, were 
independent of each other.  
 
 
3.3.2 Asymmetry and infidelity of cross-species prion conversion 
 Even when the parental S. cerevisiae [PSI
+
] variant was strong, prion isolates 
resulting from cross-species transmission to proteins with S. paradoxus or S. bayanus 
PrDs were phenotypically weak (Fig. 17). This was similar to both our previous 
observations for complete S. paradoxus and S. bayanus proteins [46] and some previous 
reports on cross-species transmission of mammalian prions [12].  
 
 
Figure 17: Reproduction and switch of prion variants during cross-
species transmission. Designations are as on Fig. 15. Patterns of [PSI
+
] 




shuffle to the control S. cerevisiae Sup35 protein or to chimeric proteins 
having either S. paradoxus or S. bayanus PrDs. This was followed by 
reverse shuffle back to S. cerevisiae Sup35 (Fig. 11).  “PrDX” refers to 
PrDs of various origins as indicated. The –Ade plate was photographed 
after 6 days. The YPD plate was photographed after 3 days of incubation 
followed by 4 days in the refrigerator. 
 
 To determine whether such an alteration of the variant-specific patterns is 
reversible, we performed a “reverse shuffle” (Fig. 11), thus transmitting the prion state 
back to the S. cerevisiae Sup35 protein. In agreement with our previous observations for 
intact proteins [46], the prion state was efficiently transmitted from protein with the S. 
paradoxus PrD to the S. cerevisiae protein, confirming asymmetry of cross-species prion 





Figure 18: Frequencies of reverse [PSI
+
] transmission in a strong and 
weak S. cerevisiae [PSI
+
] variant. Species designations are as on Fig. 15. 
For exact numbers, see  Tables 9 (Appendix) and Table 10 (Appendix).   
 
 In the case of the S. bayanus PrD, asymmetry of cross-species prion transmission 
was also observed, but it was less pronounced for strong S. cerevisiae prion variant. 
Alteration of phenotypic patterns of the strong prion variant propagated via the S. 
paradoxus PrD was reversible, as strong [PSI
+
], phenotypically indistinguishable from 




Sup35 protein (Fig. 17). In contrast, [PSI
+
] isolates produced by the reverse shuffle from 
the protein with S. bayanus PrD to the S. cerevisiae protein were weaker (Fig. 17) and 
produced more protein in the soluble state (Fig. 19), compared to the strong S. cerevisiae 
[PSI
+
] variant that has not been propagated through the heterologous PrD. These isolates 
were confirmed by plasmid isolations and subsequent DNA analysis to contain the 
unaltered S. cerevisiae SUP35 gene (data not shown), thus excluding the possibility that 
they might originate from any recombination events during the period of coexistence of 
the S. cerevisiae and S. bayanus genes within the same cell. Therefore, our data 
demonstrate that variant-specific prion patterns could be altered irreversibly during cross-
species transmission involving S. bayanus PrD, so that the resulting prion may keep a 
“memory” of being transiently propagated via a heterologous PrD.  
 
 
Figure 19: Centrifugation analysis of Sup35 aggregation. 
Ultracentrifugation was performed for cell lysate from two different 
isolates obtained via shuffle from the strong S. cerevisiae [PSI
+
] strain to 
the chimeric protein with S. bayanus PrD, followed by a reverse shuffle to 
the S. cerevisiae protein as shown on Figure 17. Extract of the strong S. 
cerevisiae strain that has not been propagated through a heterologous 
protein (“Strong Sc”) is shown as a control. Protein extracts were 
fractionated by centrifugation at 39 000 x g. Supernatant (S) and pellet (P) 
fractions were boiled in 2% SDS, run on a SDS-PAGE gel, and analyzed 
by western blotting with the Sup35C antibody. The prion isolates obtained 
from reverse shuffle contain more Sup35 protein in the supernatant, as 
compared to the control strong prion strain. This confirms irreversible 
change in the prion variant patterns during propagation through a 






 Moreover, various [PSI
+
] isolates obtained from reverse shuffle exhibited 
different levels of suppression, even though none of them could match the original strong 
S. cerevisiae [PSI
+
] variant in suppression efficiency (Fig. 20). This indicates that 
heterologous conversion could be imprecise and generate multiple variants of a prion.  
 
 
Figure 20: Variability in [PSI
+
] stringency after propagation through 
a protein with the S. bayanus PrD. The shuffle was performed starting 
from the strong S. cerevisiae [PSI
+
] strain GT256-23C, as shown on 
Figure 11 and Figure 17. Designations “Sc” and “Sb” refer to S. cerevisiae 
protein and protein with the S. bayanus PrD, respectively. “P50Y” refers 
to a mutation at amino acid position 50 of the S. bayanus Sup35 sequence. 
All colonies shown on the figure originate from reverse shuffle and 
contain only S. cerevisiae Sup35 protein.  Prion derivatives that come 
from reverse shuffle via the S. bayanus PrD show variable stringencies of 
suppression (as measured by intensity of growth on –Ade medium), in 
contrast to the control isolates propagated only through the S. cerevisiae 
protein that are always homogenous. Remarkably, some prion variants 
originated from reverse shuffle through the Sb (P50Y) protein (denoted by 
squares) match the S. cerevisiae strong [PSI
+
] by stringency, while prion 
variants originated from reverse shuffle through the Sb protein never do.  
 
 Such an infidelity in prion transmission was not detected with the weak S. 
cerevisiae [PSI
+
] variant, which produced even weaker prion isolates while propagated 
via a heterologous protein but was restored after the reverse shuffle (Fig. 21). Therefore, 
the S. bayanus PrD can faithfully propagate weak S. cerevisiae prion despite a temporary 
change in its phenotypic expression, but irreversibly alters patterns of the strong S. 






Figure 21: Reproduction of prion variants during cross-species 
transmission Patterns of [PSI
+
] isolates obtained from a weak S. 
cerevisiae prion variant via direct shuffle to the control S. cerevisiae 
Sup35 protein and chimeric proteins with either S. paradoxus or S. 
bayanus PrDs, followed by reverse shuffle back to S. cerevisiae Sup35 
(Fig. 11). “PrDX” refers to PrDs of various origins as indicated. The –Ade 
plate was photographed after 7 days; The YPD plate was photographed 
after 3 days of incubation followed by 4 days in the refrigerator. 
 
3.3.3  Construction of Sup35 proteins with the chimeric prion domains 
 To determine which specific region of Sup35N is responsible for the species 
barrier, we constructed a set of chimeric SUP35 genes as described in chimeric genes 
diagram (Fig. 35). The convenient location of conserved restriction sites enabled us to 
divide the Sup35N-coding region of the SUP35 gene into 3 exchangeable modules, 
designated as modules I, II and III (Fig. 22). Module I includes most of the QN region up 
to (and including) position 33, encompassing the whole fragment 8-27 with the maximal 
percentage of QN residues, which is primarily responsible for the species barrier in the 
Saccharomyces-Candida combination [41]. Module II includes the very end of the QN 
region and the whole ORs region, while module III includes the remaining portion of 
Sup35N. There is no difference in aa sequence between S. cerevisiae and S. bayanus 
within the “tail” of the QN region that falls into module II (positions 34 to 40), and there 






Figure 22: Modules of Sup35 PrDs from three closely related 
Saccharomyces species. Designations “PrD” “QN,” and “ORs” refer to 
prion domain, QN-rich region, and region of oligopeptide repeats, 
respectively. Roman numerals represent exchangeable modules of Sup35 
PrD used in our experiments. Numbers correspond to amino acid 
positions. The “Tail” (position 34-40) of the QN region in module II is 
identical in S. cerevisiae and S. bayanus and shows one amino acid change 
in S. paradoxus. Dashed lines mark a missing oligopeptide repeat in S. 
bayanus. Short, bold lines denote amyloid stretches, according to a 
hexapeptide consensus from ref. [74], as shown. Residues forbidden or 
permitted at a given position (indicated by number) are placed within { } 
or [ ], respectively. 
 
 
Figure 23: Divergence of Sup35 prion domains in Saccharomyces 
sensu stricto yeast. “Sc”, “Sp,”and “Sb” refer to S. cerevisiae, S. 
paradoxus, and S. bayanus, respectively. QNR and ORs refer to QN-rich 
stretch and the oligopeptide repeats, respectively. Locations of the 
exchangeable modules are indicated. 
 
 We generated a set of SUP35 genes with chimeric SUP35N domains, combining 
modules I, II and III of S. cerevisiae, S. paradoxus or S. bayanus in various combinations 
(Fig. 24). Chimeric PrDs were fused in frame to the SUP35MC region from S. cerevisiae 
and placed under control of the endogenous S. cerevisiae SUP35 promoter (PSUP35), 




All constructs were proven to maintain viability of S. cerevisiae in the absence of 
endogenous Sup35, and remained completely functional in translation termination, as 
confirmed by inability of the [psi
-
] sup35Δ strain, bearing each of these constructs, to 
grow on –Ade medium, that is, to read through the ade1-14 reporter. Each chimeric 
construct tested was expressed at the same level as S. cerevisiae Sup35 when placed on a 
plasmid of the same structure (Fig. 38). For most chimeric proteins, we also show that the 
protein can be induced into a prion ([PSI
+
]) state by transient overproduction of the same 
chimeric construct and/or at least one of the parental SUP35 genes. All the constructs 
could generate both strong and weak prion strains, with the exception of constructs 
containing module II of S. bayanus that produced preferentially weak variants (data not 
shown).    
 
 
Figure 24: Chimeric PrDs constructed in this study. Exchangeable 
modules are designated by Roman numerals. Designations “PrD” “ORs” 
refer to prion domain and region of oligopeptide repeats, respectively. 










3.3.4 Identification of PrD modules responsible for the species barrier 
 In order to determine which module of Sup35N controls the species specificity of 
prion conversion from S. cerevisiae Sup35 to the other S. sensu stricto Sup35 proteins, 
we performed the plasmid shuffle experiments (Fig. 11) with each of the chimeric SUP35 
constructs. Our results unambiguously demonstrated that module I of S. paradoxus is 
responsible for the transient decrease in [PSI
+
] phenotypic stringency (data not shown) 
and for the species barrier in prion transmission (Fig. 25 A and B, and Tables 5 
(Appendix) and Table 7 (Appendix)), while the region encompassing modules II and III 
of S. paradoxus exhibits little or no effect. In contrast, module II of S. bayanus was 
responsible for the species barrier, while modules I and III of S. bayanus exhibited little 
or no affect Fig. 25 A and B and Tables 5 (Appendix) and 7 (Appendix)). Even in this 






Figure 25: Frequency of transmission of strong and weak [PSI
+
] to 
Sup35 proteins with chimeric PrDs by plasmid shuffle. Direct plasmid 
shuffle was performed beginning with either a strong (panel A) or weak 
(panel B) [PSI
+
] variant as shown on the plasmid shuffle scheme Figure 
11. Data for the control S. cerevisiae construct reproduce those shown on 
Fig. 15(B) and 16 (B).  For exact numbers, see Tables 5 (Appendix) and 





These results were generally confirmed by cytoduction experiments Fig. 26 A and B and  
Tables 6 (Appendix) and 8 (Appendix)).  
 
 
Figure 26: Frequency of cytoduction transmission of strong and weak 
[PSI
+
] to Sup35 proteins with chimeric PrDs.  Cytoduction was 
performed beginning with either a strong (left panel) or weak (right panel) 
[PSI
+
] variant as shown on Cytoduction scheme Fig. 13. Data for the 
control S. cerevisiae construct reproduce those shown on Fig. 15 (C) and 
16 (C). 
 
 Notably, the insertion of an additional OR unit of S. cerevisiae origin into the S. 
bayanus module II somewhat increased cross-species prion conversion but did not 
completely eliminate the barrier in plasmid shuffle (Fig. 25, A and B) and did not show 
any effect on the barrier in cytoduction (Fig. 26, A). This indicates that while the size of 
module II plays a certain role in cross-species prion transmission, its specific sequence 
features are also important. Importantly, module II of S. bayanus was both required and 
sufficient for switching the strong [PSI
+
] variant to the weaker variant as detected in 
reverse shuffle (Fig. 27).This demonstrates that in addition to controlling the frequency of 
cross-species prion conversion in the S. cerevisiae / S. bayanus combination, module II 
also controls fidelity of reproduction of the variant-specific prion patterns via a 
heterologous stage. Based on the observed differential effects of PrD modules, we 




of S. paradoxus would show “promiscuous” behavior, while the reciprocal artificial PrD, 
composed of S. paradoxus module I and S. bayanus modules II and III would exhibit a 
very stringent species barrier in all combinations.  Indeed, our data confirmed this 
prediction (Fig. 25 and Fig. 26).  
 
 
Figure 27: Changes in phenotypic patterns after reverse shuffle. 
Phenotypic patterns of strong prion variant are switched in the chimeric 
constructs bearing module II of S. bayanus, as detected after reverse 
shuffle to the S. cerevisiae Sup35 protein, performed as shown on Plasmid 
shuffle scheme Fig. 11. –Ade plates were photographed after 6 days. 
 
3.3.5 The role of amyloid stretches in cross-species prion conversion 
Within module I, more amino acid substitutions are found between S. cerevisiae and S. 
bayanus (5 out of 33 positions) than between S. cerevisiae and S. paradoxus (only 3, see 
Fig. 23). This seems to disagree with our observation that module I of S. paradoxus is 
sufficient for the species barrier while module I of S. bayanus is not (see above, Fig. 25 
and Fig 26). However, all three aa substitutions in the S. paradoxus sequence are located 
between positions 12 and 20, while S. bayanus has only 2 substitutions within this 
fragment (Fig. 23).  It therefore appears that identity of the fragment 12-20 rather than 
that of the whole module I is crucial for prion transmission and stringency. Moreover, 2 
out of 3 variable positions within this region are changed in both S. paradoxus and S. 
bayanus, so that only asparagine (N) to serine (S) substitution at position 12 is specific to 
S. paradoxus. We changed the codon for S12 into a codon for N in the S. paradoxus 




transmission of weak S. cerevisiae [PSI
+
] from either complete S. paradoxus PrD or 
chimeric PrD containing S. paradoxus module I (Fig. 28), and phenotypic stringency of 




Figure 28: The effects of the S12N mutation at position 12 on cross-
species [PSI
+
] transmission. Frequencies of the S. cerevisiae prion 
transmission in direct shuffle from either a strong (panel A) or weak 
(panel B) variant to derivatives containing S. paradoxus module I with the 
S12N mutation at residue 12. 
 
 
Figure 29: The effects of position 12 exchange on phenotype. Residue 
12 controls phenotypic expression of the strong S. cerevisiae prion in the 
S. cerevisiae / S. paradoxus combination, as seen on –Ade plates 





 Next, we mutated the codon for N12 (S. cerevisiae version) into a codon for S (S. 
paradoxus version) in the otherwise intact S. cerevisiae SUP35 gene, and demonstrated 
that transmission of weak S. cerevisiae prion to the mutant protein is decreased, even 
though not to such an extent as in the case of the substitution of the whole module I by its 
S. paradoxus counterpart (Fig.30). In the case of the strong prion variant, N12S 
substitution impaired prion transmission more severely than did the whole module I of S. 
paradoxus (Fig.28) and decreased the phenotypic stringency of the prion maintained by a 
heterologous protein (Fig. 29).  This was not due to inability of the mutant protein to 
maintain a phenotypically strong prion variant in principle, as it could be induced into a 
strong prion variant de novo by overproduction of the S. cerevisiae Sup35N fragment 
(data not shown).Taken together, our results show that a single aa substitution at position 
12 of the Sup35 protein plays an important role in both specificity of prion transmission 
and stringency of the prion isolates obtained from cross-species conversion, even though 
it is not solely responsible for the specificity. 
 
 
Figure 30: Frequencies of the S. cerevisiae prion transmission in direct 
shuffle to the S. cerevisiae protein with N12S mutation at residue 12. 
Frequencies of the S. cerevisiae prion transmission in direct shuffle from 
either a strong (panel A) or weak (panel B) variant to derivatives 





 The location of residue 12 is quite remarkable, as it falls within the only sequence 
found in module I (see above, Fig. 23) that satisfies requirements for the “amyloid 
stretch” (Fig. 22), a consensus hexapeptide detected in most proteins efficiently forming 
amyloids in vitro [92, 74]. Moreover, the N12S substitution breaks this consensus (Fig. 
22). Despite a relatively high level of flexibility allowed at some positions of the amyloid 
stretch (Fig. 22), the S. cerevisiae Sup35N region contains only two more hexapeptides 
satisfying the consensus requirements, at positions 45-50 within module II, and 102-107 
within module III (see above, Fig. 22). Both stretches are conserved in S. paradoxus; 
however, they contain respectively one and two aa substitutions in S. bayanus. 
Substitutions within module III do not break the amyloid stretch consensus, but 
substitution of tyrosine (Y) to proline (P) at position 49 (S. bayanus position 50) within 
module II does (Fig. 22). We mutated P50 into Y in the S. bayanus sequence and found 
that this substitution significantly increased cross-species transmission of both strong and 
weak S. cerevisiae prions to the mutated protein (Fig. 31). 
 
 
Figure 31: Frequencies of the S. cerevisiae prion transmission in direct 
shuffle to the S. bayanus PrD derivatives with the P50Y mutation at 
position 50. Data for the control Sb-Sb-Sb construct reproduces that 
shown on Fig. 15 (B) and 16 (B). Data for the Sc-Sb-Sb construct 




figures. Shuffle was performed as shown on Plasmid shuffle scheme Fig. 
11. Exact numbers are shown in Tables 5 (Appendix) and Table 7 
(Appendix). Species designations are as on previous figures.  
  
In the case of weak [PSI
+
], the species barrier was essentially eliminated when 
mutated module II of S. bayanus was combined with module I of S. cerevisiae origin. 
Although P50Y substitution did not restore the phenotypic stringency of a heterologous 
prion (Fig. 32), and did not completely restore the fidelity of reproduction of the variant-
specific prion patterns during reverse shuffle in case of strong [PSI
+
] (Fig. 20), it altered 
the spectrum of the prion variants obtained after reverse transmission to the S. cerevisiae 
Sup35 protein, so that at least some isolates now matched the original strong S. cerevisiae 
prion in suppression efficiency. 
 
 
Figure 32: Effect of the Y49P and P50Y substitutions on the phenotypic 
expression of strong [PSI
+
] in direct shuffle.   
  
Reciprocal substitution Y49P within the S. cerevisiae Sup35N domain moderately 
decreased transmission of the strong S. cerevisiae prion but had no detectable effect on 
transmission of the weak S. cerevisiae prion to a mutated protein, indicating that 
disruption of the amyloid stretch II consensus by itself is not sufficient for the species 






Figure 33: Frequencies of the S. cerevisiae prion transmission in direct 
shuffle to the S. cerevisiae protein with altered position 49. Data for the 
control Sc-Sc-Sc reproduces that shown on Fig. 15 (B) and Fig. 16 (B). 
Species designations are as on previous figures. Shuffle was performed as 
shown on Plasmid shuffle scheme Fig 11.  Exact numbers are shown in  
Tables 5 (Appendix) and Table 7 (Appendix). Species designations are as on 
previous figures. Shuffle was performed as shown on Fig. 1E. Exact numbers 
are shown in  Tables 5 (Appendix) and Table 7 (Appendix).  
Notably, this mutation decreased phenotypic stringency of the strong prion (Fig. 
32),  although this was not sufficient for the irreversible switch of a prion variant, as 
stringency was restored after the reverse shuffle to the non-mutant S. cerevisiae protein 
(data not shown). Taken together, our data point to the important even though not 
exclusive role of amyloid stretches in control of the species specificity and fidelity of 




3.4.1 Relationship between coaggregation, polymerization and prion transmission 
Interestingly, the efficiency of prion conversion of the heterologous Sup35 protein 
does not appear to be entirely determined by its PrD. Transmission of the strong S. 
cerevisiae prion variant to the intact S. paradoxus Sup35 protein is inefficient at the 




shows only a weak barrier in prion transmission (Fig. 15). This result somewhat 
contradicts our previous observation of a strict species barrier in transmission of strong S. 
cerevisiae [PSI
+
] to the chimeric protein with S. paradoxus PrD made for a small sample 
of colonies [46]. It is possible that we have either dealt with a statistical fluctuation 
previously, or more likely, overlooked the [PSI
+
] colonies appearing after heterologous 
transmission, as Sup35 PrD from S. paradoxus significantly decreases suppression 
efficiency of [PSI
+
] generated by transmission from S. cerevisiae protein, thus requiring 
longer time for detection of [PSI
+
] by suppression (for example, see Fig. 29). In any case, 
our new data unequivocally confirm that while the PrD of S. paradoxus is sufficient to 
generate a strong transmission barrier for the weak [PSI
+
], it causes only a slight decrease 
in transmission of strong [PSI
+
]. However, it should be stressed that PrD of Sup35 
remains the major region responsible for the species barrier between S. cerevisiae and S. 
bayanus, and at least in case of weak [PSI
+
], between S. cerevisiae and S. paradoxus.  
 As Sup35C domains of S. paradoxus and S. cerevisiae are 100% identical to 
each other, the differences in behavior of complete S. paradoxus protein and chimeric 
protein with S. paradoxus PrD must be due to Sup35M. Indeed, we previously observed 
that the Sup35M region of S. paradoxus is partly responsible for extreme mitotic 
instability of prions generated by intact S. paradoxus Sup35 in the S. cerevisiae cell [46]. 
The non-PrD region of S. bayanus Sup35 also influences some patterns of cross-species 
interactions, as introduction of the chimeric protein with S. bayanus PrD into the strong 
S. cerevisiae [PSI
+
] strain results in a larger fraction of protein remaining in the 
supernatant and a larger proportion of non-polymerized protein associated with 




Interestingly, the non-PrD region of S. bayanus acts “in favor” rather than “against” 
prionization.  One possibility is that interactions with the host-specific cellular factor, 
such as chaperone Hsp104 [88, 89], partly modulated by Sup35M [90], might influence 
physical stability of heteroaggregates and/or a freshly generated heterologous prion (see 
future discussion in Chapter 6, Model Fig. 58). If so, this may point to an additional level 
at which specificity of cross-species prion transmission could be controlled. However it 
should be noted that, in general, correlation between the mitotic instability (observable 
after 20-40 generations for weak prions in general and some heterologous prions in 
particular, see Table 11 (Appendix)) and species barrier has not been observed, as  some 
constructs exhibiting instability (e.g. Sb-Sp-Sp) did not show a strong barrier.  
 
3.4.2 Prion variants and species barrier 
Our results confirm previous findings in mammalian and yeast systems showing 
that variant-specific patterns of a prion affect cross-species prion transmission. In 
addition, we also demonstrate that different prion variants of Sup35 may influence prion 
transmission at a different level. The stringency of the prion variant influenced cross-
species prion transmission to different orthologous proteins in different ways, so that a 
strong prion variant was transmitted to S. paradoxus PrD more efficiently than a weak 
variant, while for S. bayanus PrD, the ratio was the opposite (Fig. 15 (B) and 16 (B). 
Interestingly, the S. bayanus PrD usually drives a weak prion phenotype in S. cerevisiae 
[46], and this pattern is, at least in part, controlled by its module II region including the 





The weak S. cerevisiae [PSI
+
] prion variants possess a larger portion of the PrD 
that is “protected” from hydrogen exchange and is, therefore, likely to be included in the 
β-structured region [38]. Weak variants also require a larger PrD region for the faithful 
propagation of variant-specific patterns [70, 71, 63], as compared to the strong prion 
variants. It is possible that prions formed by S. bayanus PrD are weak because shorter β-
structured regions are insufficient for keeping this protein in the amyloid-proficient state.  
Therefore, more efficient transmission of the weak S. cerevisiae prion variant to S. 
bayanus PrD could be due to a larger size of the β-structured region involved in such a 
conversion, while a shorter region generated in the case of a strong prion cannot be stably 
maintained by the S. bayanus PrD sequence. 
 
3.4.3 The fidelity of cross-species prion conversion 
While transmission of the prion state from the S. cerevisiae protein to a protein 
with the S. paradoxus PrD, or transmission of the weak S. cerevisiae prion to a protein 
with the S. bayanus PrD resulted in phenotypically weakened prion variants, the patterns 
of the original S. cerevisiae prion were restored after reverse transmission back to S. 
cerevisiae protein (Fig. 17 and Fig. 21).  Possibly in these cases, sequence divergence led 
to the alteration of growth and/or fragmentation kinetics of prion polymers; however, the 
structural characteristics of prion units remained faithfully reproducible and were restored 
upon return back to the original sequence. In contrast, the variant patterns were switched 
irreversibly when strong S. cerevisiae prion was transmitted to the protein with S. 
bayanus PrD and then back to S. cerevisiae protein (Fig. 17 and Fig 19). Perhaps the 




only in exceptional situations when an extended β-structured region is occasionally 
formed in the heteroaggregate. Resulting S. bayanus prion represents a new (weaker) 
variant which in turn, generates weaker variants of the S. cerevisiae prion in the reverse 
shuffle. Appearance of the multiple prion variants reflects imprecise interactions between 
the divergent PrD regions. Such a mechanism could fit into the “conformational 
selection” model [12], with a clarification that formation of the new conformational 
variant is stimulated within a heteroaggregate when accurate transmission of the 
properties of a pre-existing conformer is impaired due to differences in the sequence. It is 
unlikely that new conformers pre-exist in the strong prion “population,” as intraspecies 
transmission of the strong prion does not produce weak variants at a detectable level. The 
variant switch apparently does not occur in the case of transmission of the weak S. 
cerevisiae prion variant via S. bayanus PrD (Fig. 21) as the weak variant already contains 
a large β-structured region. Generation of multiple prion variants was previously reported 
in the case of promotion of prion formation by a highly divergent Sup35 protein [43]; 
however, this occurred with a much lower frequency than in the S. bayanus / S. cerevisiae 
reverse shuffle. Prion transmission between some artificially modified derivatives of 
Rnq1 protein with altered combinations of prionogenic regions also generated multiple 
prion variants [53].  
 
3.4.4 Identity determinants of prion proteins 
  Previous work with highly divergent Sup35 proteins implicated the N-proximal 
QN-rich region of the PrD, encompassing the first 40 aa residues, as a major determinant 




25, 26 and 27) surprisingly show that in the S. cerevisiae / S. bayanus combination, 
specificity of transmission is primarily determined by module II of PrD encompassing 
residues 34-96. As the “tail” of the QN region located within module II (positions 34-40) 
is identical in both species, it is obvious that sequence elements located within the region 
of ORs contribute to transmission specificity. Indeed, mutational alteration at position 50 
(Fig. 31 and/or addition of the missing OR unit to S. bayanus PrD significantly increased 
cross-species prion conversion (Fig. 25 and Fig 26).    
Moreover, even in the S. cerevisiae / S. paradoxus combination where the QN 
region is the primary determinant of the species barrier, it is not the overall sequence 
divergence of this region that is most important.  Indeed, the QN region of S. paradoxus, 
which is responsible for the barrier in transmission of a weak prion from S. cerevisiae, is 
less divergent from S. cerevisiae than is the QN region of S. bayanus which does not 
show a barrier (Fig. 23 and Fig 25, (B). A combination of the QN region of S. bayanus 
with the rest of the PrD sequence from S. paradoxus generates an artificial PrD that is 
highly susceptible to transmission of prion state from S. cerevisiae (Figures 25, 26 and 
27), despite retaining only about 93% of sequence identity.  This is less than in case of 
the complete S. paradoxus PrD (94%) which does not exhibit such promiscuity, at least 
for the weak prion variant. In contrast, the reciprocal chimeric combination (Sp-Sb-Sb) 
possesses a slightly higher identity to the S. cerevisiae PrD than does the complete S. 
bayanus PrD but exhibits an even stronger barrier. The only plausible explanation for 
these phenomena is that identity of the relatively short aa stretches located at different 
positions within the PrD is more important for determining conversion specificity than is 




least two short stretches, one of which is located within the QN region and is identical 
between S. cerevisiae and S. bayanus but different in S. paradoxus, while another stretch 
is located within ORs region and is identical for S. cerevisiae and S. paradoxus but 
different in S. bayanus, we would get the observed results. This model also agrees with 
the recent observations for Rnq1 prion, where multiple prion determinants control 
transmission specificity [53].  
 Remarkably, our search for the altered prion identity determinant located within 
module I (QN region) of S. paradoxus led to the base substitution at position 12, that 
disrupts the only hexapeptide in module I satisfying the requirements for the amyloid 
stretch (Fig. 22), a consensus sequence detected in most proteins that efficiently form 
amyloids in vitro [92, 74]. Even though position 12 is not solely responsible for the 
barrier, its alteration has a drastic effect on the efficiency of cross-species prion 
transmission (Fig. 28 and Fig. 30). Notably, single aa substitutions with an anti-prion 
effect were previously generated in the region between positions 8 and 26 that surrounds 
and includes amyloid stretch I [59]. Amyloid stretch I also overlaps with the Sup35N 
peptide (7-13) shown to form amyloid-like microcrystals in vitro [93], and is included in 
the region between positions 9 and 20, present in all peptides capable of efficiently 
immobilizing Sup35NM on the peptide array in vitro and promoting its conversion into 
an amyloid [72].  
There are two more amyloid stretches in the S. cerevisiae Sup35 PrD, that are 
located within modules II (ORs region) and III, respectively (Fig. 22 and Fig. 23). 
Consensus of stretch II is broken by an aa substitution at position 50 in S. bayanus (Fig. 




cross-species prion transmission (Fig. 31). Interestingly, substitutions within amyloid 
stretch I or II weaken the phenotypic patterns of the S. cerevisiae prion (Fig. 29 and Fig. 
32). However, none of these substitutions alone is sufficient for the irreversible variant 
switch. Stretch III, located at positions 102-107, is conserved in S. paradoxus and 
conforms to consensus requirements despite two aa substitutions in S. bayanus (Fig. 22). 
Interestingly, this stretch is located within the second (less stringent) region of 
intermolecular interactions uncovered by the peptide array analysis [72]. It remains to be 
seen if alterations within this region contribute to the species specificity of prion 
transmission. 
 In addition to specific sequences, the size of a PrD is apparently playing a role in 
the species barrier, as it could be seen in the case of addition of a missing OR unit to S. 
bayanus PrD (Figures 24, 25, 26 and 27) Possibly, PrD size is important for the proper 
formation of the β-structured amyloid core and/or for correct alignment of the interacting 
sequences in different amyloid units. Experiments with Rnq1 protein also indicate that 
alterations of PrD size via removing certain prionogenic regions influence efficiency of 
prion transmission between the normal and altered protein [53].   
The specific mechanism of the action of amyloid stretches remains unclear, as 
structural models of Sup35 amyloids, based on different experimental approaches, 
disagree with each other (for example, see [68, 65, 66]. It does not seem likely that 
amyloid stretches, deduced from in vitro experiments, are required for the prion 
formation in yeast per se, as some yeast  PrDs (e. g. Ure2) do not appear to contain them 
(data not shown). Attempts were made recently to define compositional determinants of 




[94]. However, it is possible that amyloid stretches mark some (although not necessarily 
all) regions of intermolecular interactions determining the specificity of transmission of 
the amyloid state to a newly immobilized protein molecule, rather than the initial amyloid 
formation. Due to a significant level of flexibility allowed by consensus requirements for 
an amyloid stretch, it can potentially be formed in various sequences of similar aa 
composition. Indeed, each of the “reshuffled” Sup35 PrDs retaining prion-forming 
properties [96, 97] contains one or more amyloid stretches, however of different 
sequences and locations (data not shown), which may explain the generation of prion 
transmission barriers between these proteins. Previous data for both chimeric Candida-
Saccharomyces prion [42] and mammalian prions [95, 69] demonstrated that even single 
aa substitutions may generate transmission barriers, suggesting that short stretches rather 
than large regions are involved in control of prion specificity in these cases as well.  
Further experiments are needed to completely decipher the in vivo code of amyloid 
recognition.  
 
3.5. MODEL FOR SPECIFICITY AND FIDELITY OF PRION TRANSMISSION 
 
We propose that the specificity and fidelity of amyloid transmission is primarily 
determined by the identity of short amino acid sequences, termed “specificity stretches” 
(Fig. 34) These sequences initiate intermolecular interactions, immobilizing new 
molecules into an amyloid. Association of heterologous molecules at only one specificity 
stretch is insufficient for prion conversion. Specificity stretches also control the variant-
specific prion patterns via determining the location and size of the cross-β region. 
Formation of the intermolecular “zippers” by at least two stretches initiates generation of 




interactions may include more than two stretches and multiple cross-β regions can be 
formed, but existing data are insufficient to state this with certainty.)  
If at least one of the stretches in a newly joining molecule is altered, heterologous 
association may still occur, but conversion of the new molecule into a prion could be 
impaired, thus generating a barrier. In the case of a reversible change in the variant-
specific patterns (as in the S. cerevisiae / S. paradoxus combination), the interaction 
between the altered stretches still occurs, but it is weakened. However, the size of the 
cross-β core remains intact after cross-species transmission, and only the stringency of 
intermolecular interactions is changed, leading to alteration of either the rate of polymer 
growth or efficiency of its fragmentation by Hsp104, thus altering the phenotypic 
manifestation of the variant patterns. Restoration of sequence identity restores the 
original prion variant. 
In the case of a variant switch (as in S. cerevisiae / S. bayanus combination), the 
interaction between altered sequences within one of the pairs of specificity stretches is 
too weak to initiate the cross-β structure. However, the occasional use of secondary 
specificity stretch(es), located outside of the typical core region, may overcome the 
barrier (Fig. 34). In this case, a new prion variant can be generated, with a cross-β region 
of a different location and/or size. As alternative stretches located at different positions 
could be employed, multiple variants with the cross-β core of different locations and /or 
sizes can be formed. A weak prion does not show a variant switch in the same 
combination, as its core region is longer and is initiated by other (possibly unaltered or 




In the parallel in-register ß-sheet model [1, 48, 49], specificity stretches would be 
located on the flanks of the cross-β region and would be responsible for initiation of its 
formation (Fig. 34).  In another proposed β-helical model [50] (not shown), specificity 
stretches may coincide or overlap with “recognition elements” that are responsible for the 
“head-to-head, tail-to-tail” intermolecular interactions, holding the units of the amyloid 
fiber together. However, it should be noted that the ß-helical model does not currently 
suggest a mechanism for continued propagation of distinct variants formed by protein of 
the same sequence.  
Recent experiments with mammalian PrP [57] suggest that, in reality, at least 
some prion variants (“strains”) represent a mixture of the sub-variants (“substrains”) from 
which different predominant variants could be selected in specific conditions. Within the 
framework of our model, this could be explained by limited range of fluctuations in size 
of the cross-region. Sub-variant selection may provide an additional mechanism for the 
reversible change in prion phenotypic manifestations, as different sequences may provide 
an advantage to different subvariants. Formation of multiple variants as a result of a 
variant switch could reflect fixation of different subvariants as new variants after crossing 
the transmission barrier.  
 
 
Figure 34: Model for strain adaptation. “Sc” and “Sb” refer to S. cerevisiae 
and S. bayanus, respectively. Box regions depict areas of the prion core 






















































the soluble portion of the protein. A prion may make efficient interactions 
with key sequence stretches (shown as red and cerulean) in a homologous 
monomer and readily transmit the prion state to the same protein. Regions of 
sequence divergence in these stretches between heterologous proteins may 
prevent or inhibit typical points of interaction, causing a species barrier. In 
rare cases, atypical interactions at different sequence stretches (shown as 
navy) may facilitate transmission to a heterologous protein. This could change 
the borders of the prion core, expanding it and altering the variant. This new 
variant may then be transmitted back to the original protein, resulting in a 
permanent variant switch through propagation in a heterologous protein. 
 
3.6 CHAPTER 3 CONCLUSIONS: 
 The efficiency of cross-species conversion is influenced by the prion variant 
 Variant-specific prion patterns can be altered irreversibly during cross-species 
transmission.  
 Heterologous conversion can be imprecise and generate multiple variants of a 
prion. 
 Module I of S. paradoxus is responsible for the transient decrease in [PSI+] 
phenotypic stringency and for the species barrier. The region encompassing 
modules II and III of S. paradoxus exhibits little or no effect.  
 Module II of S. bayanus was responsible for the species barrier, while modules I 
and III of S. bayanus exhibited little or no effect. 
 In addition to controlling the frequency of cross-species prion conversion in the S. 
cerevisiae / S. bayanus combination, module II also controls the fidelity of 
reproduction of the variant-specific prion patterns via a heterologous stage.   
 The size of module II plays a role in cross-species prion transmission together 




 A single amino acid substitution at position 12 of the Sup35 protein plays an 
important role in both specificity of prion transmission and stringency of the prion 
isolates obtained from cross-species conversion, but is not solely responsible for 
the specificity. 
 A single amino acid substitution at position P50 in the Sup35 protein significantly 
affected cross-species transmission of both strong and weak S. cerevisiae prions 
to the mutated protein.  
 Our data suggest the important of amyloid stretches, rather than overall sequence 


























4.1 CHAPTER SUMMARY 
 Initial investigations of sequence-dependent effects on species barrier and prion 
interference were performed in the S. cerevisiae cell environment. Interestingly, both 
transitory and permanent phenotype changes to [PSI
+
] were observed when the prion was 
transmitted through proteins from different species and back to the original Sup35Sc 
protein. Presumably, the transitory phenotype changes may be due to differential 
interactions with S. cerevisiae cellular factors such as chaperones that fragment [PSI
+
] 
aggregates. However, the extent of the influence of protein sequence vs. cell environment 
was unknown. It was hypothesized that performing the same experiments in related 
species would facilitate identification of species-specific cellular factors contributing to 
these processes. The closely related S. paradoxus and S. bayanus members of the 
Sacccharomyces sensu stricto group were selected for these comparisons, thus 
necessitating the genetic strain modifications described in this chapter. In addition, we 
show that strong and weak [PSI
+
] used for experiments in S. cerevisiae (see Chapter 3) 
were transfected to the modified S. paradoxus and S. bayanus strains in attempts to 











Plasmids PFA6a-kanMX6 [83], pBluescript-URA3 I plasmid (constructed by J. 
Kumar), pRS303N [84], and pRS303H [84] were used in PCR to amplify genes used for 
genetic markers. Plasmid pRS317 was used in the S. paradoxus ade1-14Sc construction 
(as described) to increase transformation efficiency of the PCR product. 
4.2.2 Strains 
Descriptions and genotypes of all S. paradoxus, S. bayanus, and S. cerevisiae 
strains used or constructed in this study are described in Chapter 2 and are listed in Table 
1 (Appendix).  
 
4.3 RESULTS AND DISCUSSION 
4.3.1 S. paradoxus and S. bayanus strain modifications: auxotropic mutations 
 
Generation of lys2 and ura3-P2 mutations 
Both the lys2 and ura3-P2 auxotrophic mutations were present in all S. paradoxus 
and S. bayanus strains used for this work. Gary Newnam (Chernoff lab) introduced both 
mutations in S. paradoxus and the lys2 mutation in S. bayanus by subjecting the strains to 
UV light for 15-45 seconds to induce each mutation (Fig. 39). For S. paradoxus, haploid 
versions containing each mutation were independently obtained and mated to generate 
diploids having both the lys2 and ura3 genotype. Diploids were sporulated, dissected and 
plated on –Ura and –Lys medium to verify the diploid contained both mutations. For S. 





Figure 39: Generation of lys2 and ura3-P2 mutants in S. paradoxus 
and S. bayanus. A—A diploid S. paradoxus strain was irradiated with UV 
light for 15-45 seconds and was plated on α-aa medium to select for lys2 
mutants and also independently on 5-FOA medium to independently select 
for ura3 mutants. Haploid versions of strains containing a mutation were 
mated to generate diploids and were sporulated and dissected, and selected 
for the inability to grow on both –Ura and on –Lys media.  B—A haploid 
S. bayanus strain already containing the ura3 mutation was irradiated with 
UV light for 15-45 seconds and was plated on α-aa medium to select for 
lys2 mutants.  
 
 
4.3.2 S. paradoxus strain constructions 
 
HO disruption (Fig. 40, A) 
Haploid yeast can switch between two distinct mating types (a and α), frequently 
producing undesirable diploid strains from haploid strains. A gene coding for the 
homothallic switching endonuclease (HO) initiates mating-type conversion by 
engineering a double-stranded DNA break, facilitating homologous recombination to 
replace the particular MAT allele. S. paradoxus mating-types were stabilized by HO 
replacement with the bacterial KANMX6 gene. (See Figure 4.X).  
To prevent a mating type switch, KANMX6 (highlighted in gray) was amplified 














































homology to flanking regions of the S. paradoxus HO gene on both sides. The PCR 
fragment was used to transform the GT749-1B S. paradoxus diploid strain (homozygous 
for the wildtype HO gene), and the fragment was incorporated by homologous 
recombination. Replacement of HO by KANMX6 conveyed G418 resistance in yeast, and 
PCR was used to verify the gene disruption. A haploid strain having the desired 
ho::KANMX6 genotype was obtained by sporulation and dissection. (HO replacement 
was performed by B. Chen) 
 
Generation of the ade1-14Sc mutation in S. paradoxus (Fig 40, B-C) 
In S. paradoxus, replacement of the wildtype ADE1 allele with the ade1-14Sc 
mutant allele was desired to facilitate [PSI
+
] detection by read-through suppression (see 
Figure 4).  Specifically, ade1-14 originating from S. cerevisiae (“ade1-14Sc”) was desired 
for comparison of [PSI
+
] between different Saccharomyces species. The replacement was 
performed in two steps. 1) Disruption of ADE1 by URA3Sc followed by 2) URA3Sc 
replacement with ade1-14Sc. To disrupt ADE1 in S. paradoxus with URA3 from S. 
cerevisiae (URA3Sc), URA3Sc was PCR amplified from the pBluescript-URA3 I plasmid 
(constructed by J. Kumar) using primers with 40 bp 5’ extensions having homology on 
both sides to ADE1. The PCR fragment was used to transform a S. paradoxus haploid 
strain having a wildtype copy of ADE1 and was incorporated by homologous 





and were selected on synthetic “drop-out” media. 
 Both ade1-14Sc and ura3 mutations were desired in S. paradoxus for [PSI
+
] 
detection and for auxotropic selection, respectively. To create these, ade1-14Sc 




bp 5’ extensions homologous to flanking regions of URA3SC. To further increase the 
length of the homologous regions for more efficient homologous recombination, a second 
round of PCR was performed. The product from the first round was used as a template to 
add additional 80 bp 5’ extensions homologous to flanking S. paradoxus sequences 
located further upstream and further downstream, respectively. The final PCR product 
contained 140 bp 5’ extensions and was transformed together with the pRS317 LYS2 
plasmid (to increase transformation efficiency) into a haploid ade1Δ::URA3SC S. 
paradoxus strain. Homologous recombination produced target ade1-14, ura3 
transformants that were selected on 5-FOA media and were subsequently tested on –Ade 
and –Ura media. These were further verified by PCR and sequencing. A strain containing 
ADE1 from S. cerevisiae (rather than ade1-14) was also created using the same steps 







Figure 40 S. paradoxus strain construction steps. A—The HO gene was 
disrupted by replacement with the bacterial KANMX6 gene as described in 
section 4.3.2. B— The ADE1 gene in S. paradoxus was disrupted by the 
URA3 gene from S. cerevisiae (URA3Sc) as described in section 4.3.2. C— 
ade1-14 and ura3 mutations were engineered by replacing URA3SC 
(previously inserted to disrupt ADE1) with ade1-14Sc as described in 
section 4.3.2. D— The SUP35 gene in a S. paradoxus chromosome was 
replaced by natNT2 (conveying resistance to nourseothricin) as described 
in section 4.3.2.  E— A S. paradoxus strain having both the ade1-14 and 
sup35Δ::natNT2 genotype, was obtained by crossing two S. paradoxus 
yeast strains (one containing ade1-14 and another containing 
sup35Δ::natNT2 and a wildtype copy of SUP35 on a plasmid) of opposite 


























































































Generation of sup35Δ::natNT2 in S. paradoxus (Fig 40, D) 
In S. paradoxus, deletion of the chromosomal SUP35 gene was desired for study 
of complete or chimeric SUP35 versions (on a centromeric plasmid) originating from 
different species. The SUP35 gene on a S. paradoxus chromosome was replaced by 
natNT2 (conveying nourseothricin resistance). PCR was used to amplify NatNT2 
(highlighted in gray) from plasmid pRS303N [84]. The primers had 40 bp 5’ extensions 
with homology to flanking regions of the S. paradoxus SUP35 gene on both sides. The 
PCR fragment was used to transform a diploid S. paradoxus strain homozygous for 
wildtype SUP35 and was incorporated by homologous recombination. An essential 
SUP35 copy was provided on a plasmid. This was followed by sporulation and 
dissection, and sup35Δ::natNT2 recombinants were selected on YPD with added 
nourseothricin. The sup35Δ::natNT2 replacement was performed by B. Chen 
 
Generation of a S. paradoxus strain having both ade1-14Sc and sup35Δ::natNT2  
(Fig 40, E) 
To obtain a S. paradoxus strain having both the ade1-14 and sup35Δ::natNT2 
genotype, two S. paradoxus yeast strains (one containing ade1-14 and another containing 
sup35Δ::natNT2 with a wildtype copy of SUP35 on a plasmid ) of opposite mating type 
were crossed and followed by sporulation and dissection. Synthetic “drop out” media and 
YPD containing nourseothricin were used to screen for the desired phenotype. The strain 






Generation of hsp104Δ::HYG in S. paradoxus 
A hsp104Δ S. paradoxus strain was required for mating interference experiments, 
so HYG was amplified from the pRS303H plasmid with primers each having a 20 bp 
homology to HYG and a 40 bp flanking region complementary to HSP104 from S. 
paradoxus. The PCR product was transformed into the desired S. paradoxus strain and 
was incorporated by homologous recombination. YPD containing hygromycin was used 
to select for colonies with the hsp104Δ::HYG genotype. The strain having ade1-14Sc, 




Figure 41 S. paradoxus hsp104Δ strain construction steps. HYG Was 
amplified from plasmid pRS303H using primers with homology to HYG 
and flanking regions homologous to HSP104Sp. The PCR product was 
transformed into a S. paradoxus strain and was incorporated by 
homologous recombination. Target colonies having hsp104Δ were 




4.3.3 S. bayanus strain constructions (by B. Chen) 
 
HO disruption 
The S. bayanus strains obtained from N. Talarek already had the HO replacement with 



























Generation of the ade1-14Sc mutation in S. bayanus (Fig 42, A-B) 
In S. bayanus, replacement of the wildtype ADE1 gene with the ade1-14 mutant 
allele was desired to facilitate [PSI
+
] detection by read-through suppression (see Figure 
4).  Specifically, ade1-14 originating from S. cerevisiae (“ade1-14Sc”, used in previous S. 
cerevisiae experiments) was employed for comparison of [PSI
+
] between different 
Saccharomyces species. This replacement was performed in two steps. 1) Disruption of 
ADE1 by URA3Sc, followed by 2) replacement of URA3Sc with ade1-14Sc. To disrupt the 
ADE1 gene in S. bayanus with the URA3 gene from S. cerevisiae (URA3Sc), URA3 Sc was 
PCR amplified from the pBluescript-URA3 I plasmid (constructed by J. Kumar) using 
primers with 40 bp 5’ extensions having homology on both sides to ADE1. The PCR 
fragment was used to transform a S. bayanus haploid strain having a wildtype copy of 
ADE1 and was incorporated by homologous recombination. Target ade1Δ::URA3Sc 




 phenotype and were selected on synthetic “drop-out” 
media. Both ade1-14Sc and ura3 mutations were desired in S. bayanus for [PSI
+
] 
detection and for auxotropic selection, respectively. To create these, ade1-14 (highlighted 
in gray) from a S. cerevisiae strain was PCR amplified using primers with 60 bp 5’ 
extensions homologous to flanking regions of the URA3Sc on the S. bayanus 
chromosome. The final PCR product was transformed into a haploid ade1Δ::URA3SC S. 
bayanus strain. Homologous recombination produced target ade1-14, ura3 




 phenotype. These were selected on 5-FOA media 
and were subsequently tested on –Ade and –Ura media. These were further verified by 
sequencing. A S. bayanus strain containing ADE1 from S. cerevisiae (rather than ade1-






Figure 42 S. bayanus strain construction steps. A— The ADE1 gene in 
S. bayanus was disrupted by the URA3 gene from S. cerevisiae (URA3SC) 
as described in section 4.3.3. B— ade1-14 and ura3 mutations were 
engineered by replacing URA3Sc (previously inserted to disrupt ADE1) 
with ade1-14Sc as described in section 4.3.2. C—The SUP35 gene in a S. 
bayanus chromosome was replaced by natNT2 as was described in section 
4.3.3.  
 
Generation of sup35Δ::natNT2 in S. bayanus (Fig 42, C) 
In S. bayanus, deletion of the chromosomal SUP35 gene was desired for study of 
various complete or chimeric SUP35 versions (on a centromeric plasmid) originating 
from different species. The SUP35 gene on a S. bayanus chromosome was replaced by 
natNT2 (conveying resistance to nourseothricin). PCR was used to amplify natNT2 
(highlighted in gray) from plasmid pRS303N [84]. The primers had 40 bp 5’ extensions 
with homology to flanking regions of the S. bayanus SUP35 gene on both sides. The PCR 
fragment was used to transform a diploid S. bayanus strain (ADE1/ade1Δ::ade1-14SC 


















































homologous recombination. An essential copy of SUP35 was provided on a centromeric 
plasmid. This was followed by sporulation and dissection, and sup35Δ::natNT2, ade1-









] can be transferred across the cell 
membrane of a [psi
-
] strain to induce prion infection (Section 2.2.4, Fig. 9). The 
“transfection” process differs from de novo [PSI
+
] formation by introduction of a pre-
formed aggregate, reflecting characteristic of unique conditions of its induction 
environment. Typically, in the same species, the phenotype of a particular [PSI
+
] donor 
variant is expected to be faithfully perpetuated in a recipient protein of the same 
sequence. However, transfection of prion material into a new species may cause the 
transfected prion to exhibit a phenotype unlike de novo [PSI
+
] formed in the same cell 
environment. This may occur even though the recipient strain expresses the same protein. 
Transfection, thus, becomes a valuable tool, giving us the ability to examine one and the 
same prion variant in different cellular backgrounds, providing insight into the effects of 
the cell environment on [PSI
+
] maintenance.  
In addition, we show it is possible to transfect a donor prion formed in one 
Saccharomyces species into a different Saccharomyces species and observed that at least 
some properties of prion variants are maintained by the same protein in the cells of a 
different species (Fig 43). For example, cellular extract transfected from the GT256-23C 
strong [PSI
+
] S. cerevisiae strain generated strong [PSI
+
] in both S. paradoxus and S. 
bayanus [psi
-
] recipient species (Fig 43). Strong [PSI
+




S. paradoxus was found to propagate a stable strong [PSI
+
] phenotype (See Table 12 




 Cell extract from the GT988-1A weak [PSI
+
] S. cerevisiae strain generated weak, 
unstable [PSI
+
] in S. paradoxus, but no prion was detected with the YPD color assay or –
Ade suppression assay following transfection of weak [PSI
+
] to S. bayanus. Interestingly, 
the conventional YPD color assay and –Ade suppression assay were less useful for [PSI
+
] 
detection in S. bayanus, although a subtle [PSI
+
]-dependent color difference was 
observed (for transfection of a strong variant) on synthetic media lacking uracil and 
tryptophan (-Ura-Trp). Because of this difference, a boiled-gel approach was effectively 
used for [PSI
+




Figure 43: Cross-species prion transfection from S. cerevisiae. A — 
Cellular extract was transfected from either a strong or weak [PSI
+
] S. 
cerevisiae (Sc) strain into a [psi
-
] S. paradoxus (Sp) strain, expressing a 
version of Sup35 from S. cerevisiae. Representatives of [PSI
+
] S. 
paradoxus transfectants obtained from either the strong (left) or weak 
(right) [PSI
+
] donor strains are shown. Yeast were grown on YPD (for 
color assay) and on –Ade medium (for suppression assay) at 30°C for 8 
days.   B — Cellular extract was transfected from a strong [PSI
+
] S. 
cerevisiae (Sc) strain into a [psi
-
] S. bayanus (Sb) strain, expressing a 
version of Sup35 from S. cerevisiae. A Representative [PSI
+
] S. bayanus 
transfectant obtained is shown. No [PSI
+
] phenotype was observed for S. 
bayanus transfected with cellular extract from a weak [PSI
+
] S. cerevisiae 






]-dependent color difference on –Ura-Trp was noted for the S. 
bayanus species.  C— Transfectant potentials (Colonies transformed by 
the empty –Ura marker plasmid) were replica plated onto YPD, -Ade, and 
–Ura-Trp  to look for potential [PSI
+
] transfectants. The total number of 
colonies tested is recorded with those displaying a potential [PSI
+
] 
phenotype labeled as “potentials”.  Colonies biochemically examined for 
[PSI
+
] and numbers of verified [PSI
+
] colonies are indicated. D — A 
“boiled gel” verified the [PSI
+
] phenotype for S. bayanus transfected with 
cellular extract from a strong [PSI
+
] S. cerevisiae strain. No aggregated 
Sup35 was observed for two randomly chosen S. bayanus colonies 
obtained after attempts to transfect cellular extract from a weak [PSI
+
] S. 
cerevisiae strain. These 2 colonies obtained the URA3 marker plasmid but 
may not have taken up the protein. A negative control having S. bayanus 
transfected without cellular extract did not show any aggregated Sup35. 
 
4.5 CHAPTER 4 CONCLUSIONS: 
 Cross-species prion transfection can be successfully performed to introduce a pre-
formed aggregate into a different species. 
 At least some underlying properties of prion variants are maintained after cross-
species [PSI
+























CHAPTER 5: COMPARISON OF SPECIES BARRIER IN S. 
PARADOXUS VS S. CEREVISIAE 
 
 
5.1 CHAPTER SUMMARY 
As described in Chapter 3, a shuffle procedure performed in both a strong and a 
weak [PSI
+
] S. cerevisiae variant produced a clear species barrier to prion transmission. 
We questioned whether the barriers obtained were due to interactions of the proteins, 
themselves, or could be partially attributed to factors present within the particular cell 
environment. To test this, the same experiments were performed in a different cell 
environment (S. paradoxus) and are presented in this chapter for comparison with results 





Centromeric plasmids expressing chimeric SUP35 versions or complete SUP35 versions 
originating from S. cerevisiae, S. paradoxus, or S. bayanus are described in Chapter 2. 
5.2.2 Strains 
S. cerevisiae, S. paradoxus, and S. bayanus strains used for plasmid shuffle, cytoduction, 








5.3 RESULTS AND DISCUSSION 
5.3.1 The effect of cell environment on a species barrier 
 
Comparison of cross-species transmission in strong [PSI
+
] S. paradoxus vs. S. 
cerevisiae using direct shuffle 
To begin with the same variant used in S. cerevisiae, cell lysate from a strong or 
weak Sup35Sc [PSI
+
] variant was transfected into a haploid S. paradoxus strain that 
expressed the same SUP35Sc version (Fig 43, A). Next, a shuffle procedure was 
performed in the S. paradoxus strong [PSI
+
] variant. Phenotypes in S. paradoxus 
produced from transmission to heterologous proteins are presented in Figure 44.  
 
Figure 44: Phenotypes of [PSI
+
] produced from direct transmission in 
S. paradoxus. Direct shuffle experiments for strong [PSI
+
] and in S. 
paradoxus were performed as on Fig. 1 22).1. Numerals I, II, and III refer 
to the exchangeable modules of the PrD (Fig. “Sc”, “Sp”, and “Sb” refer 
to S. cerevisiae, S. paradoxus, and S. bayanus, respectively. Phenotypic 
patterns of strong prion variant are changed when transferred to the new 
protein. –Ade and YPD plates were photographed after 8 days. 
 
Results listing the efficiency of prion transmission to different Sup35 PrDs are 
shown in the Appendix on Table 13 (Appendix) and are compared to results obtained in 
S. cerevisiae (Fig 45). For both cell environments, a very strong barrier was observed for 
Sup35 S. cerevisiae transmission to the Sup35 S. bayanus PrD. In fact, the barrier was 
absolute in the S. paradoxus cell environment (0% transmission in the S. paradoxus cell, 






phenotype for Sup35Sc transmission to any Sup35 PrD chimera comprised of 
combinations of S. cerevisiae and S. paradoxus. Transmission to any Sup35 S. 
cerevisiae/S. bayanus PrD chimera that contained module II from S. bayanus created a 
weak prion with a dark pink color on YPD and noticeable darker brown phenotype on 
YPD and -Ade medium (Fig. 44)  
A shuffle procedure from the weak [PSI
+
] S. paradoxus variant to different PrDs 
was also attempted. However, a majority of colonies lost [PSI
+
] during the transformation 
process, preventing analysis of transmission efficiency. 
  
 
Figure 45: Comparison of prion transmission barriers in performed 
in S. cerevisiae and S. paradoxus. Direct shuffle experiments for strong 
[PSI
+
] in S. cerevisiae (presented in Chapter 3) and in S. paradoxus were 
performed as on Fig 11. Numerals I, II, and III refer to the exchangeable 
modules of the PrD (Fig 22). “Sc”, “Sp”, and “Sb” refer to S. cerevisiae, S. 
paradoxus, and S. bayanus, respectively. Frequencies of prion 
transmission are shown above each bar. Red and blue bars indicate that the 
experiment was performed in the S. cerevisiae or S. paradoxus cell 
environments, respectively. See Tables 5 and Table 13 in the Appendix for 












1 2 3 4 5 6 7 8 9
99 97
12
































































Reverse shuffle in S. paradoxus 
 Similar to results in S. cerevisiae, direct transmission produced weaker than the 
original strong [PSI
+
] phenotypes when donor proteins had S. paradoxus and S. bayanus 
PrDs (Fig 44 and Fig 47) and for certain versions with S. cerevisiae /S. paradoxus or S. 
cerevisiae/ S. bayanus chimeric PrDs. We questioned whether this is caused by transitory 
interactions between the new protein and cellular factors or is due to a permanent 
structural change in the folding of the prion core. To test this, a reverse shuffle was 
performed to transfer the prion back to the original Sup35Sc protein (See Table 14 in the 
Appendix) 
 A comparison is made to reverse shuffle results obtained for S. cerevisiae 
(Chapter 3) in Figure 46. In general, reverse shuffle results for strong [PSI
+
] in the S. 
paradoxus cell environment show similar trends to results obtained in S. cerevisiae. 
Reverse shuffle from the Sup35 S. paradoxus PrD or from chimeric PrD’s comprised of 
modules from S. cerevisiae and S. paradoxus (having a weak [PSI
+
] phenotype) to the S. 
cerevisiae PrD restored the original strong [PSI
+
] variant. This implicates the efficiency 
of interactions between the S. paradoxus PrD with cellular factors as the cause for the 
weakened phenotype rather than a permanent structural change to the prion core. 
Conversely, reverse shuffle beginning with any version of chimeric Sup35 having module 
II originating from S. bayanus transmitted a weak [PSI
+
] variant to the original Sup35Sc 
protein, suggesting a permanent structural change caused by propagation through the 
heterologous protein. It is important to note that no prion was transmitted in direct shuffle 
from the Sup35 S. cerevisiae PrD to the complete S. bayanus PrD, so only chimeric 




direct and reverse shuffle results showed that the major rules of a transmission barrier are 
generally invariant in S. cerevisiae and S. paradoxus host cells and do not depend on the 
presence of the [PIN
+
] prion, although some specific numerical differences were detected. 
Therefore, both transmission barrier and conformational fidelity appear to be primarily 
determined by the protein itself rather than by the cell environment 
 
Figure 46: Comparison of reverse prion transmission for reverse 
shuffle in S. cerevisiae and S. paradoxus. Reverse shuffle experiments 
for strong [PSI
+
] in S. cerevisiae and in S. paradoxus were performed as 
on Fig 11. Numerals I, II, and III refer to the exchangeable modules of the 
Sup35 PrD (Fig 22). “Sc,” “Sp”, and “Sb” refer to S. cerevisiae, S. 
paradoxus, and S. bayanus, respectively. Frequencies of prion 
transmission are shown above each bar.  Red and blue bars indicate that 
the experiment was performed in the S. cerevisiae or S. paradoxus cell 
environments, respectively. Reverse transmission from the complete S. 
bayanus PrD was not possible, as no colonies were obtained from direct 
shuffle due to an absolute transmission barrier. Numbers showing reverse 
transmission from the Sc-Sb-Sc chimeric PrD was not presented due to 
few colonies available from direct shuffle for testing. See Tables 9 and 14 










































































Figure 47: Reproduction and switch of prion variants in cross-species 
transmission in the S. paradoxus cell environment. Patterns of [PSI
+
] 
isolates obtained from a strong S. cerevisiae prion variant in the S. 
paradoxus cell environment went through direct shuffle to the control S. 
cerevisiae Sup35 protein or chimeric proteins with either S. paradoxus 
PrD or S. bayanus Module II PrDs, followed by reverse shuffle back to S. 
cerevisiae Sup35 (Fig 11). “PrDX” refers to PrDs of various origins as 
indicated. These data are representatives of direct shuffle results presented 
in Table 13 (Appendix) and reverse shuffle results presented in Table 14 
(Appendix). Numbers of independent isolates obtained for each phenotype 
can be found on those tables. Unlike variations in phenotype observed for 
reverse shuffle from combinations with Sb module II performed in S. 
cerevisiae, no noticeable variations were observed for reverse shuffle from 
combinations with Sb module II in the S. paradoxus cell environment.  
 
5.3.2 Comparison of the species barriers in transfection with the other assays 
We previously demonstrated how a plasmid shuffle procedure or cytoduction assay is 
useful to detect and measure species-specific barriers to cross-species prion transmission 
(Chapter 3). Here we demonstrate that a cross-species transfection procedure also 
generates a species barrier, and the barrier produced is stronger than that observed for 
both a plasmid shuffle or cytoduction assay. With the transfection procedure, transfection 
of a strong [PSI
+
] S. cerevisiae PrD variant produced in S. cerevisiae into a S. paradoxus 
strain expressing the same Sup35Sc protein yielded an efficiency of 19% to the S. 
cerevisiae PrD, and no transmission to the S. paradoxus and S. bayanus PrD versions 




from the strong Sup35Sc [PSI
+
] variant to the S. paradoxus PrD version expressed in S. 
paradoxus (A), even though this strong barrier was not detected by either the plasmid 
shuffle  (B) or cytoduction (C) procedures for the same strong variant. This result may be 
attributed to differences between the host and recipient cell environments or to the length 
of heterologous protein co-expression, as proteins were co-expressed for shorter intervals 
in transfection than for shuffle and cytoduction procedures. The shortened interaction 
time may prevent sufficient heterologous interactions needed to overcome a species 
barrier. The cross-species transfection procedure was also tested in parallel in a weak 
[PSI
+
] variant. 7% transmission to the S. cerevisiae PrD was observed with no 
transmission to the S. paradoxus or S. bayanus PrDs. 
 
 
Figure 48. Comparison of cross-species transmission efficiency for 
transfection from S. cerevisiae to S. paradoxus. A— Cell lysate from 
either a S. cerevisiae strong or weak [PSI
+
] variant was transfected into a 
[psi
-
] sup35Δ S. paradoxus strain. The S. paradoxus strain produced 
Sup35 from a plasmid (originating from either S. cerevisiae (Sc), S. 
paradoxus (Sp), or S. bayanus (Sb)). The percentages of [PSI
+
] colonies 
obtained are presented. Data shown are presented in Table 15 (Appendix). 
B—Direct cross-species transmission to heterologous Sup35 PrD’s was 
performed in a strong S. cerevisiae variant (data previously presented in 
Table 5 (Appendix)). C—Cytoduction transmission to heterologous Sup35 
PrD’s was performed in a strong S. cerevisiae variant (data previously 
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5.4 CHAPTER 5 CONCLUSIONS: 
 A transmission barrier and conformational fidelity are primarily determined by 
the protein itself rather than the cell environment. 
 A species barrier in transfection is stronger than in the plasmid shuffle or 



















CHAPTER 6: PRION INTERFERENCE 
6.2 MATERIALS 
6.2.1 Plasmids 
Centromeric plasmids expressing chimeric SUP35 versions or complete SUP35 versions 
originating from S. cerevisiae, S. paradoxus, or S. bayanus are described in Chapter 2 and 
Chapter 3. 
6.2.2 Strains 
S. cerevisiae, S. paradoxus, and S. bayanus strains used for interference studies 
and SDD-AGE are described in Chapter 2.  
 
6.3 RESULTS AND DISCUSSION 
6.3.1The effects of heterologous Sup35 co-expression on [PSI
+
] propagation. 
 Modifications to the shuffle assay were made to study the effects of transient 
coexpression of heterologous proteins on [PSI
+
] propagation (modifications described in 
Chapter 2, Fig 12). A [PSI
+
] strain is transformed with plasmids carrying either 
homologous, heterologous, or chimeric SUP35 versions. After a brief period of co-
expression (6 days), the new plasmid is removed, and [PSI
+
] propagation is checked to 
compare the percentage of [psi
-
] colonies to the same strain receiving a homologous 
Sup35Sc copy. The terms “interference” and “poisoning” describe destabilization of the 
original prion after transient co-existence with a divergent protein. Notably, results 
showed that co-expression of a divergent Sup35 prion domain can strongly interfere with 
prion propagation. Table 16 (Appendix) provides a detailed list of all Sup35 versions 
tested for [PSI
+




interference in the S. paradoxus strain. A strong [PSI
+
] Sup35Sc variant produced in S. 
paradoxus presented 53% [PSI
+
] loss after transient co-expression of Sup35 with the S. 
paradoxus PrD. Practically no interference (0.1% [PSI
+
] loss) was observed for 
coexpression of Sup35 with the S. cerevisiae PrD.  
 
 
Figure 49: An example of prion interference in the S. paradoxus cell 
environment. This experiment was performed in a strong [PSI
+
] sup35Δ 
S. paradoxus strain that expressed a S. cerevisiae version of SUP35 from a 
plasmid. Either Sup35 having a PrD from S. cerevisiae (left) or S. 
paradoxus (right) protein was introduced and then removed (by expression 
on a centromeric plasmid) (See Figure 12). When the photograph was 
taken, the cells were only producing the original S. cerevisiae Sup35 
protein.  Red colonies are [psi
-
]. White colonies retain the prion. Both 
white and red colonies produced after the loss of the interfering plasmid 
remained stable in subsequent passages on YPD.  
 
6.3.2 The relationship between prion interference and a prion transmission barrier 
As previously described, modifications to the plasmid shuffle procedure allow 
determination of both 1) the efficiency of prion transmission and 2) the extent of prion 
interference for the same protein (Fig. 11, Fig. 12). The results of both techniques were 
compared in the S. paradoxus cell environment by introducing Sup35 having the PrD 
from either S. cerevisiae, S. paradoxus, or S. bayanus (Fig. 50). A strong [PSI
+
] variant 
produced in Sup35Sc was used as the starting variant. Prion transmission to Sup35 with 
the S. cerevisiae PrD was virtually complete (97% transmission) with no interference 
(0.1% [PSI
+
] loss) observed. A minor transmission barrier (84% [PSI
+




observed for Sup35 with the S. paradoxus PrD. However, this protein exhibited high 
interference (53% [PSI
+
] loss) after transient coexpression. Sup35 having the S. bayanus 
PrD, however, produced an absolute barrier (0% [PSI
+
] transmission) yet exhibited 
almost no interference (1.2% [PSI
+
] loss) in propagation of the original strong [PSI
+
] 
variant. Therefore, we conclude that prion interference does not correlate with a prion 
transmission barrier when performed in the S. paradoxus cell environment. It should be 
noted that results for both transmission and interference experiments shown here are 
performed in haploid strains with 6 days of heterologous protein co-expression. Shorter 
periods of co-expression cause less interference, and differences in interference are 
observed when performed in diploid strains. (see Section 6.3.6).  
 
Figure 50: Comparison of prion transmission barriers and prion 
interference. A—Direct shuffle experiments for strong [PSI
+
] in S. 
paradoxus were performed as on Fig. 11. Numerals I, II, and III refer to 
the exchangeable modules of PrD (Fig. 22). “Sc”, “Sp” and “Sb” refer to 
S. cerevisiae, S. paradoxus, and S. bayanus, respectively. Frequencies of 
prion transmission and loss are shown on each chart. Blue sectors indicate 
the percentage of individual transformants displaying the [PSI
+
] 
phenotype. Red sectors indicate the percentage of individual transformants 
that did not obtain the prion (percentage indicated on each chart). Data 
presented in panel A are also included in Figure 45 and Table 13 
(Appendix). B—See Figure 12 for the prion interference scheme. PrD 
modules of protein transiently coexisting with Sc Sup35 are indicated 
below each chart. The percentages of [psi
-
] cells after loss of coexisting 




6.3.3 The influence of the cell environment on prion interference 
 We also questioned whether prion interference is caused by interactions of the 




environment. To test this, we performed a similar interference experiment in the S. 
cerevisiae cell environment, beginning with the strong [PSI
+
] Sup35Sc variant used in the 
S. paradoxus experiments and co-expressed the same set of proteins (Fig, 51). Contrary 
to data obtained in S. paradoxus, no interference (0% [PSI
+
] loss) was observed for 
Sup35 having the PrD from S. cerevisiae, S. paradoxus or S. bayanus. Based on the 
comparisons of the same experiments in the two species, we concluded that [PSI
+
] 
interference depends on factors present within the cell environment. Again, the 
interference data obtained in the S. cerevisiae environment did not correlate to 
transmission data (Table 5 (Appendix); Fig. 15) obtained in the same species. 
(Specifically, there was only 12% [PSI
+
] transmission from the S. cerevisiae PrD to the S. 
bayanus PrD, yet no interference was observed. In addition, there was a very slight 
reduction of transmission efficiency to the S. paradoxus PrD (93% transmission) when 
compared to homologous transmission (99% transmission to the S. cerevisiae PrD) but no 
interference by the S. paradoxus or S. cerevisiae PrD was observed in the S. cerevisiae 
cell environment.  
 
 
Figure 51: Prion interference in the S. cerevisiae cell environment. See 
Figure 12 for the prion interference scheme. “Sc,” “Sp,” and “Sb” 
designate S. cerevisiae, S. paradoxus, and S. bayanus, respectively. The 
percentage of [psi
-
] cells after loss of a coexisting plasmid are indicated as 
percentages. PrD modules of protein transiently coexisting with Sc Sup35 








6.3.4 The effects of PrD module exchange on [PSI
+
] interference in S. paradoxus 
 To study the effects of particular Sup35 regions on prion interference, SUP35 
PrD’s from S. cerevisiae, S. paradoxus and S. bayanus were divided into three 
exchangeable modules, with the sizes and sequence of each module described on Figure 
22. Different modules were combined to create chimeric Sup35 proteins (all having M 
and C domains from S. cerevisiae) which were tested for prion interference. Results for 
all constructs are reported in Table 16 (Appendix) with graphs shown in Figure 52. As 
predicted, neither an additional dose of the original Sup35Sc protein (giving 0.1% [PSI
+
] 
loss), nor the expression of an empty control plasmid (0% [PSI
+
] loss) interfered with 
[PSI
+
] propagation. Co-expression of the complete Sup35Sp protein (62% [PSI
+
] loss) and 
the S. paradoxus PrD (53% [PSI
+
] loss) gave the highest levels of interference. 
Surprisingly, both the complete Sup35Sb protein (0% [PSI
+
] loss) and the S. bayanus PrD 
(1% [PSI
+
] loss) showed little to no interference, despite complete Sup35Sb having the 
greatest sequence divergence from S. cerevisiae. For the S. cerevisiae/S. paradoxus PrD 
chimeric constructs, it was noted that sequence differences in Module I caused 
interference in prion transmission (26% [PSI
+
] loss when module I from S. cerevisiae was 
exchanged with Module I from S. paradoxus). Sequence differences in both Modules I 
and II causing a synergistic effect for prion interference (Relatively no interference 
observed when Modules II and III from S. cerevisiae were exchanged for S. paradoxus, 
but there was 51% [PSI
+
] loss when both were combined with the exchange of Module I 
from S. paradoxus). Differences in either Module I or Module II between S. cerevisiae 
and S. bayanus cause prion interference (22-24% [PSI
+
] loss when either Module I or 





Figure 52: The effect of module exchange on prion interference in the 
S. paradoxus cell environment. All data shown here are included in 
Table 16 (Appendix). See Figure 12 for the prion interference scheme. 
PrD modules of protein transiently coexisting with SC Sup35 are indicated 
below each chart. The % of [psi
-
] cells after loss of coexisting plasmid are 
indicated 
 
6.3.5 The identity of a single residue influences prion interference 
       The discovery that sequence differences of particular modules has a profound 
effect on prion interference led us to question the influence that identity of short stretches 
or even individual residues may have on prion interference. Previous data showed that 
exchange of module 1 from S. cerevisiae to S. paradoxus presented a barrier to prion 
transmission and contributed to interference (Fig 52), so it was of interest to investigate 
the effects at the order of a single residue. Only one residue (at position 12) is conserved 
between S. cerevisiae and S. bayanus (asparagine) but differs in S. paradoxus (serine), so 
site-directed mutagenesis was used to exchange this residue. Interestingly, this residue 
lies within residues 9-14 which in S. cerevisiae meets the criteria for a universal 
consensus sequence (Fig 22) thought to be crucial for amyloid formation [74]. Though 
the asparagine residue at position 12 in S. cerevisiae or S. bayanus conforms to the 
residue requirement needed at this position, the serine at position 12 in S. paradoxus is 
predicted to disrupt the consensus (Fig 53, A). We exchanged this residue to document its 




S12N mutation is sufficient to eliminate prion interference. In reverse, the N12S mutation 
induced interference in the context of the Sc-Sp-Sp chimera (No interference was 
observed when it was exchanged in the Sup35 Sc-Sc-Sc PrD) which seems to indicate a 
synergistic effect from residue 12 in module I and one or more regions of module II or 
III. Overall, we concluded that the identity of a specific residue influences prion 
interference. 
 
Figure 53: The effect of single amino acid substitutions on prion 
interference in the S. paradoxus cell environment. A—Note species-
specific differences at residue 12 that were exchanged for these 
experiments. B—All data shown here are included in Table 16 
(Appendix). See Figure 12 for the prion interference scheme. PrD modules 
of protein transiently coexisting with SC Sup35 are indicated below each 
chart. The % of [psi
-
] cells after loss of the coexisting plasmid are 
indicated 
An explanation for differences between prion transmission and prion interference 
may be that divergence in key stretches of Sup35 are required for interaction with and 
then incorporation of the soluble protein into an aggregate. The S. bayanus and S. 
cerevisiae PrDs share 77% sequence similarity, yet no transmission from the S. cerevisiae 
PrD to the complete S. bayanus PrD was observed. Interference by the S. bayanus PrD 
was also not observed.  Perhaps the same regions of divergence preventing incorporation 
of Sup35Sb PrD’s into the aggregate also prevents efficient interactions with Sup35Sc 
aggregates that would interfere with its [PSI
+































for the Sup35Sp PrD which shares a higher sequence similarity (94%) with the Sup35Sc 
PrD. Interestingly [PSI
+
] is transferred from Sup35Sc to Sup35Sp with a high efficiency of 
84% and yet shows high levels of Sup35Sc [PSI+] interference (53.3%). This would be 
explained by similarity in key stretches that would allow interaction with and 
incorporation with the aggregate, but the heteroaggregate formed is hypothesized to be 
less efficiently propagated (see section 6.3.7). 
 
 





] interference by heterologous proteins was observed in S. paradoxus but not 
in S. cerevisiae. This was attributed to environmental factors such as chaperones that may 
vary in concentration and sequence among species. One hypothesis states that different 
Hsp104 levels or perhaps species-specific Hsp104/ Ssa ratios may affect [PSI
+
] 
propagation of the same protein differently in particular cell environments. Numerous 
attempts to compare Hsp104 and Ssa chaperone levels using western blot with 
densitometry were not sensitive enough to accurately detect reproducible differences. 
Therefore, a mating interference technique was used to document the effects of Hsp104 
dosage on [PSI
+
] interference. The mating procedure (Fig. 54) involves crossing a [PSI
+
] 
haploid MATa strain (expressing Sup35Sc from a plasmid) to a [psi
-
] haploid MATα strain 
expressing different SUP35 versions from URA3 plasmids. The strains were crossed on 
YPD and incubated for fixed amounts of time, with diploids obtained by velveteening the 
yeast onto “drop-out” media selective for both plasmids. Then the URA3 plasmid coding 
for the desired Sup35 protein was removed by replica plating onto 5-FOA medium. 




(see Chapter 4), allowing comparison of diploids having one or two functional HSP104 
gene copies.  
 In addition to Hsp104 dosage comparisons, the length of heterologous protein co-
expression in the diploid system was also compared. The previously described plasmid 
shuffle procedure for assessing transmission and interference (Fig. 12), required 6 days of 
protein co-expression before the newly introduced plasmid could be removed (4 days to 
obtain colonies after plasmid transformation and 2 days growth on a master plate), but the 
mating interference procedure enabled even shorter lengths of coexpression (a minimum 
of 1.5 days coexpression). In general, little interference was detected for shorter length of 
heterologous co-expression (Fig. 55, Table 18 (Appendix)); however, subtle color 
differences were observed in [PSI
+
] colonies (Table 19, Appendix). Ultimately, our 
results comparing 1.5 vs. 6 days of heterologous protein co-expression showed a 
profound difference in levels of prion interference with the Sup35 Sp PrD (24% [PSI
+
] 
loss after 1.5 days, with 97% [PSI
+
] loss after 6 days of coexpression.)  Co-expression of 
the Sup35Sb PrD showed 0% [PSI
+
] loss after 1.5 days, but 21% [PSI
+
] loss after 6 days 
of coexpression.) (see Fig. 55) showing data obtained.) Overall, we concluded that the 
length of heterologous Sup35 co-expression is positively correlated with [PSI
+
] 
interference and that deletion of one out of two HSP104 copies from a diploid S. 







Figure 54: Mating interference scheme. A—a [psi
-
] sup35Δ strain with 
the S. cerevisiae SUP35 gene on a LYS2 plasmid was transformed with 
a URA3 plasmid bearing a variable SUP35 construct. Transformants were 
obtained on medium lacking uracil to selective for the new plasmid. The 
original LYS2 plasmid was lost, and the strain was mated to a [PSI
+
] 
sup35Δ strain of the opposite mating type having SUP35 gene on 
a LEU2 plasmid. Individual transformants having the URA3 plasmid were 
mixed with the [PSI
+
] strain of the opposite mating type for either 8 hours 
(short-term) or longer on YPD and then velveteened to –Ura-Leu  media 
to select for diploids. Diploids were replica plated onto YPD (color assay), 
YPG (petite screen), -ura-lys-ade (diploid selection) and 5-FOA (for loss 
of URA3 plasmid) media. Each patch was streaked from 5-FOA media to 
YPD to assess prion loss. Numbers of white or  pink [PSI
+
] vs red [psi
-
] 




Figure 55: Effects of Hsp104 copy number and length of heterologous 
protein co-existence on prion interference in S. paradoxus. Mating 
interference experiments were performed as shown on Fig. 54. Diploid 
strains either had one (red) or two functioning copies (blue) of the 
HSP104 gene with strains designated by color. Percentages above each 
bar represent the percentage of individual transformants retaining the 
[PSI
+
] phenotype following either a long-term (panel A) or short-term 
(panel B) co-existence with a heterologous protein.  
 
 
6.3.7 Models for [PSI
+
] interference 
 Both white and red colonies were obtained from interference by Sup35Sp protein 
co-expression. The white colonies displayed a strong and stable [PSI
+
] variant, having the 
same characteristics as the initial variant present before the interfering protein was 
Longer co-existence Shorter co-existence
1 dose of Hsp104

















introduced; the red colonies were found to be [psi
-
]. Based on this result, it was 
hypothesized that heterologous proteins may less efficiently (due to differences in key 
sequence stretches) compete with homologous protein to join onto the ends of prion 
seeds, “capping” them to prevent addition of Sup35 monomers. White colonies would, 
therefore, represent yeast obtaining homologous Sup35Sc aggregates and red [psi
-
] 
colonies would arise from cells receiving “capped” aggregates that cannot efficiently 
propagate. Thus, this “amyloid capping” model predicts the presence of shorter 
aggregates and is presented in Figure 56. A semi-denaturing detergent agarose gel 
electrophoresis procedure (SDD-AGE) (Described in section 2.4.6) was employed to 
measure aggregate size in a S. paradoxus strain co-expressing either two homologous 
Sup35Sc copies (negative control) or one Sup35Sc and one Sup35Sp copy. Surprisingly, 
aggregates co-expressing both Sup35Sc and Sup35Sp were larger than those expressing 
two Sup35Sc copies (control) (Fig. 57), thus failing to support the amyloid capping 
model. 
 
Figure 56: Amyloid capping model. A—In the amyloid capping model, 
high Sup35Sc and Sup35Sp sequence similarity is proposed to facilitate 
Sup35Sp interaction with Sup35Sc aggregates. Sup35Sp monomers would 
theoretically join to the ends of Sup35Sc aggregates, capping them and 
preventing aggregate growth. B—The amyloid capping model suggests 
that high sequence divergence between some regions of Sup35Sc and 
Sup35Sb would prevent interactions of Sup35Sb with Sup35Sc aggregates, 




















     
 
Figure 57: Aggregate size from heterologous Sup35 co-expression. A 
sup35Δ S. paradoxus strain having a strong [PSI+] variant produced 
Sup35Sc from a centromeric plasmid. This strain was transformed with 
another centromeric plasmid to produced either Sup35Sc (control) or 
Sup35Sp. Following a period of heterologous co-expression, the total cell 
lysate was extracted and run on a semi-denaturing detergent agarose gel 
electrophoresis (SDD-AGE) gel (see Chapter 2 methods). Aggregates 
were transferred to a nitrocellulose membrane by capillary action and were 
probed with Sup35M antibody. 
 
 Based on the findings that larger aggregates are produced from heterologous 
Sup35Sc/Sup35Sp co-expression than produced by homologous Sup35Sc/Sup35Sc co-
expression, a different interference model was proposed. This “interference 
fragmentation” model (Fig 58) highlights the impaired interactions of cellular factors in 
the propagation of [PSI
+
] heteroaggregates. Specifically, this model suggests that 
homologous aggregates (left of figure) are more efficiently propagated by more favorable 
interactions with cellular components (such as Hsp104) that fragment aggregates to 
generate prion “seeds” for later cycles of propagation. Less efficient disaggregation 
would produce fewer seeds leading to larger aggregates and, ultimately, impairing [PSI
+
] 
propagation. Hsp104 is one cellular chaperone implicated, as it has an established role in 
[PSI
+
] propagation and is known to disaggregate [PSI
+
] (see Fig 58). In this model, 
heterologous Sup35 co-expression of more divergent proteins (Sup35Sc/ Sup35Sb) might 












interactions leading to incorporation of the divergent protein (Sup35Sb) into the Sup35Sc 
aggregates. However, interactions of key regions of more similar sequences in 
heterologous Sup35 proteins may provide sufficient opportunities for interaction between 
the aggregate and the protein (Sup35Sp) and allow incorporation into the aggregate. Yet, 
growth of the heteroaggregate would cause less efficient interactions with the 
endogenous Hsp104 may sufficiently reduce disaggregation causing fewer and larger 
seeds. Fewer seeds lessens the efficiency of future rounds of [PSI
+
] propagation and 
larger aggregates may not be transferred as frequently to daughter cells, ultimately 





Figure 58: Interference fragmentation model. A—In the prion model, 
homologous Sup35Sc monomers join onto the ends of Sup35Sc aggregates or 
“seedsm” causing aggregate growth. Cellular factors including Hsp104 interact 
with the aggregates and fragment them to form additional “seeds” which continue 
the propagation cycle. B— The interference fragmentation model proposes that 
sequence similarities may allow heterologous proteins to be incorporated into the 
aggregates but may interact less efficiently with cellular factors such as Hsp104 
that fragment the aggregates. Heterologous aggregates would remain larger and 








































































Additionally, larger aggregates might also be less efficiently transmitted to 
daughter cells.  
 
6.4 CHAPTER 6 CONCLUSIONS: 
 Co-expression of a divergent Sup35 prion domain can interfere with prion 
propagation 
 Prion interference does not correlate with a prion transmission barrier. 
 [PSI+] interference is dependent on factors present within a cell environment. 
 In S. paradoxus, different PrD regions are primarily responsible for prion 
interference in different cross-species combinations  
 The identity of specific residues (sequences), rather than the overall level of 
PrD homology is crucial for determining prion interference. Prion interference 
is not directly correlated with the overall PrD divergence. 
 Overall, deletion of one out of two HSP104 copies from a diploid S. paradoxus 
strain decreases prion interference  




 Co-expression of a divergent Sup35 prion domain can interfere with prion 
propagation 
 Prion interference does not correlate with a prion transmission barrier. 
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CHAPTER 7: THE INFLUENCE OF DIFFERENT [PIN
+
]-
INDEPENDENT INDUCERS ON CROSS-SPECIES PRION 
INFECTIVITY IN S. PARADOXUS 
 
7.1 CHAPTER SUMMARY 
S. paradoxus and S. bayanus strains used for this work were previously found to 
be [pin
-
] (Results by B. Chen). Different [PIN
+
]-independent inducers (constructed by B. 
Chen) were overexpressed in attempts to induce [PSI
+
] de novo in [psi
-
] S. paradoxus and 
S. bayanus strains that produce Sup35 from various origins. The characteristics of the 
[PSI
+
] variants successfully produced in S. paradoxus were documented for each type of 
variant observed from different combinations of inducee and inducer. Throughout this 
chapter, the term “inducee” refers to the version of Sup35 expressed in the sup35Δ strain, 
and this Sup35 version is originated from either  S. cerevisiae, S. paraodoxus, or S. 
bayanus. “Inducer” refers to the Sup35NM-Hpr6.6 version overexpressed to facilitate de 
novo [PSI
+
] formation. The [PSI
+
] variants obtained then served as initial prions for 
plasmid shuffle and cytoduction assays, allowing us to document the importance of 
inducer sequence and protein origin on the types of variants produced by de novo [PSI
+
] 












Plasmids pmCUP-NMSB-HRP6.6, pmCUP-NMSC-HRP6.6 , and pmCUP-NMSP-
HRP6.6  were used as described in section 7.2.3 to induce [PSI
+
] de novo by serving as 
artificial [PIN
+
]-independent factors. Plasmids pRS317-PS-SUP35SC, pRS317-PS-
SUP35SP, and pRS317-PS-SUP35SB were transformed into sup35Δ strains as an 
essential source of Sup35, a factor required for viability.  
 
7.2.2 Strains 
The S. paradoxus strain GT1320-5B was a haploid derivative of SP7-1D with the 
following genotype: S. paradoxus MATα ura3-P2 lys2 Δho::KanMX6 ade1SP::ade1-
14SC [LYS2 SUP35SX]. This strain contained the sup35Δ::natNT2 transplacement on the 
chromosome (constructed as described in Chapter 4), and was maintained alive by S. 
cerevisiae – E. coli shuttle plasmids bearing the SUP35 gene originating from either S. 
cerevisiae, S. paradoxus, or S. bayanus. [PSI
+
] of varying strengths was induced in 
Sup35 of different origins by various Sup35NM-Hpr6.6 [PIN
+
]-independent inducers. 
The karyogamy-deficient recipient strains for cytoduction were constructed on the basis 
of the previously described (Chen et al., 2007) strain 1B-D910 (MATa ade1–14 his3 leu2 






]), by substituting the original plasmid 
bearing the S. cerevisiae SUP35 gene by plasmids with a LEU2 marker, each carrying 










] formation was induced de novo in S. paradoxus and S. bayanus for the 
following experiments using artificial [PIN
+
]-independent inducers (constructed by B. 
Chen), as [PIN
+
] is not present in these species. Each inducer consisted of SUP35NM 
from either S. cerevisiae, S. paradoxus, or S. bayanus fused to the human membrane 
progesterone receptor (HPR6.6) gene that codes for a 195 amino acid human protein 
having a transmembrane domain (Fig. 59). This artificial inducer was placed under PCUP1 
promoter control. The Hpr6.6 transmembrane domains of homologous chimeras were 
predicted to interact, thus bringing Sup35NM proteins into contact, facilitating [PSI
+
] 
nucleation. Once formed, the aggregate was expected to adopt a [PIN
+
]-like role to cross 
seed aggregation of full length Sup35 produced. The inducers (on plasmids) were over 
expressed to facilitate de novo [PSI
+
] formation in a sup35Δ S. paradoxus strain 
producing either Sup35Sc, Sup35Sp or Sup35Sb from a plasmid. The inducer plasmid was 
then removed. Descriptions and images of [PSI
+
] versions obtained using various 
combinations of Sup35 origin and inducer are shown in Table 20 and on Figures 60 and 
61. De novo [PSI
+
] variants in S. paradoxus were then used as starting prions for plasmid 






Figure 59: The creation of a [PIN
+
]-independent induction system. A 
—The presence of an inducing factor (such as [PIN
+
]) promotes efficient 
induction of the [PSI
+
] prion by serving as a template for Sup35 
aggregation (top scheme). Sup35 may rarely formn [PSI
+
] without an 
aggregation factor (bottom scheme). B —Each [PIN
+
]-independent 
inducer was constructed by fusing SUP35NM from either Saccharomyces 
cerevisiae, Saccharomyces paradoxus, or Saccharomyces bayanus to the 
human membrane progesterone receptor (HPR6.6) gene. The HPR6.6 
gene codes for a 195 aa human protein having a transmembrane domain 
(black sector). This artificial inducer was placed under the control of a 
copper-inducible promoter (PCUP1). Numbers correspond to aa positions, 
with aa’s from Hpr6.6 shown in parentheses. C —the amino acid sequence 
for the Hpr6.6 protein is shown with the transmembrane domain 
highlighted in bold.  
 
 
7.3 RESULTS AND DISCUSSION 






] induction in S. paradoxus 
To generate [PSI
+
] de novo in S. paradoxus using different inducers, a S. 
paradoxus sup35ΔnatNT2 strain expressing a plasmid copy of SUP35, from either S. 
cerevisiae, S. paradoxus, or S. bayanus, were transformed with plasmids expressing 




bayanus. This gave 9 different combinations of Sup35 protein / inducer. Transformants 
were plated on –Ade medium containing 25 μM CuSO4 to cause overexpression of the 
inducer and were incubated at 25°C for 21 days. Ade
+
 papillae (Fig 60) were checked for 
[PSI
+
] using a YPD color test, a –Ade suppression test, and a GuHCl curability assay. 
Results obtained for specific papillae for each of the 9 Sup35 / inducer combinations are 
presented in Table 20. Pictures of different [PSI
+
] phenotypes obtained are shown in 





] de novo induction in S. paradoxus. Different versions 





paradoxus strain to induce de novo [PSI
+
] formation in a target Sup35 
protein. The S. paradoxus strain had only one version of the Sup35 protein 
present, which was either from S. cerevisiae (Sc), S. paradoxus (Sp), or S. 
bayanus (Sb).  The strain, producing a version of the Sup35 target protein, 
was transformed with different versions of the SUP35-HPR6.6 inducer 
constructs or an empty plasmid (negative control) under control of the 
PCUP1 promoter. Cells were plated on media lacking adenine and 
containing 25 μM CuSO4 for promoter induction. Images shown were 
















































SP #1 Strong 
SB #1 Strong 
Table 20: Properties of de novo induced [PSI
+
] in S. paradoxus A 
haploid S. paradoxus strain, produced Sup35 from either S. cerevisiae 
(Sc), S. paradoxus (Sp) , or S. bayanus (Sb) on a plasmid (inducee). Each 
version was transformed with three different SUP35NM-HPR6.6 [PIN
+
]-
independent inducers (containing Sup35NM from either S. cerevisiae, S. 
paradoxus, or S. bayanus) to create 9 different combinations. Each 
combination was plated on -Ade media containing 25 μM CuSO4 for 
overexpression of the [PIN
+
]-independent inducers. Individual Ade
+
 
papillae (Figure 60) were screened for [PSI
+
] on –Ade medium and by 
guanidine hydrochloride sensitivity. Representative [PSI
+
] samples from 
the 9 different combinations were assigned isolate numbers and are listed 
in this table and shown on Figure 61. Some were used to perform shuffle 










] induced de novo in S. paradoxus Sup35 
Overall, the Sup35Sc protein induced by Sup35Sc-Hpr6.6 exclusively produced 
strong [PSI
+
], but induction by Sup35Sp-Hpr6.6 generated both strong and weak [PSI
+
]. 
Induction by Sup35Sb-Hpr6.6 produced only weak [PSI
+
]. 
 The Sup35Sp protein induced by Sup35Sc-Hpr6.6 exclusively generated 
weak [PSI
+
]; however, induction with Sup35Sp-Hpr6.6 or Sup35Sb-Hpr6.6 produced either 
strong or weak [PSI
+
].  
The Sup35Sb protein induced with Sup35Sc-Hpr6.6 exhibited both strong and weak 
[PSI
+
], but produced only detectable strong [PSI
+
] when induced with Sup35Sp-Hpr6.6 or 
Sup35Sb-Hpr6.6. 
 
Figure 61: de novo [PSI
+
] in S. paradoxus generated from [PIN
+
]-
independent inducers. A haploid S. paradoxus strain, expressed SUP35 
from either S. cerevisiae (Sc), S. paradoxus (Sp) , or S. bayanus (Sb) on a 
plasmid. Each version was transformed with three different SUP35NM-
HPR6.6 [PIN
+
]-independent inducers (containing Sup35NM from either S. 
cerevisiae, S. paradoxus, or S. bayanus) under PCUP promoter control to 
create 9 different combinations. Each combination was plated on -Ade 
media containing 25 μM CuSO4 for overexpression of the [PIN
+
]-
independent inducers . Individual Ade
+
 papillae were screened for [PSI
+
] 
using synthetic “drop-out” media and by performing 3 passages on YPD 
containing guanidine hydrochloride (GnHCl) to check for GnHCl 
sensitivity and [PSI
+
] curing. Representative [PSI
+




different combinations, described in table 4.X, are shown here. The Sup35 
version being expressed by the strain is indicated to the left in bold. The 
version of the SUP35NM-HPR6.6 [PIN
+
]-independent inducer used in 
denoted by either “Sc”, “Sp”, or “Sb.” Colonies were spotted on YPD or –
Ade media and were incubated at 30°C. 
 
Attempts to induce [PSI
+
] de novo in S. bayanus 
 A similar attempt was made to induce [PSI
+
] in the S. bayanus species, but the 
prion was not detected by the YPD color assay or by suppression on –Ade medium 
(result by B. Chen). Later, a prion transfection procedure (described in Section2.2.4) was 
used to successfully introduce a pre-formed strong [PSI
+
] variant into S. bayanus. 
Interestingly, the strong [PSI
+
] phenotype obtained through transfection was detected on 
–Ura-Trp medium and by biochemical analysis, but was not readily visible from the YPD 
color assay and –Ade suppression assay for the same prion propagated in S. cerevisiae 
and S. paradoxus. Thus, we propose that de novo [PSI
+
] may have been generated in S. 
bayanus, but was not detected by typical screening methods for [PSI
+
]. Further screening 
is needed to determine whether [PIN
+
]-independent inducers can be used to generate 
[PSI
+























Figure 62: The proposed influence of different [PIN
+
]-independent 
inducers on de novo [PSI
+
] formation —The presence of a [PIN
+
]-
inducing factor (such as a prion form of the Rnq1 protein) promotes 
efficient induction of the [PSI
+
] prion by serving as a template for Sup35 
aggregation. Different versions of the [PIN
+
]-independent inducing factor, 
created by fusing the N and M domains of SUP35 from either S.cerevisiae, 
S. paradoxus, or S. bayanus to the human membrane progesterone 
receptor (HPR6.6) gene, were predicted to affect the type of [PSI
+
] variant 
formed. The artificial inducers (under the control of a copper-inducible 
promoter (PCUP1) were overexpressed in a S. paradoxus strain producing 
either full length Sup35Sc, Sup35Sp or Sup35 Sb. 
 
 
Five different direct shuffle experiments were performed, each beginning with a 
[PSI
+
] variant induced de novo by a unique combination of Sup35 protein and Sup35NM-
Hpr6.6 inducer (see Figure 59 and Figure 61). All variants were checked for efficiency of 
[PSI
+
] transmission to Sup35 having the PrD from either S. cerevisiae, S. paradoxus, and 
S. bayanus prion domains. Results are presented for each inducee/ inducer combination in 
Tables 21-25. 
 
7.4.2 Plasmid shuffle from [PSI
+
] formed in Sup35 having the S. cerevisiae PrD 
The following results measure transmission from [PSI
+
] in Sup35Sc generated 
with different inducers:. Results showed [PSI
+




Sup35 having a prion with the S. cerevisiae PrD that was induced by Sup35NMScHpr6.6 
but with 80% efficiency when induced by Sup35NMSp-Hpr6.6 or Sup35NMSb-Hpr6.6. 
 [PSI
+
] was transmitted with reduced efficiency to Sup35 having a prion with the 
S. paradoxus PrD, when induced by Sup35NMScHpr6.6 (55%) or Sup35NMSp-Hpr6.6 
(40%) but with 94% efficiency when induced by Sup35NMSb-Hpr6.6.  
Finally, use of the Sup35NMSc-Hpr6.6 inducer produced no transmission to a 
prion having the S. bayanus PrD, but efficiencies of 17% and 85% were observed from 
use of the Sup35NMSp-Hpr6.6 and Sup35NMSp-Hpr6.6 inducers, respectively. 
 
7.4.3 Plasmid shuffle from [PSI
+
] formed in Sup35 having the S. paradoxus PrD 
The following results measure transmission from [PSI
+
] in Sup35Sp generated with 
different inducers. Results showed [PSI
+
] was transmitted with 91% efficiency to Sup35 
having the S. cerevisiae PrD, when induced by Sup35NMScHpr6.6 but with 88% 
efficiency when induced by Sup35NMSp-Hpr6.6.  
[PSI
+
] was transmitted with increased efficiency to Sup35 having the S. 
paradoxus PrD, when induced by Sup35NMScHpr6.6 (97%) and with absolute efficiency 
(100%) by Sup35NMSp-Hpr6.6.  
Finally, use of either the Sup35NMSc-Hpr6.6 or the Sup35NMSp-Hpr6.6 inducer 
produced no transmission to Sup35 having the S. bayanus PrD. 
Overall, differences in transmission was observed for experiments performed in 
[PSI
+
] generated under various conditions of inducer and inducee, suggesting that 
inducers may reflect the de novo [PSI
+






Figure 63:  Prion transmission in S. paradoxus [PSI
+
] generated with 
different combinations of Sup35 origin and [PIN
+
]-independent inducers —
Prion shuffle experiments were performed in S. paradoxus [PSI
+
] strains.  
Different combinations of [PIN
+
]-independent inducers were used to produce 
[PSI
+
] in Sup35 originating from either S. cerevisiae, S. paradoxus, or S. bayanus. 
The efficiency of [PSI
+
] transmission to Sup35 from either S. cerevisiae 
(Sup35Sc), S. paradoxus (Sup35Sp) or S. bayanus (Sup35Sb) is recorded for each. 
See data presented in Tables 21-25 (Appendix). 
 
 




Cytoduction experiments were performed in S. paradoxus to study effects of 
Sup35 sequence and inducer sequence on [PSI
+
] characteristics such as infectivity. [psi
-
] 
cytoductants received cytoplasm (but not the donor nucleus) from a [PSI
+
] donor strain 
by a process detailed in Chapter 2 (Fig 12). Prion transfer was detected by growth on 
synthetic ethanol glycerol (SEG) medium lacking adenine with added cycloheximide 
(cyc). Donor [PSI
+
] variants (S. paradoxus) were generated as previously described in a 













] (control) S. paradoxus donor strains were then crossed to a [psi
-
] 
S. cerevisiae sup35Δ recipient strain expressing either SUP35Sc, SUP35Sp, or SUP35Sb 
from a plasmid. Rare colonies getting URA3 plasmid from the donor were excluded. 
7.5.1 Cytoduction from [PSI
+
] formed in Sup35 having the S.cerevisiae PrD 
The following results detail cytoduction from [PSI
+
] in Sup35Sc generated with 
different inducers. Results showed that [PSI
+
] (induced by Sup35NMScHpr6.6 or 
Sup35NMSpHpr6.6) was transmitted efficiently to Sup35 having the S. cerevisiae PrD, 
but not to Sup35 having the S. paradoxus or S. bayanus PrD. However, [PSI
+
] (induced 
by Sup35NMSbHpr6.6) was transmitted much more efficiently to Sup35 having the S. 
paradoxus PrD than to Sup35 with the S. cerevisiae or S. bayanus PrDs. 
 
7.5.2 Cytoduction from [PSI
+
] formed in Sup35 having the S. paradoxus PrD 
The following results detail cytoduction from [PSI
+
] in Sup35Sp generated with 
different inducers. Results showed that [PSI
+
] (induced by Sup35NMScHpr6.6 or 
Sup35NMSpHpr6.6) was transmitted in a decreasing order of efficiency to Sup35 having 
the S. cerevisiae PrD, the S. paradoxus PrD, and then to Sup35 having the S. bayanus 
PrD. However, [PSI
+
] (induced by Sup35NMSpHpr6.6 or Sup35NMSbHpr6.6 or) was 
transmitted most efficiently to Sup35 having the S. paradoxus PrD than to Sup35 with the 







7.5.3 Cytoduction from [PSI
+
] formed in Sup35 having the S. bayanus PrD 
The following results detail cytoduction from [PSI
+
] in Sup35Sb generated with 
different inducers. Results showed that [PSI
+
] (induced by Sup35NMScHpr6.6) was 
transmitted most efficiently to Sup35 having the S. paradoxus PrD than to Sup35 with the 
S. cerevisiae or S. bayanus PrDs. 
 
 





] transfer from S. paradoxus to S. cerevisiae. 
Cytoduction was used to study the effect of the origin of SUP35NM-
HPR6.6 [PIN
+
]-independent inducers on the type of [PSI
+
] formed. De 
novo [PSI
+
] was generated in a haploid sup35Δ S. paradoxus strain 
expressing SUP35 (inducee) from  either S. cerevisiae (Sc), S. paradoxus 
(Sp), or S. bayanus (Sb) on a plasmid. [PSI
+
] was induced, in each, by 
overexpression of a Sc, Sp, or Sb version of a SUP35NM-HPR6.6 [PIN
+
]-




] (control) S. paradoxus 
donor strains were crossed to a [psi
-
] S. cerevisiae sup35Δ recipient strain 
expressing either a SUP35Sc (Panel A), SUP35Sp (Panel B), or SUP35Sb 
(Panel C) version from a plasmid. Cytoductants received the donor 
cytoplasm but not the donor nucleus in a process previously described on 
Figure 13. [PSI
+
] transfer was detected by growth on synthetic ethanol 
glycerol (SEG) medium lacking adenine with added cycloheximide (cyc). 




control that was mated to a [psi
-
] donor strain (marked with a dash). Plates 
were incubated at 30°C. 
 
 
7.6 CHAPTER 7 CONCLUSIONS: 
 The prion inducer does influence prion characteristics that determine cross-
species infectivity 
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CHAPTER 8: ANALYSIS OF SUP35 BARRIERS TO 
AGGREGATION IN VITRO 
 
8.1 CHAPTER SUMMARY 
All evidence presented in previous chapters for species barriers and heterologous 
prion interference was obtained in vivo, and was caused by the interplay between cellular 
factors and the protein sequence divergence. To specifically determine the influence of 
protein sequence on these processes, it becomes helpful to study these processes with 
purified Sup35NM in vitro, thus eliminating influences of cellular factors. In this chapter, 
bacterial purified Sup35NM from S. cerevisiae, S. paradoxus, and S. bayanus were 
aggregated under different conditions (with and without seeding by a pre-existing 
amyloid seed) to assess the impact of the cell environment on aggregation. In particular, 
cross-seeding aggregation was performed to generate species barriers between  proteins 
from different Saccharomyces species.       
8.2 MATERIALS 
8.2.1 Strains 
Yeast strains GT17, GT671, GT256-23C, GT988-1A and bacterial strains HMS174 and 
the E. coli gammabody expression strain BL21(DE3)pLysS are described in Chapter 2.  
 
8.2.2 Plasmids 
The E. coli expression vectors pET20b-SUP35NM, pET20b-SUP35NMSpar, and 
pET20b-SUP35NMSbay containing SUP35NM from the species indicated are described 
in Chapter 2. The E. coli gammabody expression vectors pGBSup3512-21, pGBSup357-26, 
and pGBSup357-17 contain short SUP35 sequences grafted into a variable domain of the 




8.3 RESULTS AND DISCUSSION 
8.3.1 transfection of in vitro generated amyloid into yeast 
Purified Sup35NM(His)6 was aggregated in vitro with rotation to generate “seeds” for 
future experiments to investigate the influence of aggregation conditions and protein 
sequence on species barriers and amyloid interference. Sup35NM(His)6 originating from 
S. cerevisiae or S. bayanus was purified from E. coli (Methods sections 2.4.7) and was 
incubated at either 4° or 37°C until aggregated  to produce prion “seeds” (Section 2.4.8). 
The aggregated protein was sonicated and transfected into the S. cerevisiae yeast strain 
GT17 (Methods section 2.2.4). The phenotype and transfection efficiencies of each were 
analyzed. Figure 65 shows images of representative phenotypes. Interestingly, 
Sup35NMSc(His)6  aggregated at 4°C showed an exclusively strong phenotype, whereas, 
aggregation under the same conditions at 37°C yielded a weak phenotype. However, 
Sup35NMSb(His)6 produced a weak phenotype when aggregated at both 4°C and 37°C 
(See Table 26). Overall, we concluded that transfection of in-vitro generated amyloid into 
yeast produces different prion strains depending on the initial amyloid formation. 
 
 
Figure 65 Patterns of Sup35NM amyloids obtained in vitro. 
Sup35NM(His)6 from either S. cerevisiae (Sc) or S. bayanus (Sb) was 
aggregated at 4°C or 37°C with rotation. Transfection of the aggregates 
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Table 26 Phenotypes of yeast transfected with Sup35NM(His)6 seeds.  
 
 “Sc” and “Sb” refer to S. cerevisiae and S. bayanus, respectively. 
Sup35NM(His)6 protein was aggregated in vitro at the indicated 
incubation temperature with rotation (See Figure 65). Transfection of 
seeds into the S. cerevisiae yeast strain GT17 produced different prion 
variant phenotypes, dependent upon the protein sequence and the 
aggregation kinetics for different conditions.  
 
 
8.3.2 The effects of rotation conditions on aggregate seeding in vitro 
Four different Sup35NMSc(His)6 and Sup35NMSb(His)6 “seeds” (described in 
Section 8.3.1) were used to attempt to seed aggregation of Sup35NMSc(His)6 protein. 
Samples were aggregated with rotation in vitro at either 4°C or 37°C until polymerized. 
A control (without seed) was also aggregated until polymerized. Each sample was then 
transfected into S. cerevisiae strains GT17 and GT671, and the transfection efficiency 
and phenotype for each combination were recorded. 
 Virtually all seeding reactions performed at 4°C produced a strong [PSI
+
] 
phenotype, regardless of the origin or variant of the seeds (see Table 27 and Table 28). 
All [PSI
+
] obtained from the 4°C aggregation control (without seed) also produced a 
strong phenotype. However, aggregation at 37°C rarely produced transfectants. Only two 
colonies were obtained from all 37°C aggregation reactions with S. cerevisiae seed, and 
these exhibited a strong phenotype like the strong seed used. (Table 27). One colony was 
obtained from the 37°C aggregation using S. bayanus seed and was weak like the 
phenotype of the S. bayanus seed (Table 28). 
 
Sup35 source Incubation T° # [PSI+], % Total # Phenotype
4° 13 (12%) 106 All strong
37° 4 (4%) 108 All weak
4° 12 (13%) 94 All weak






Table 27 Phenotypes of yeast transfected with S. cerevisiae seeded 
Sup35NMSc(His)6 aggregates.  
 
 
“Sc” refers to S. cerevisiae protein. Sup35NMSc(His)6 seeds (described in 
Table 26) were used to attempt to seed the aggregation of monomeric 
Sup35NMSc(His)6 protein in vitro at different temperatures using rotation. 
The aggregates were transfected into the S. cerevisiae yeast strain GT17 
and produced the indicated variant phenotypes. 
  
 
 Table 28 Phenotypes of yeast transfected with S. bayanus seeded 
Sup35NMSc(His)6 aggregates.  
 
“Sc” refers to S. cerevisiae protein. Sup35NMSb(His)6 seeds (described in 
Table 26) were used to attempt to seed the aggregation of monomeric 
Sup35NMSc(His)6 protein in vitro at different temperatures using rotation. 
The aggregates were transfected into the S. cerevisiae yeast strain GT17 
and produced the indicated variant phenotypes. Heterologous seeding (if 
present) was not apparent due to the competition of homologous de novo 
aggregation reaction by Sup35ScNM(His)6.  
 
Overall, our results suggest that a strong prion is favored for aggregation 
conditions at 4°C and a weak prion is favored for aggregation conditions at 37°C (See 
Table 26, Figure 65). When seeded aggregation is performed with rotation, a competition 
exists between seeded aggregation and de novo aggregation of the monomer. Reaction 
conditions (such as temperature) may favor one aggregation type over the other, thus, 
influencing the dominant variant produced. Therefore at 4°C in the presence of weak 
Incubation T° Seed used # [PSI+], % Total # Phenotype
none 10 (11%) 91 All strong
Sc 4° 8 (15%) 54 All strong
Sc 37° 3 (3%) 108 All strong
none 0 ( %) 106 NA
Sc 4° 2 (2%) 108 All strong
Sc 37° 0 (0%) 107 NA
4°
37°
Incubation T° Seed used # [PSI+], % Total # Phenotype
none 10 (11%) 91 All strong
Sb 4° 43 (40%) 108 42 strong, 1 weak
Sb 37° 23 (22%) 106 All strong
none 0 (0%) 106 NA
Sb 4° 0 (0%) 101 NA






homologous seed, the strong de novo-formed prion proliferates faster and outcompetes a 
slow growing prion seeded by the weak seed. Conversely, in conditions favoring de novo 
formation of a weak prion (37°C), de novo produced prions are weak. Therefore a 
stronger prion produced from the homologous strong seed overtakes.  
Heterologous seeding is predicted to be less efficient than homologous seeding 
due to impaired interactions between the divergent proteins, but provides similar 
competition between de novo homologous aggregation and heterologous seeded 
aggregation. This hypothesis is supported by Sup35Sc(His)6 seeded by S. bayanus seed. 
Transfected S. bayanus seed alone produces a weak variant, but when used to seed 
aggregation, virtually all strong colonies were obtained (with the exception of one weak 
colony out of 214 observed). Alternatively, S. bayanus seed may rather serve a [PIN
+
]-
like role, to sequester Sup35Sc(His)6, facilitating that proteins’ interactions to more 




8.3.3 Quiescent aggregation conditions 
As noted, rotation conditions for in vitro aggregation facilitated high rates of 
unseeded aggregation and thwarted attempts to compare the effect of the type of seed 
used on the phenotype and species barrier. Thus we sought conditions that would enrich 
for seeded but eliminate unseeded aggregation. A quiescent protocol (see Methods in 
Chapter 2), lacking the rotation element, was found to produce the desired conditions and 







8.3.4 Seeding to generate in vitro aggregates produces a species barrier 
Species barrier presented by heterologous proteins 
Seeded aggregation, but not de novo aggregation, was successfully detected for 
quiescent aggregation reactions performed to measure the kinetics of cross-species 
seeding effects. As seen from Figure 66, the unseeded monomeric control failed to 
aggregate, while seeded reactions did generate polymerized protein. In addition, a species 
barrier was observed for quiescent conditions when Sup35NMSc(His)6 and 
Sup35NMSb(His)6 were incubated with seed prepared at 37°C (see Fig. 66). Overall, it 
was observed that homologous seeding (S. cerevisiae by S. cerevisiae and S. bayanus by 
S. bayanus) was more efficient than heterologous seeding (S. cerevisiae by S. bayanus). 
Other results revealed that Sup35NMSp(His)6 seeds also seeded the S. cerevisiae 
monomer less efficiently overall (Fig 67). Furthermore, our results were reproduced in a 
different species when Sup35NMSb(His)6 seeded by amyloid from either S. cerevisiae, S. 
paradoxus, or S. bayanus showed a significantly higher efficiency of homologous 
seeding (S. bayanus by S. bayanus) than for  seeding by S. cerevisiae or S. paradoxus 
(Fig. 68). Thus aggregation kinetics were used to detect a species barrier for heterologous 






Figure 66. A Species barrier observed under quiescent aggregation 
conditions in vitro. After 43 hrs without rotation at 37°, Sup35NM is 
polymerized only with pre-existing seed. Homologous seeding (Sc by Sc 
and Sb by Sb) is more efficient than heterologous seeding (Sc by Sb).  
 
 
Effects of seed aggregation temperature on aggregation kinetics 
Interestingly, differences in aggregation kinetics were detected for seeds prepared 
using the same Sup35NMSc(His)6 protein but under different conditions. Seed prepared at 
4°C, for example, seeded homologous aggregation to completion However, seed prepared 
at 37°C was less efficient under the same conditions, leaving a majority of the protein 
detected in the soluble fraction (Fig. 67). Sup35NMSp(His)6 seed prepared at 25°C also 
seeded aggregation of Sup35NMSp(His)6 slightly more efficiently than seeds prepared at 
4°C (Fig. 67 and Fig. 68). 
The effect of seed temperature on aggregation efficiency appears to agree with 
results obtained from transfection of different seeds into yeast (section 8.3.1). Upon 
transfection, Sup35NMSc(His)6 seeds produced at 4°C exhibited a strong [PSI
+
] 
phenotype that is correlated with shorter prion core length and mostly polymerized 
protein. Weaker transfection phenotypes were observed for Sup35NMSc(His)6 seed 
produced at 37°C and for Sup35NMSb(His)6 seed produced at both 4°C and 37°C. This 




and monomeric fractions. Such was observed for aggregation using Sup35NMSc(His)6 
seed produced at 37°C and for Sup35NMSb(His)6 seeds aggregated at both temperatures. 
Lastly, in addition to aggregation kinetics, transfection of aggregates generated in these 
studies into yeast provides additional verification of the strengths of variants produced 
and are ongoing experiments. 




Figure 67. Seed aggregation conditions affect the species barrier for 
Sup35ScNM(His)6 aggregation. After 6 hrs at 4°C without rotation, 
Sup35NMSc is polymerized only with pre-existing seed. Aggregation 
efficiency depended on the temperature used to aggregate seeds. (faster 
aggregation for Sc seed prepared at 4°C rather than 37°C, but faster 
aggregation for Sp seed prepared at 25°C rather than 4°C. Results were 





Figure 68. Seed aggregation conditions affect the species barrier for 
Sup35ScNM(His)6 aggregation. After 3 or 10 hrs without rotation at 4°C , 
Sup35NMSb is polymerized only with pre-existing seed. Homologous 
seeding (Sb by Sb) is more efficient than heterologous seeding (Sb by Sc 




aggregate seeds (faster aggregation for Sp seed prepared at 25°C than at 
4°C). Results were obtained by K. Jang and K. Bruce. 
 
 
Use of purified Sup35 aggregates from S. cerevisiae to seed in vitro Sup35NMSc 
aggregation  
Previously described rotation and quiescent seeding experiments were performed using 
protein purified from E. coli and with seed completely generated in vitro. Such reactions 
provide valuable insight into the role of protein sequence and aggregations conditions on 
amyloid nucleation, amyloid growth and seeding mechanisms, in general. However, the 
lack of cellular factors normally present within a cell environment may generate 
conditions and aggregates that differ from those formed in vivo. To remedy this, a LEU2 
plasmid producing Sup35NMSc(His)6 was transformed into a strong [PSI
+
] sup35Δ strain 
producing full length Sup35 from a URA3 plasmid. Sup35NMSc(His)6 aggregates were 
purified using Ni-NTA His-bind® resin and eluted in phosphate buffer with imidazole. 
Different amounts of aggregated Sup3ScNM(His)
6
 (or no seed for the control) was added 
to seed aggregation, and aliquots were periodically removed and ran on a boiled gel assay 
to measure the seeding effects (Fig. 69). Overall, the in vivo aggregated protein did seed 
aggregation of the Sup35NMSc(His)6 monomer, and the seeding effect was dose 
dependent. This experiment was twice performed by K. Jang. Currently, experiments are 
underway to compare seeding from protein purified from different variants should reveal 
whether the extracted variant phenotype is retained in the in vitro system. The phenotypes 





Figure 69 Seeing of Sup35NMSc by purified strong [PSI
+
] 
Sup35NMSc(His)6 aggregates: Sup35NMSc(His)6 was purified from a 
stong [PSI
+
] S. cerevisiae strain using nickel-NTA resin. Varying doses of 
the purified yeast aggregate (or a negative control without seed) were use 
to seed the aggregation of E. coli purified Sup35ScNM(His)6 monomer. 
The aggregation was performed at 4°C under quiescent conditions 
(described in Chapter 2), and samples were taken at different times and 
run on a boiled gel to assess the progress of aggregation (see Methods 
section 2.4.4, Fig 14). (results by K. Jang) 
 
8.3.5 Gammabody analysis 
 Typically, amyloid aggregation is thought to involve initial recognition 
interactions between an existing aggregate and key residues or “stretches” of a 
homologous monomer. Following successful recognition, the monomer uses the 
aggregate as a structural template, adopts its folding pattern, and is incorporated as a part 
of the aggregate. It was further hypothesized that the key recognition sequences are prion 
variant-specific, thus, identifying these stretches would be extremely useful for prion 
variant typing and for uncovering mechanisms of protein misfolding and propagation. 
We, therefore, attempted to use grafted amyloid-motif antibodies (“gammabodies”) for 
studies of [PSI
+
] recognition sequences. (See Fig. 70). Gammabodies are actually 
antibodies, having desired short regions of a target protein sequence grafted in [98]. If 
particular grafted sequences include the recognition element(s) required for a monomer to 
interact with a particular variant, this gammabody is also predicted to become 
incorporated into the aggregate, thus “detecting” the aggregate. It was previously shown, 
for example, that gammabodies having various grafts from the Aß peptide exhibited 
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different sensitivities of detection to Aß soluble oligomers vs. fibrils [98, 99]. 
Conversely, grafted sequences that are outside of key recognition elements would not 
facilitate interactions with the aggregate, so these gammabodies would not bind to or 
“detect” the aggregate. Monomers are not detected by gammabodies, for example, as 
there is no aggregate for a monomer to become incorporated into. 
  To date, we have shown that the gammabody grafted with the 7-26 or 12-21 
fragment of Sup35N recognize aggregated, but not the monomeric form of 
Sup35NMSc(His)6 in vitro (Fig 70, Fig 71,). We have also shown that these gammabodies 
exhibit a higher sensitivity to the “stronger” variant generated at 4
o
C than a variant 
generated at 37
 o
C (or sometimes 25
o
C) in the same protein (Fig 71). Interestingly, an 
initial gammabody experiment also showed binding to proteins extracted from both S. 
cerevisiae strong and weak [PSI
+
] variants, but no detection of extract from the same [psi
-
] strain (Interference in S. paradoxus [PSI
+
] propagation. 
 Binding of Sup35NMSp(His)6 and Sup35NMSc(His)6 aggregates but not to their 
monomers was also observed for this experiment.  
 
Figure 70. Gammabodies and Detection of Sup35NM(His)6. A – 
expected recognition of different exposed β-strands in different prion 
strains by gammabodies with different grafts. B – 7-26 gammabody 
recognizes the amyloid polymer but not monomer. Sup35M antibody is 
used as a control.  
 
 




Figure 71 Gammabody 12-21 detection of in vitro aggregated 
Sup35NMSc(His)6 protein.  Sup35NMSc(His)6 aggregated at either 4°C, 
room temperature (RT), or 37°was spotted on a nitrocellulose membrane 
and detected with a gammabody incorporating the 12-21 fragment of 
Sup35Sc. A monomer (M) was also spotted. The gammabody used 
incorporated Sup35 residues 12-21.  
 
 
Figure 72 Gammabody detection of  S. cerevisiae cell extracts and in 
vitro aggregated Sup35NM(His)6 protein. “Sc” and “Sb” refer to S. 
cerevisiae and bayanus, respectively. A —S. cerevisiae yeast total lysate 
isolated from a strong or weak [PSI
+
] strain and a [psi
-
] strain B —
Sup35NMSc(His)6 aggregated at 4°C, room temperature, 37°C, and 
monomeric protein (control). C—Sup35NMSb(His)6 aggregated at 4°C, 
37°C, room temperature, and monomeric protein (control).  
 
 
8.4 CHAPTER 8 CONCLUSIONS: 
 Transfection of in-vitro generated amyloid into yeast produces different prion 
strains depending on the conditions of amyloid formation, thus confirming results 
by the Weissman lab  
 For aggregation performed with rotation, a competition exists between seeded 
aggregation and de novo aggregation of the monomer. The reaction conditions 














 A quiescent protocol can be used to separate a seeded from an unseeded 
aggregation reaction. 
 A species barrier was observed for in vitro quiescent conditions as homologous 
seeding was more efficient than heterologous seeding 
 The temperature of the seed aggregation dictates the type of strain formed, thus a 
barrier in vitro, depends on the strain (like a barrier in vivo). 


































CHAPTER 9: OVERALL CONCLUSIONS AND FUTURE 
PERSPECTIVES 
 
9.1 OVERALL CONCLUSIONS: 
 
 It is possible to transfect and propagate [PSI+] into S. bayanus and S. paradoxus  
 The specificity of prion transmission is determined by the protein itself rather than 
the cell environment 
 Variant-specific prion patterns can be altered irreversibly during cross-species 
transmission through S. bayanus Module II  
 A divergent protein can “interfere” with [PSI+] propagation and is dependent on 
the cell environment 
 The identity of specific regions, rather than the overall level of PrD homology is 
crucial for determining cross-species transmission and interference  
 Prion interference does not correlate with a prion transmission barrier 
 
 
9.2 FUTURE PERSPECTIVES 
The results presented in this work highlight the contributions of both protein 
sequence and cell environment to the efficiency of cross-species prion transmission and 
interference in Saccharomyces species. The effects of sequence divergence were tested 
by exchanging different modules of the Sup35 PrD, and our focus was narrowed further 
to show the significance of individual amino acid residues. To date, the individual 
contributions of additional residues differing between these species remain untested and 
may shed light on protein interactions crucial for conversion of monomers into the prion 
fold. Knowledge of these interactions may further aid in predicting the specific 






] propagation were performed only in the context of full length Sup35 
proteins. Future work to identify the minimal residues necessary for Sup35 prion 
interference may provide insight into engineering interfering peptides to prevent or slow 
progression of similar amyloid and prion diseases in mammals.  
Our work performing cross-species transmission and interference experiments in 
vitro using purified Sup35 proteins provides further insight into the role of protein 
sequence in these processes and is independent of contributing factors of the yeast cell 
environment. Effects generated by manipulation of temperature and other aggregation 
conditions are also explored. Additional in vitro seeding experiments are useful to assess 
whether variant-specific properties are maintained in vitro, in the absence of these 
cellular factors. These experiments would be performed by seeding in vitro purified 
Sup35 with purified Sup35 in the [PSI
+
] state isolated from yeast. The protein aggregated 
in vitro (absent of the presence of cellular factors) will then be transfected into yeast 
using methods described in Chapter 4, and the stringency of the prion variant will be 
compared to the original variant generated in vivo. 
Furthermore, we have shown that cross-species transfer of a S. cerevisiae prion 
through chimeric proteins containing module II from S. bayanus and back to S. cerevisiae 
permanently weakened the stringency of the prion strain. Potentially, therapies targeting 
strain conversion may be useful in slowing, delaying, or preventing amyloid or prion 
disease in mammals by permanently converting the conformation of a protein fold to a 
desired variant that is consistent with longer incubation periods, slower progression of 







Table 1: Yeast strains used in this work. 
Strain Genotype/description 















] [CEN LEU2 SUP35SC] 
GT256-23C S. cerevisiae MATα ade1-1SC 4 his3  (or 11,15) lys2 leu2-3,112 trp1 ura3-52 
sup35::HIS3 [PSI
+
][CEN LEU2 SUP35SC] 
GT671 S. cerevisiae MAT  ade1-14 his3Δ (or 11,15) lys2 ura3-52 leu2-3,112 trp1 
sup35::HIS3 [CEN LEU2 SUP35] [psi-][pin
-
] 
GT749-1B S. paradoxus MATα/MATa lys2/lys2 ura3-P2/ura3-P2 
GT983 S. paradoxus MATα/MATa lys2/lys2 ura3-P2/ura3-P2 HO/ho::KANMX6 
GT983-2A S. paradoxus MATa lys2 ura3-P2 ho::KANMX6 
GT986 S. bayanus MATa ade1::URA3SC  ura3-1, ho::KANMX4 
GT988-1A S. cerevisiae MATα ade1-14SC his3  (or 11,15) lys2 leu2-3,112 trp1 ura3-52 
sup35::HIS3 weak [PSI
+
][CEN LEU2 SUP35SC] 
GT991 S. bayanus MATa ade1::ADE1SC  ura3-1, ho::KANMX4 
GT992 S. paradoxus MATa ade1::URA3SC lys2 ura3-P2 ho::KANMX6  
GT1020 S. bayanus MATα, ura3-1 lys2 ho::KANMX4 
GT1028 S. bayanus MATa ade1::ade1-14SC  ura3-1 ho::KANMX4 
GT1037 S. paradoxus MATa ade1::ura3SC lys2 ura3-P2 ho::KANMX6 
GT1041 S. bayanus MATα/MATa ADE1/ade1::ade1-14SC LYS2/lys2 ura3-1/ura3-1 
ho::KANMX4/ ho::KANMX4 
GT1041-7A S. bayanus MATa ade1::ade1-14SC lys2 ura3-1 ho::KANMX4 









] [CEN URA3 SUP35NSCMCSC] 









] [CEN URA3 SUP35(NI)SC(NII,III)SP(MC)SC] 









] [CEN URA3 SUP35(NI)SP(NII,III)SB(MC)SC] 









] [CEN URA3 SUP35(NI)SB(NII,III,MC)SC] 









] [CEN URA3 SUP35(NI)SB(NII,III)SP(MC)SC] 









] [CEN URA3 SUP35(NI)SP(NII,III,MC)SC] 









] [CEN URA3 SUP35(NI)SC(NII-III)SB(MC)SC] 
GT1216-2C S. paradoxus MATα ura3-P2 lys2 Δho::KanMX6 Δsup35::ClonNAT [LYS2 SUP35Sc] 
GT1116 S. paradoxus MATa ade1::ADE1SC  lys2 ura3-P2 ho::KANMX6 
GT1122 S. bayanus MATα/MATa ADE1/ade1::ade1-14SC LYS2/lys2 ura3-1/ura3-1 
ho::KANMX4/ ho::KANMX4 SUP35/sup35 natNT2 
GT1122-4B S. bayanus MATα ade1::ade1-14SC lys2 ura3-1 ho::KANMX4 sup35 natNT2 [hphNT1 
SUP35SP] 
GT1131 S. bayanus MATα ade1::ade1-14SC lys2 ura3-1 ho::KANMX4 sup35 natNT2 [LYS2 
SUP35SP] 
GT1132 S. bayanus MATα ade1::ade1-14SC lys2 ura3-1 ho::KANMX4 sup35 natNT2 [LYS2 
SUP35SB] 
GT1133 S. bayanus MATα ade1::ade1-14SC lys2 ura3-1 ho::KANMX4 sup35 natNT2 [LYS2 
SUP35SC] 
GT1144 S. bayanus MATα ade1::ade1-14SC lys2 ura3-1 ho::KANMX4 sup35 natNT2 [hphNT1 
SUP35SC] 
GT1188 S. paradoxus MATa ade1::ade1-14SC lys2 ura3-P2 ho::KANMX6 

















S. bayanus MATa, ura3-1, ho::KANMX4 
OT295 
(Su1B) 
































Table 2: Plasmids used in this work. 
SUP35 Plasmids used in this study 









SUP35 N  
SUP35 M 
 






pBC105 URA3 PSUP35 Sc Sp Sp Sc Sc 
pBC107 URA3 PSUP35 Sb Sc Sc Sc Sc 
pBC109 URA3 PSUP35 S Sc Sc Sc Sc 
pBC110 URA3 PSUP35 Sc Sb Sb Sc Sc 
pBC111 URA3 PSUP35 Sc Sb+1 Sb Sc Sc 
pKB102 URA3 PSUP35 Sc Sb+1 Sc Sc Sc 
pBC112 URA3 PSUP35 Sc Sc Sb Sc Sc 
pBC113 URA3 PSUP35 Sp(S12N) Sc Sc Sc Sc 
pBC114 URA3 PSUP35 Sc(N12S) Sc Sc Sc Sc 
pBC106 URA3 PSUP35 Sp Sb Sb Sc Sc 
pBC108 URA3 PSUP35 Sb Sp Sp Sc Sc 
pBC103
1
 URA3 PSUP35 Sp Sp Sp Sc Sc 
pBC104
2
 URA3 PSUP35 Sb Sb Sb Sc Sc 
pBC102
3
 URA3 PSUP35 Sc Sc Sc Sc Sc 
pGN100 URA3 PSUP35 Sc Sb(P50Y) Sb Sc Sc 
pGN102 URA3 PSUP35 Sc Sc(Y49P) Sc Sc Sc 
pGN103 URA3 PSUP35 Sb Sb(P50Y) Sb Sc Sc 
pKB103 URA3 PSUP35 Sb Sc Sb Sc Sc 
pKB100 URA3 PSUP35 Sc Sb Sc Sc Sc 
pKB101 URA3 PSUP35 Sp(S12N) Sp Sp Sc Sc 
pBC100
4
 URA3 PSUP35 Sp Sp Sp Sp Sp 
pBC101
5
 URA3 PSUP35 Sb Sb Sb Sb Sb 












 T7 Sb Sb Sb Sb -- 
pmCUP1
MCSC 
























LYS2 PSUP35 Sb Sb Sb Sb Sb 



















Promoter Gene of interest 
pRS316-GAL URA3 PGAL --- 
pGBSup3512-21 --- T7 SUP35aa 12-21 
pGBSup357-26 --- T7 SUP35aa 7-26 
pGBSup357-17 --- T7 SUP35aa 7-17 
PFA6a-kanMX6 --- SP6 KANMX6 
pBluescript-
URA3 I 
  URA3 
pRS303N natNT2  NatNT2 
pRS303H hphNT1  HYG 
pRS317 LYS2  --- 
    
1
 Also called p316-PS-SUP35NSP-MCSC 
2
 Also called p316-PS-SUP35NSB-MCSC 
3
 Also called p316-PS-SUP35NSC-MCSC 
4
 Also called p316-PS-SUP35SP 
5


















































Table 3: Primers used in this work. 





Forward primer for module I of Sc, 






Reverse primer for module II Sb and 










Reverse primer for module II Sb which 








Forward primer for module I Sp which 








Reverse primer for module III Sc 










Forward primer for module I Sc which 









Forward primer for module I Sc which 














Forward primer for module I Sc which 
includes the Y49P mutation and 




             Hsp104-HYGF  
 
               5’-
AAGAAAAAGCAATCAACTACA
CG     
               
TGCAATAAAACATACAGAATA
TGAAT 
               
TCGAGCTCGTTAAAGC-3’ 
 
Forward primer to amplify the HYG 
gene. This primer has flanking 
Hsp104Sp ends 
             Hsp104-HYGR  
 
               5'-
TCACGGATTCTTATCCAAAAA
TTTT 
               
CTATACGAATCACACTAAATG
CAG 
               
GTCGACGGATCCCCGG-3' 
 
Reverse primer to amplify the HYG 





































Table 4: The effects of sonication on transfection efficiency of in vitro 
generated aggregates. 
Yeast strain Sc aggregate [PSI
+
], % Total number 
GT671 
Control 1 (1%) 109 
4°, unsonicated 51 (49%) 104 
4°, sonicated 16 (15%) 108 
37°, unsonicated 4 (4%) 102 
37°, sonicated 9 (9%) 103 
    
GT17 
Control 0 (0%) 28 
4°, unsonicated 6 (40%) 15 
4°, sonicated 7 (32%) 22 
37°, unsonicated 0 (0%) 24 
37°, sonicated 3 (13%) 24 
Sup35NM(His)6 protein originated from S. cerevisiae (Sc) was purified from E. 
coli and aggregated at either 4° or 37° C.  The protein was transfected into two 
yeast strains, either with prior sonication (S) or without (NS) sonication. The 
numbers of transfectants obtained were recorded with percentages of [PSI
+
] 
shown. Yeast having no protein transfected was also included as a negative 
control. The yeast strain GT17 carried a chromosomal copy of SUP35, while 





































], Confidence limits Total number 
Sc-Sc-Sc 196  99% (97.6-100.0) 198 
Sp-Sp-Sp 95  93% (88.1-97.9) 102 
Sp-Sc-Sc 75  88% (81.1-94.9) 85 
Sc-Sp-Sp 52  95% (88.9-100.0) 55 
Sb-Sb-Sb 15  12% (6.5-17.5) 130 
Sb-Sc-Sc 83  98% (94.7-100.0) 85 
Sc-Sb-Sb 3  5% (0.1-9.9) 67 
Sc-Sb-Sc 1  3% (0.0-8.9) 33 
Sb-Sc-Sb 35  100% (96.7-100.0) 35 
Sc-Sc-Sb 77  100% (97.8-100.0) 77 
Sc-Sb+1-Sb 4  11% (1.0-21.0) 37 
Sc-Sb+1-Sc 15  46% (29.0-63.1) 33 
Sb-Sp-Sp 34  90% (80.2-99.8) 38 
Sp-Sb-Sb 3  6% (0.0-12.7) 49 
Sp(S12N)-Sp-Sp 63  98% (94.9-100.0) 64 
Sp(S12N)-Sc-Sc 71  99% (96.3-100.0) 72 
Sc(N12S)-Sc-Sc 33  57% (44.3-69.7) 58 
Sb-Sb(P50Y)-Sb 13  65% (44.0-86.0) 20 
Sc-Sb(P50Y)-Sb 7  30% (11.2-48.8) 23 
Sc-Sc(Y49P)-Sc 21  75% (58.9-91.1) 28 
Direct shuffle was performed in the strain GT256-23C as shown on Plasmid 
































] (%) Total  
numbers 
Sc-Sc-Sc 96 (99%) 97 
Sp-Sp-Sp 79 (80%) 99 
Sp-Sc-Sc 48 (81%) 59 
Sc-Sp-Sp 51 (94%) 54 
Sb-Sb-Sb 4 (5%) 83 
Sb-Sc-Sc 48 (81%) 59 
Sc-Sb-Sb 0  68 
Sc-Sb-Sc 2 (6%) 32 
Sc-Sb+1-Sb 0  58 
Sb-Sp-Sp 51 (59%) 87 
Sp-Sb-Sb 8 (9%) 86 
Cytoduction was performed in the strain GT256-23C as shown in Cytoduction 









































], Confidence limits Total number 
Sc-Sc-Sc 100 92% (86.9-97.1) 109 
Sp-Sp-Sp 16 27% (15.8-38.2) 60 
Sp-Sc-Sc 26 39% (27.2-50.8) 67 
Sc-Sp-Sp 30 86% (74.4-97.6) 35 
Sb-Sb-Sb 24 26% (17.0-35.0) 92 
Sb-Sc-Sc 39 83% (72.2-93.8) 47 
Sc-Sb-Sb 10 15% (6.2-23.8) 65 
Sc-Sb-Sc 1 2% (0-6.9) 64 
Sb-Sc-Sb 12 67% (45.2-88.8) 18 
Sc-Sc-Sb 22 88% (75.3-100.0) 25 
Sc-Sb+1-Sb 24 51% (36.7-65.3) 47 
Sc-Sb+1-Sc 21 58% (41.9-74.1) 36 
Sb-Sp-Sp 19 100% (95.5-100.0) 19 
Sp-Sb-Sb 0 0% (0-3.14) 37 
Sp(S12N)-Sp-Sp 26 58% (43.5-72.5) 45 
Sp(S12N)-Sc-Sc 52 77% (67.0-87.0) 68 
Sc(N12S)-Sc-Sc 76 70% (61.4-78.6) 109 
Sb-Sb(P50Y)-Sb 20 48% (32.9-63.1) 42 
Sc-Sb(P50Y)-Sb 28 80% (66.7-93.3) 35 
Sc-Sc(Y49P)-Sc 35 95% (87.8-100.0) 37 
































] (%) Total     
Numbers 
Sc-Sc-Sc 87 (68%) 128 
Sp-Sp-Sp 8 (10%) 81 
Sp-Sc-Sc 18 (21%) 87 
Sc-Sp-Sp 79 (93%) 85 
Sb-Sb-Sb 48 (60%) 80 
Sb-Sp-Sp 88 (79%) 111 
Sp-Sb-Sb 2 (2%) 92 
Cytoduction was performed in the strain GT988-1A as shown in figure 







































Reverse shuffle results 




], Confidence limits 
Number  
tested 
Sc-Sc-Sc 5 174 100% (98.4-100.0) 174 
Sb-Sc-Sc 2 130 100% (98.2-100.0) 130 
Sc-Sc-Sb 3 63 98% (94.9-100.0) 64 
Sc-Sb-Sc 1 16 76% (57.8-94.2) 21 
Sc-Sb-Sb 3 9 56% (31.7-80.3) 16                                                                                                                                             
Sb-Sb-Sb 4 76 45% (37.6-52.5) 170 
Sp-Sp-Sp 4 56 100% (97.5-100.0) 56 
Sp-Sc-Sc 4 39 87% (77.0-97.0) 45 
Sc-Sp-Sp 4 56 100% (97.5-100.0) 56 
Sp(S12N)-Sp-Sp 4 50 96% (90.7-100.0) 52 
Sp(S12N)-Sc-Sc 3 42 100% (97.1-100.0) 42 
Sc(N12S)-Sc-Sc 4 36 82% (80.8-83.2) 44 
Sb-Sb(P50Y)-Sb 2 7 13% (4.18-21.8) 55 
Sc-Sb(P50Y)-Sb 2 6 11% (2.96-19.0) 56 
Sc-Sc(Y49P)-Sc 2 49 98% (94.1-100.0) 50 
Sc-Sb+1-Sb 2 0 0% (0.0-3.14) 40 
 [PSI
+
] isolates obtained by direct shuffle (Plasmid shuffle scheme Fig 112.3) 
were used in the reverse shuffle to S. cerevisiae SUP35. Several independent 
isolates were analyzed per each construct in most cases, as indicated. Total 




























Reverse shuffle results 
 
















Sb-Sb-Sb 1 8  73% (46.7-99.3) 
1
1 




































] isolates obtained by direct shuffle (plasmid shuffle scheme Fig. 2.X ) were 
used in the reverse shuffle to S. cerevisiae SUP35. Several independent isolates 





























Table 11: Mitotic stability for selected Sup35 prion isolates generated by chimeric 
Sup35 protein.   
 




















Sc-Sc-Sc 3 0 50-90 
Sp-Sp-Sp 4 0 33-98 
Sp-Sc-Sc 3 0 32-78 
Sc-Sp-Sp 2 0 50-80 
Sb-Sb-Sb 2 0 44-50 
1 17.9 39 
1 56.7 60 
Sb-Sp-Sp 3 0 35-64 






Sc-Sc-Sc 3 0 89-106 
1 0.6 161 
Sp-Sp-Sp 1 0 75 
2 1.4-1.9 53-69 
1 80.0 50 
Sp-Sc-Sc 1 0 50 
Sb-Sb-Sb 1 0 98 
1 68.8 32 
1 90 50 




] isolates obtained from direct shuffle (see Figures 1E, SIII, and 
SV) in either a strong or weak [PSI
+
] strain were streaked-out through three 





] colonies were counted as shown here.  Mosaic 
colonies (usually rare in stable [PSI
+
] isolates) were counted as [PSI
+
].  Strain 
background refers to the stringency of the prion strain in which the experiment 




































Figure 35: Construction of the SUP35 genes with chimeric SUP35N domains. 
Designations “Sc,” “Sp” and “Sb” refer to S. cerevisiae, S. paradoxus and S. bayanus, 
respectively. Designations N, M and C refer to SUP35N, SUP35M and SUP35C domains, 
respectively. Modules of SUP35N domain (Fig 22) are designated by Roman numerals. 
A—Plasmids  pBC102, pBC103 and pBC104 (Table 2) were digested with HindIII, and 
the 0.3 kb fragments containing modules II and III of different origins in conjunction 
with the small portion of S. cerevisiae SUP35M region were exchanged between 
plasmids. B—To construct the plasmid bearing modules I and II of S. cerevisiae in 
conjunction with module III of S. bayanus, the S. cerevisiae fragment corresponding to 
modules I and II has been PCR-amplified with primers SUP35-PAR-F and SP-S12N-R 
(Table 3), containing BamHI and PflMI sites, cut with BamHI and PflMI and inserted 
into plasmid pBC102 at the same sites with the BamHI site upstream of the SUP35 ORF 
and cut with the same enzymes. C—In order to generate a plasmid bearing S. cerevisiae 




unit of S. cerevisiae added to the ORs region, the fragment encompassing module I of S. 
cerevisiae and module II of S. bayanus was PCR-amplified from the S. cerevisiae / S. 
bayanus chimeric construct generated as described above with primers SUP35-PAR-F 
and SB-Insertion-R (Table 3), respectively, including the region with BamHI site ahead 
of the ORF, and the region before (and including) PflMI site with an artificially added 
sequence corresponding to one S. cerevisiae repetitive unit. This fragment was inserted 
into the plasmid pBC102 cut with BamHI and PflMI. D—In order to generate a plasmid 
bearing S. cerevisiae modules I and III flanking module II of S. bayanus, the fragment 
encompassing module I of S. cerevisiae and module II and III of S. bayanus was PCR-
amplified from the S. cerevisiae / S. bayanus chimeric construct generated as described 
above with primers SUP35-PAR-F and SP-S12N-R (Table 3), containing BamHI and 
PflMI sites, cut with BamHI and PflMI and inserted into plasmid pBC102 at the same 
sites with the BamHI site upstream of the SUP35 ORF and cut with the same enzymes. 
E—In order to generate a plasmid bearing S. bayanus modules I and III flanking module 
II of S. cerevisiae, the fragment encompassing module I and II was cut from plasmid 
PBC107 with BamHI and PflMI and inserted into plasmid pBC104 at the same sites with 
the BamHI site upstream of the SUP35 ORF and cut with the same enzymes. F—In order 
to generate a plasmid bearing S. cerevisiae module I and III in conjunction with modules 
II of S. bayanus with an extra repetitive unit of S. cerevisiae added to the Ors region, the 
fragment encompassing module I of S. cerevisiae and module II of S. bayanus with the 
extra repetitive unit was cut from plasmid pBC111 with BamHI and PflMI and inserted 
into plasmid pKB100 at the same sites with the BamHI site upstream of the SUP35 ORF 



































Figure 36: Construction of the SUP35 genes with chimeric SUP35N domains. For 
designations of the SUP35 domain and modules, see Figure 35 legend. A—Plasmid 
pBC109 (Table 2) was PCR-amplified using primers SP-S12N-F#2 and NSC-R-BglII-
SacI (Table 3). The former primer introduces a G to A substitution at nucleotide position 
35, changing coding capacity of codon 12 from serine (S) to asparagine (N). Resulting 
fragment was digested by BamHI and SacI, inserted into plasmid pBluescript KSII (+) 




BamHI and BglII, fused to the SUP35MC region of S. cerevisiae by inserting into 
pmCUP1MCSC (Table 2) cut with BamHI, and the BamHI-SacI fragment encompassing 
full-size gene of chimeric SUP35 bearing the S12N was inserted into plasmid pBC104 
(Table 2) bearing PSUP35 promoter cut with BamHI and SacI. A similar strategy was 
used for construction of pKB101 (Table 2). B—Plasmid pBC102 ( Table 2) was PCR-
amplified using primers NSC-MCSC(N12S) and NSC-R-BglII-SacI (Table 3). The 
former primer introduces an A to G substitution at nucleotide position 35, changing 
coding capacity of codon 12 from asparagine (N) to serine (S). Resulting fragment was 
digested with BamHI and SacI, inserted into plasmid pBluescript KSII (+) from 
Stratagene (cut with the same enzymes), verified by sequencing, digested with BamHI 
and BglII, fused to the SUP35MC region of S. cerevisiae by inserting into 
pmCUP1MCSC (Table SI) cut with BamHI, and the BamHI-SacI fragment encompassing 
the full-size gene of SUP35 of S. cerevisiae bearing the N12S was inserted into plasmid 





































Figure 37: Construction of the SUP35 derivatives with a mutation at position 19/50.  
For designations of the SUP35N domains and modules, see Fig. S8 legend. A—Plasmid 
pBC110 (Table SI) was PCR-amplified using primers NSB(P50Y)-F and SUP35REV-
517 (Table SII). The former primer also introduces a CC to TA substitution at nucleotide 
position 148 and 149, changing coding capacity of codon 50 from proline to tyrosine. 
Resulting fragment was digested with HindIII, inserted into plasmid pBluescript KSII (+) 
from Stratagene (cut with the same enzyme), verified by sequencing, digested with 
HindIII,  inserted into plasmid pBC110 (Table SI) cut with HindIII and verified 
orientation of the insert. A similar strategy was performed to construct the plasmids 
pGN101 and pGN103 (Table SI). B—Plasmid pBC102 (Table SI) was PCR-amplified 
using primers NSC(Y49P)-F and SUP35REV-517 (Table SII). The former primer also 
introduces a TA to CC substitution at nucleotide position 145 and 146, changing coding 
capacity of codon 49 from tyrosine to proline. Resulting fragment was digested with 
HindIII, inserted into plasmid pBluescript KSII (+) from Stratagene (cut with the same 
enzyme), verified by sequencing, digested with HindIII, inserted into plasmid pBC102 







Figure 38: Levels of the Sup35 protein produced by the chimeric or mutant 
constructs. Proteins were isolated from the derivatives of the strain GT256-23C 
(see materials and methods) bearing URA3 plasmids with either chimeric or 
mutant SUP35 PrDs fused to the MC regions of S. cerevisiae and expressed from 
the PSUP35 promoter. Protein isolation and western analysis were as described in 
Chapter 2. A—and B—refer to two different gels, each containing the Sc control 


































Table 12: Stability of strong [PSI
+
] transfected to S. paradoxus from GT256-23C. 
 
Colony # 
Stability of Transfected strong [PSI
+
] 
In S. paradoxus 
# Light  
pink 
# Medium  
pink 
# red Total number % [PSI
+
] 
A 299 0 3 302 99% 
B 338 0 1 339 100% 
C 415 0 0 415 100% 
D 349 0 0 349 100% 
E 220 0 1 221 100% 
 [PSI
+
] from S. cerevisiae strain GT256-23C was transfected into S. paradoxus to 
produce the strong [PSI
+
] strain used for direct and reverse transmission 
experiments and interference studies. [PSI
+
] colonies were streaked out on YPD 

































PrD shuffled in 






], Confidence limits Total number 
Sc-Sc-Sc 75  97% (93.3-100.0) 77 
Sp-Sc-Sc 64 94% (88.3-99.7) 68 
Sc-Sp-Sp 52 100% (97.3-100.0) 52 
Sp-Sp-Sp 26 84% (71.1-96.9) 31 
Sb-Sb-Sb 0 0% (0.0-3.2) 61 
Sc-Sb-Sb 3 4% (0-8.5) 74 
Sc-Sb-Sc 2 4% (0-9.3) 51 
Sb-Sc-Sc 46 85% (75.4-94.6) 54 
Sc-Sc-Sb 22 100% (95.9-100.0) 22 
Sp-Sb-Sb 9 12% (4.8-19.3) 77 
Sb-Sp-Sp 11 31% (15.9-46.1) 36 
A direct shuffle procedure was performed beginning with a strong [PSI
+
] variant 



































PrD shuffled from 





], Confidence limits 
% 
Total number 
Sc-Sc-Sc 21 100% (95.7-100.0) 21 
Sc-Sb-Sb* 7 41% (17.6-64.4) 17 
Sb-Sc-Sc 14  88% (72.1-100.0) 16 
Sc-Sc-Sb 7 100% (86.3-100.0) 7 
Sp-Sp-Sp* 6 38%(14.2-61.8) 16 
Sp-Sc-Sc 7 70% (41.6-98.4) 10 
Sc-Sp-Sp 8 89% (68.6-100.0) 9 
Sb-Sp-Sp 7 47% (21.7-72.3) 15 
 [PSI
+
] isolates obtained by direct shuffle (see Table 135.1) were used in the 
reverse shuffle to Sup35Sc in the S. paradoxus sup35Δ::natNT2 strain. Several 
independent isolates were analyzed per each construction in some cases, as 
indicated. Total numbers tested are shown. *Reverse transmission was checked 
for three different isolates from Sc-Sb-Sb and for two different isolated from Sp-






























Table 15: Efficiency of cross-species transmission from S. cerevisiae to S. paradoxus. 
Sup35 version  
in S. paradoxus  
Transfection from S. cerevisiae to S. paradoxus  
Lysate  





],  Confidence 
limits 





5 19% (3.9-34.1) 26 
Sup35Sp 0 0% (0-5.2) 37 





3 7% (0-14.6) 43 
Sup35Sp 0 0%  (0-4.6) 42 
Sup35Sb 0 0% (0-7.7) 25 
Cell lysate from either a S. cerevisiae strong or weak [PSI
+
] variant was 
transfected into a [psi
-
] sup35Δ::natNT2 S. paradoxus strain. The S. paradoxus 
strain produced Sup35 (originating from either S. cerevisiae, S. paradoxus, or S. 
bayanus) on a centromeric plasmid. Following transfection, cells were plated on –
Ura media to select for colonies likely receiving the protein (Colonies 
successfully transformed by the control plasmid had a greater likelihood of also 
receiving the transfected protein.) Ura
+
 colonies were checked for the presence of 
[PSI
+
], and the numbers and percentage of [PSI
+
] colonies are recorded. The 















































Empty vector 4 0.0% 110 
Sc-Sc-Sc 2 0.1% 25 
Sp-Sc-Sc 41 27.6% 42 
Sc-Sp-Sp 11 1.3% 37 
Sp-Sp-Sp 60 53.3% 60 
Sb-Sb-Sb 11 1.2% 44 
Sc-Sb-Sb 30 19.1 34 
Sc-Sb-Sc 50 21.4% 51 
Sb-Sc-Sc 48 23.7% 50 
Sc-Sc-Sb 0 0.0% 23 
Sp-Sb-Sb 20 0.4% 24 
Sc(N12S)-Sc-Sc 13 0.2% 42 
Sc(N12S)-Sp-Sp 37 59.3% 37 
Sp(S12N)-Sc-Sc 2 0.0% 22 
Sp(S12N)-Sp-Sp 3 0.1% 23 
Sp complete 28 62.2% 28 
Sb complete 0 0.0% 48 
 “Sc,” “Sp” and “Sb” denote S. cerevisiae, S. paradoxus, and S. bayanus, respectively. 
Rates of interference by a heterologous Sup35 PrD or complete Sup35 version are 
recorded as percentages. Not all colonies exhibited [PSI
+
] loss; however, numbers of 
colonies showing some degree of [psi
-
] colonies are recorded together with the total 




































% interference (% [psi
-
]) Total number 
Empty vector 0 0.0% 18 
Sc-Sc-Sc 0 0.0% 16 
Sp-Sp-Sp 0 0.0% 24 
Sb-Sb-Sb 0 0.0% 4 
 “Sc,” “Sp” and “Sb” denote S. cerevisiae, S. paradoxus, and S. bayanus, 
respectively. Rates of interference by a second homologous or  heterologous 
Sup35 PrD are recorded as percentages. “Total number” refers to the number of 
independently transformed isolates tested for interference. For those tested, No 
colonies exhibited [PSI
+




































Table 18. HSP104 copy number and length of heterologous protein co-
existence on prion interference in S. paradoxus. 
























Sc 6 2.7% 8 
Sp 8 90.8% 8 
Sb 7 3.8% 7 
2 copies 
Sc 8 1.6% 8 
Sp 8 97.0% 8 
Sb 8 21.0% 8 




Sc 4 1.3% 6 
Sp 5 5.7% 6 
Sb 6 2.1% 6 
2 copies 
Sc 4 0.8% 6 
Sp 6 24.5% 6 
Sb 1 0.2% 6 
 “Sc,” “Sp” and “Sb” denote S. cerevisiae, S. paradoxus, and S. bayanus, respectively. 
Rates of interference by a second homologous or heterologous Sup35 PrD are recorded as 
percentages. “Total number” refers to the number of independently transformed isolates 
tested for interference. Mating interference experiments were performed as shown on Fig. 

























Table 19: Phenotypical differences for short-term heterologous Sup35 co-





Phenotype for interference (short co-expression) in S. paradoxus from 
mating interference protocol  









1 0 99 0 99 




2 0 136 1 137 
3 0 72 0 72 
4 0 133 2 135 
5 0 130 1 131 
6 0 70 1 71 
1 copy 
Hsp104 






2 47 71 1 119 
3 27 72 4 103 
4 6 84 1 91 
5 25 11 1 37 
6 46 53 0 99 





1 0 71 33 104 




2 0 69 47 116 
3 0 76 8 84 
4 0 91 17 108 
5 0 84 18 102 
6 0 56 22 78 
1 copy 
Hsp104 






2 25 74 3 102 
3 36 82 4 122 
4 13 91 0 104 
5 31 60 6 97 
6 20 33 14 67 





1 0 40 0 40 




2 1 96 0 97 
3 0 82 0 82 
4 0 73 0 73 
5 0 148 0 148 
6 0 165 1 166 
1 copy 
Hsp104 






2 17 59 4 80 
3 39 46 2 87 




5 46 78 3 127 




 “Sc,” “Sp” and “Sb” denote S. cerevisiae, S. paradoxus, and S. bayanus, 
respectively. “PrD” refers to prion domain. A mating interference experiment was 
performed to look for evidence of interference caused by a heterologous PrD. 
Following a short period (1.5 days) of homologous (negative control) or 














































Table 21 Results of Direct Transmission for the S. paradoxus strain having [PSI
+
] 
induced de novo with the S. cerevisiae inducee and the S. cerevisiae inducer.  
 
PrD shuffled in 








Sc-Sc-Sc 22 (100%) (2.1) 22 
Sp-Sc-Sc 22 (100%) (2.1) 22 
Sc-Sp-Sp 29 (100%) (1.8) 29 
Sp-Sp-Sp 11 (55%) (11.1) 20 
Sb-Sb-Sb 0 (0%) (1.8) 29 
Sc-Sb-Sb 4 (14%) (6.6) 28 
Sc-Sb-Sc 2 (7%) (4.7) 30 
Sb-Sc-Sc 12 (57%) (10.8) 21 
Sc-Sc-Sb 23 (100%) (2.1) 23 
Sp-Sb-Sb 6 (21%) (7.6) 29 







































Table 22.  Results of Direct Shuffle for the S. paradoxus [PSI
+
] strain having the 
Sc/Sp (inducee/inducer)  
 
 
PrD shuffled in 








Sc-Sc-Sc 8 (80%) (12.6) 10 
Sp-Sp-Sp 8 (40%) (11.0) 20 








































Table 23:  Results of Direct Shuffle for the S. paradoxus [PSI
+
] strain having the 
Sc/Sb (inducee/inducer) 
 
PrD shuffled in 








Sc-Sc-Sc 20 (80%) (8.0) 25 
Sp-Sp-Sp 29 (94%) (4.3) 31 








































 Table 24:  Results of Direct Shuffle for the S. paradoxus [PSI
+
] strain #119 having 
the Sp/Sc (inducee/inducer)  
 
 
PrD shuffled in 








Sc-Sc-Sc 21 (91%) (6.0) 23 
Sp-Sp-Sp 35 (97%) (2.8) 36 







































 Table 25:  Results of Direct Shuffle for the S. paradoxus [PSI
+
] strain #152 having 
the Sp/Sp (inducee/inducer)  
 
PrD shuffled in 








Sc-Sc-Sc 21 (88%) (6.6) 24 
Sp-Sp-Sp 21 (100%) (2.2) 21 
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